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Abstract 
 
Each month, endometrial stromal cells proliferate and differentiate into specialized 
decidual cells, in a process named decidualization, to allow the establishment of an 
eventual pregnancy. Uterine regeneration is cyclically imposed by menstruation, 
miscarriage and parturition. Impaired decidualization may result in pregnancy loss, 
miscarriage and infertility. 
Over the last years, the endocannabinoids have emerged as important mediators in 
reproduction. In addition, they control biological events such as cell proliferation, 
differentiation and death, and a deregulation of the eCB signalling has been associated 
with several pathological processes. The endocannabinoid system (ECS) comprises two 
G-protein-coupled cannabinoid receptors (CB1 and CB2), their endogenous ligands, the 
endocannabinoids (eCBs), the membrane transporter and the enzymes responsible for 
the synthesis and degradation of these compounds.  
We have previously demonstrated that the levels of anandamide (AEA), the main 
eCB, must be tightly regulated in rat decidual tissue and that high levels of this eCB 
induce apoptosis on rat decidual cells, limiting stromal cell differentiation. 
Cyclooxygenase-2 (COX-2) is a crucial enzyme for implantation and decidualization. In 
addition, the oxidative metabolism of AEA, mainly controlled by COX-2, is emerging as a 
new source of bioactive molecules, the prostamides (PMs). Therefore, in this work, we 
aimed to explore, on primary cultures of rat decidual cells, not only the role of COX-2 
oxidative metabolism on AEA-induced apoptosis but also the underlying molecular 
mechanisms. It was verified that AEA pro-apoptotic effects were mediated by COX-2 
oxidative metabolism, and this enzyme was also highlighted as a key metabolic controller 
of AEA levels during decidual remodelling. Moreover, it was demonstrated that 
prostamides may be considered novel lipid mediators in the control of cell fate. Hence, we 
hypothesized that a disruption on eCB signalling, may favor the production of COX-2-
mediated metabolites of AEA and overwhelm decidual stability.   
Decidualization is orchestrated by a complex network of growth factors, cytokines, 
interleukins, hormones and other molecules, in which lipids as eCBs and COX-2-derived 
prostaglandins (PGs) may play a central role. However, the molecular mechanisms that 
underpin this process in human reproduction are still not identified. In this way, the other 
aim of this project was to explore the role of AEA on cell proliferation, differentiation and 
apoptosis, in a human endometrial cell line and in human decidual fibroblats derived from 
term placenta. The biochemical machinery of the ECS was characterized and it was 
further disclosed that AEA inhibited endometrial stromal cell proliferation and the 
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differentiation process. The anti-proliferative effect of AEA was observed in both non-
differentiated and differentiated cells and was associated with appearance of polyploidy. 
This event was independent of cannabinoid receptor 1 (CB1) activation and appeared to 
be related to a direct interference of AEA on the process of cytoplasmic division.  
As endocannabinoids, PGs may be used as biomarkers of uterine receptivity and 
embryo implantation. Nevertheless, this knowledge has not yet been clinically translated 
mostly because of the difficulties to quantify PGs in vivo. In order to overcome this hurdle, 
it was developed and validated a sensitive ultra-performance liquid chromatography-mass 
spectrometry (UPLC-MS/MS) based method to quantify both PGE2 and PGF2α in cell 
culture medium. Using the developed methodology, it was demonstrated for the first time, 
the intimate dialogue between eCBs and PGs, two pivotal lipid molecules during 
endometrial stromal-derived cells differentiation in vitro. In addition, AEA was proposed as 
a novel mediator of the decidualization process through down-regulation of COX-2 
expression and inhibition of PGE2 release. These effects were dependent on CB1 
activation. Interestingly, it was also found an inverse correlation between AEA and PGE2 
levels that may be essential for the onset of stromal cell differentiation. Altogether these 
findings further highlight endocannabinoids and prostaglandins as potential biomarkers of 
women (in)fertility.  
 It has been postulated that a tight regulation of AEA differentially controls cell fate, 
depending on the development stage of endometrium, environmental context and cell 
type. In this regard, other aim of this work was to study the impact of a deregulation of 
AEA signalling in human endometrial stromal cells. It was observed, for the first time, the 
occurrence of apoptosis in non-differentiated cells associated with the oxidative 
metabolism of AEA by COX-2. This finding highlights the importance of a balance AEA 
tone for the endometrial cell proliferation a crucial process for stromal cell differentiation.  
In conclusion, this work greatly contributed to the understanding of the molecular 
basis governing endometrial turnover and differentiation. Alterations on AEA signalling 
and/or on the cross-talk between AEA and PGE2 during human decidualization may impair 
basic cellular process involved in endometrial remodelling, which may ultimately account 
for aberrant decidual response, pregnancy loss, miscarriage and infertility. 
 
Keywords: endocannabinoid system, anandamide, endometrium, decidualization, 
apoptosis 
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Resumo 
 
Todos os meses, as células do estroma uterino proliferam e diferenciam-se em 
células deciduais, um processo designado de decidualização, que tem como objectivo 
preparar o útero para uma eventual gravidez. A regeneração do endométrio ocorre após 
a menstruação, aborto ou parto. Um comprometimento do processo de decidualização 
pode estar relacionado com aborto espontâneo, infertilidade e distúrbios da gravidez.  
Nos últimos anos, os endocanabinóides surgiram como importantes mediadores na 
reprodução. Estes controlam eventos biológicos, tais como a proliferação celular, 
diferenciação e apoptose. A desregulação das suas vias de sinalização tem sido 
associada a vários processos patológicos. O sistema endocanabinóide (ECS) é composto 
por dois recetores acoplados à proteína-G (CB1 e CB2), os seus ligandos endógenos, os 
endocanabinóides (eCBs), um transportador membranar e enzimas responsáveis pela 
síntese e degradação destes compostos. 
No nosso laboratório, foi demonstrado que os níveis do principal endocanabinóide, a 
anandamida (AEA), são altamente regulados no tecido decidual do rato, e que, em 
culturas primárias de células deciduais de rato, a AEA induz morte celular por apoptose, 
limitando assim o processo da diferenciação das células do estroma. A ciclo-oxigenase-2 
(COX-2) é uma enzima essencial para a implantação e a decidualização. Além disso, o 
metabolismo oxidativo da AEA, controlada pela COX-2 é considerado uma fonte de 
moléculas bioactivas, as prostamides (PMs). Neste estudo foi explorado em células 
deciduais de rato, não só o papel do metabolismo oxidativo da COX-2 na apoptose 
induzida pela AEA mas também os mecanismos moleculares subjacentes. Verificou-se 
que o metabolismo oxidativo da AEA estava envolvido nos efeitos pro-apoptóticos 
observado, e assim, as prostamidas podem ser consideradas novos mediadores do 
destino das células deciduais. Por outro lado, a COX-2 poderá desempenhar um papel 
chave na regulação dos níveis de AEA durante a remodelação decidual. Assim, uma 
desregulação na sinalização do ECS pode favorecer a produção de metabolitos 
oxidativos da AEA e, deste modo, interferir na estabilidade do tecido decidual.   
O processo de decidualização é controlado por uma rede complexa de fatores de 
crescimento, citocinas, interleucinas, hormonas e outras moléculas, como os lípidos, 
nomeadamente os eCBs e as prostaglandinas (PGs), que parecem desempenhar um 
papel central neste processo. Contudo, os mecanismos celulares subjacentes ainda não 
estão totalmente identificados. Neste sentido, outro objectivo deste projeto foi estudar o 
envolvimento da AEA na proliferação, diferenciação e morte numa linha celular de células 
do endométrio e em culturas primárias de células deciduais fibroblásticas derivadas de 
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placentas de termo. Assim, o ECS foi caracterizado e foi identificado o papel da AEA, 
como inibidor da proliferação celular e do processo de diferenciação. O efeito anti-
proliferativo da AEA foi observado nas células não diferenciadas e em células 
diferenciadas e foi associado ao aparecimento de poliploidia. Estes eventos celulares 
foram independentes da acção do CB1, mas parecem estar relacionados com um efeito 
direto da AEA no processo de divisão citoplasmático. Pelo contrário, e efeito inibitório da 
AEA no processo de diferenciação foi dependente da activação do CB1. 
Tal como os eCBs, as PGs podem ser utilizadas como biomarcadores da 
recetividade uterina e implantação. No entanto, devido às dificuldades de quantificação 
das PGs in vivo ainda não foi possível a sua aplicação na clínica. Para superar este 
obstáculo, foi desenvolvido e validado um método de espectometria de massa de alta 
resolução para quantificar a PGE2 e a PGF2α em meio de cultura celulares. Recorrendo a 
esta metodologia o cross-talk entre os eCBs e as PGs durante o processo de 
diferenciação in vitro foi investigado. Além disso, a AEA foi proposta como um mediador 
do processo de decidualização, através da inibição da expressão da COX-2 e da 
produção de PGE2. Estes efeitos foram mediados pelo recetor CB1. Curiosamente, 
também se verificou-se uma correlação inversa entre os níveis de AEA e PGE2, a qual 
poderá ser um factor importante neste processo. No seu conjunto, estes resultados 
sublinham ainda que os eCBs e as PGs podem ser utilizados como potenciais 
biomarcadores da (in)fertilidade.   
A anandamida controla o destino celular de uma forma específica tendo em conta o 
estadio de desenvolvimento do endométrio, o contexto ambiental e o tipo celular. Desta 
forma, o impacto da desregulação das vias de sinalização da AEA nas células 
endometriais do estroma uterino foi estudado. Pela primeira vez, observou-se que a 
ocorrência de apoptose em células não diferenciadas estava associada ao metabolismo 
oxidativo da AEA pela COX-2. Este fato enfatiza a importância dos níveis altamente 
regulados da AEA na proliferação das células do endométrio um processo crucial para a 
diferenciação. 
Em conclusão, este trabalho contribuiu para a compreensão da base molecular que 
regula o turnover celular do endométrio materno e do processo de diferenciação. 
Alterações nas vias de sinalização da AEA e/ou do cross-talk entre a AEA e a PGE2 
durante a decidualização podem prejudicar os processos celulares envolvidos na 
remodelação endometrial que, em última análise, podem interferir com a resposta 
decidual, a gravidez e levar à infertilidade. 
 
Palavras-chave: sistema endocanabinóide, anandamida, endométrio, decidualização, 
apoptose. 
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1. Milestones of (Endo)Cannabinoids history: a lesson to learn from 
Cannabis Sativa 
 
Marijuana from the hemp Cannabis sativa, and its various alter egos, such as bhang 
and hashish are among the most popular illegal drug used worldwide. For millennia, C. 
sativa has been used medically, recreationally, and spiritually throughout the world. The 
earliest anthropological evidence comes from the oldest known Neolithic culture. In many 
ancient cultures (e.g., Chinese, Indian, and Tibetan), it was used to treat an endless 
variety of disorders including gastrointestinal disturbances, malaria, pain, snake bites, 
rheumatism and disorders of the female reproductive system (1).  
It contains at least 400 chemical components of which over 60 are cannabinoids (2). 
The identification of cannabidiol (CBD) in 1963, and shortly after of Δ9-
tetrahydrocannabinol (Δ9-THC; THC) constitute the major breakthroughs in the 
milestones of the (endo)cannabinoids history (3). The cannabinoid THC is the most 
psychoactive component of the plant. Due to its strong hydrophobic nature, it was firstly 
believed to exhibit nonspecific interactions with cell membranes (4). By the mid 1980’s, 
the synthesis of THC enantiomers and the finding that cannabinoid activity was highly 
stereoselective prompted the beginning of the endocannabinoid system (ECS) research, 
an ensemble of the cannabinoid receptors (CB), their endogenous ligands, known as 
endocannabinoids (eCB), the membrane transporter and the enzymes responsible for the 
metabolism of eCBs (5).  
Over the last decades, the recognized role of ECS in a myriad of physiological and 
pathological processes has opened new strategies based on their pharmacological 
properties (6). We currently stand at an interesting crossroads for Cannabis-related drugs, 
however, the addictive and psychomimetic properties considerably hamper the translation 
of the potential medical benefits. Nowadays, the therapeutic areas best associated with 
Cannabis-related medicines include chemotherapy-induced nausea and vomiting, 
nociception, feeding disorders, glaucoma, neurodegeneration/neuroprotection, multiple 
sclerosis, emotional disturbances, such as, anxiety and other psychiatric disorders 
including drug addiction, schizophrenia and epilepsy, as well as asthma and inflammatory 
disorders (7).  
The ECS offers a great opportunity of therapeutic based-drug targets, such as 
agonists or antagonists of CB receptors and regulators of eCBs metabolic enzymes. In 
fact, there are already medicines that activate cannabinoid receptors available in the 
clinic, such as the synthetic analogues of THC, Cesamet® (nabilone), Marinol® 
(dronabinol; Δ9-tetrahydrocannabinol) and Sativex® (Δ9-THC/cannabidiol). The first two, 
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are prescribed to reduce chemotherapy-induced nausea and vomiting. Marinol® can also 
be used to stimulate appetite, while Sativex® was approved for the symptomatic relief of 
neuropathic pain in multiple sclerosis and as an adjuvant analgesic for advanced cancer 
(8). The selective cannabinoid receptor 1 (CB1) antagonist, Rimonabant (Acomplia®), 
was effective for the management of obesity, though the therapeutic doses increased the 
risk of psychiatric adverse effects, such as depression, anxiety and suicide. It was 
withdrawn from the European market in 2009 (9). The neuroprotective role of eCBs and 
their action on neurodegenerative diseases, such as Alzheimer's disease, Parkinson's 
disease, multiple sclerosis and Huntington's disease are also emergent focus of research 
(10). Nevertheless, as it will be discussed later, CB receptors have more than one 
endogenous ligand and, on the other hand, (endo)cannabinoids may activate several 
other receptors with different efficacy and affinity, ranging from ion channels to nuclear 
receptors. Therefore time will tell whether the range of realistic therapeutic areas 
for Cannabis-related medicinal drugs is as broad as the promise. 
 
 
2. The Endocannabinoid System 
2.1  Cannabinoid receptors 
Cannabinoid receptors are members of the superfamily of G protein-coupled 
receptors (GPCRs) localized on the cell membrane with an extracellular binding site 
domain. More than two decades after THC discovery, Allyn Howlett found that 
cannabimimetic drugs induced inhibition of adenyl cyclase (AC) and decreased cyclic 
adenosine monophosphate (cAMP) levels in neuronal cells by a receptor-mediated 
mechanism (11). Subsequently, the first selective binding site for THC, the cannabinoid 
receptor 1 (CB1), was identified in 1988 and cloned from rat brain a year later (12, 13). 
Then, in 1993, the second cannabinoid receptor (CB2)  was cloned from human 
promyelocytic leukaemia HL-60 cells (14). The receptors CB1 and CB2 share only 44% of 
homology, but their binding domains exhibit an identity of 69%, and, thus, most ligands do 
not discriminate between them (14, 15). CB1 receptor has been conserved throughout 
evolution. It has 97-99% amino acid sequence identity across human, rat and mouse 
species (13), whereas the CB2 sequence of rat and human present only 81% of identity 
(16). CB1 receptor is primarily expressed in the central nervous system (CNS), mainly in 
neocortical and hippocampal areas, but also in cerebellum and basal ganglia. This pattern 
of expression correlates with the central effects of THC, i.e. memory impairment, 
catalepsy, analgesia, hypothermia and immobility (17). Besides, it is also expressed in a 
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more widespread fashion in the peripheral system, such as fat, spleen, tonsils, skeletal 
muscle, small intestine, liver and reproductive tissues (18, 19). On the contrary, CB2 
receptor is abundantly expressed in the immune system, however, it was also found in the 
CNS, in a more restricted distribution than CB1 and increased upon certain pathological 
conditions, such as neurodegenerative disorders (14, 19).   
Accumulating evidences have shown that CB1, but not CB2, can be found in the lipid 
rafts, which are membrane microdomains enriched in cholesterol, sphingolipids and 
arachidonic acid that can modulate receptor activity and limit signal transduction (20). In 
fact, it is conceivable that changes in membrane fluidity/rigidity may affect ligand 
recognition and binding properties of CB1 (21). For instance, the reduced membrane 
fluidity resulting from cholesterol enrichment, reduced AEA-binding to CB1 receptor and 
enhanced membrane transporter activity (22). On the other hand, lipid rafts may also 
represent a cellular device of CB1 intracellular trafficking by constitutive endocytosis and 
degradation in lysosomes (23, 24).  
Over the last years, orphan GPCRs have emerged as candidates for putative CB 
receptors. For instance, GPR55 was firstly considered the third CB receptor (CB3) (25). 
Although, besides eCBs, many other lipid-derived ligands are able to activate this 
receptor, which together with low homology with CB receptors, challenge its recognition 
as a cannabinoid receptor (26-28).  
 
 
2.2  Endocannabinoids  
By definition, endocannabinoids (eCBs) are endogenous compounds capable of 
binding to and functionally activate cannabinoid receptors, mimicking the cellular effects of 
THC. Chemically, these compounds are amides, esters or ethers of long-chain 
polyunsaturated fatty acids and are structurally different from THC but share critical 
pharmacophores with it (29). The molecular structure of THC and eCBs are represented 
in Figure 1. 
N-arachidonoylethanolamine (Anandamide; AEA) was the first eCB identified, 
followed by 2-arachidonoylglycerol (2-AG). These are the best characterized members of 
the eCBs family, N-acylethanolamines (NAE) and monoacylglycerols (MAG), respectively 
(30, 31). They are present in the CNS, plasma and peripheral tissues (31, 32). Although 
eCBs share molecular structures and physical properties, their affinity to CB receptors 
varies. Anandamide is a CB1 partial agonist, whereas 2-AG is a CB1/CB2 full agonist.  
Other eCBs were identified during the last years (Fig. 1), including 2-arachidonyl-
glyceryl ether (noladin ether, 2-AGE) (33), O-arachidonoylethanolamine (virodhamine) 
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(34), N-arachidonoyldopamine (NADA) (35), N-arachidonoylglycine (NAGly) (36), and Cis-
9,10-octadecanoamide (oleamide or ODA) (37). Their physiological significance, however, 
is not yet clarified. N-oleoylethanolamine (OEA) and N-palmitoylethanolamine (PEA) are 
considered endocannabinoid-like molecules whose effects may partially be attributed to 
their interference with enzymes involved in the eCB metabolism, but devoid of CB 
receptor activity (38).   
 
Figure 1. Chemical structures of the psychoactive phytocannabinoid THC and of the endogenous 
cannabinoids.  
 
 
2.2.1  N-arachidonoylethanolamine (AEA) 
Anandamide (N-arachidonoylethanolamine, AEA) was the first endogenous 
cannabinoid discovered in 1992 in the porcine brain (39). The name derives from the 
Sanskrit word ananda, which means “bliss, delight” and amide derived from its chemical 
structure. Tissue levels of AEA are very low, apart from the uterus and human brain, and 
are maintained by its metabolic enzymes (40, 41). The main biosynthetic enzyme of AEA 
is N-acylphosphatidylethanolamine (NAPE-PLD) and the fatty acid amide hydrolase 
(FAAH) is the enzyme responsible for its hydrolysis (42). Anandamide is a high affinity 
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partial agonist for CB1 receptor, an unusual feature for an endogenous ligand, while, like 
THC, it exhibits lower affinity for CB2 (43). 
Anandamide is a relevant modulator in several physiological events, not only in the 
CNS, as a retrograde messenger, but also in the peripheral system (44, 45). For instance, 
AEA has antinociceptive effects (46, 47), induces bone proliferation and differentiation 
(48, 49), controls appetite and energy balance (50, 51) and mediates anti-inflammatory 
immune responses (52, 53). In the reproductive biology, it modulates a wide spectrum of 
processes from folliculogenesis, ovulation, implantation, placental development to 
spermatogenesis and sperm function (54-58). Moreover, AEA also regulates basic cellular 
processes, such as cell differentiation (49, 59-62), cell survival and death (63-67), and 
also autophagy (68), with different outcomes depending on the molecular targets activated 
and the cellular context. 
While THC binds exclusively at CB receptors, eCBs exhibit a higher degree of 
“promiscuity” in terms of binding sites. The best established non-cannabinoid receptor for 
AEA is the transient receptor potential vanilloid type-1 (TRPV1) channel (69). This non-
selective cation channel belongs to six-trans-membrane-domain transient receptor 
potential channels. It was first identified as the receptor for the pungent active principle of 
hot chilli peppers, capsaicin, however, it is also activated by plant toxins, noxious 
temperatures, low pH and intracellular redox states (70). TRPV1 mediates some AEA-
induced effects, such as vasodilatation and cell apoptosis (69, 71-73). In addition, AEA is 
also capable to activate the peroxisome proliferator-activated receptor (PPAR) family of 
nuclear receptors, which may modulate AEA immune responses, neuroprotection, feeding 
behaviour and analgesia (74, 75). These receptors are localized intracellularly, in contrast 
to the extracellular domain of CB receptors’ binding site. Moreover, there is growing 
evidence for the presence of non-receptor mediated-effects of AEA, such as the anti-
inflammatory and proapoptotic actions through NF-κB inhibitory activity (76). 
 
 
2.2.2  N-arachidonoylglycerol (2-AG) 
2-Arachidonoylglycerol (2-AG) is the second “major” endogenous cannabinoid. It was 
identified in 1995 by Mechoulam et al. in the canine gut (32). Unlike AEA, 2-AG is a full 
agonist and binds equally to both receptors (77, 78). In addition, 2-AG may also activate 
PPAR-γ, although it does not bind TRPV1 (79). In rodents’ uterus, endogenous 2-AG 
levels are generally about 200-fold higher than AEA (80) and almost 800-fold higher in 
brain (31). Hence, it is considered one of the principal eCBs involved in the protection in 
neurodegenerative processes (81-83), but it is also involved in other physiological 
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processes, including cell survival, differentiation and death (84-87). Moreover, 2-AG 
appears to be the true endogenous ligand for the peripheral CB2, controlling analgesia, 
food intake, immune responses and reproductive events (32, 88-92). 
 
 
2.3  Biochemistry of the endocannabinoid system 
Endocannabinoid levels are finely controlled by its metabolic enzymatic machinery. In 
fact, in pathological processes, eCB signalling might become enhanced or decreased, 
either to restore homeostasis or contribute to its symptoms and progression. By virtue, 
eCBs are present in trace levels in tissues and cells, and their synthesis from cell 
membrane phospholipid precursors is stimulated on demand through diverse metabolic 
pathways (Figure 2). They act as autocrine and paracrine mediators and modulate basic 
biological processes including cell proliferation, differentiation and apoptosis (29).  
 
 
Figure 2. The endocannabinoid system. AEA (blue circles) biosynthesis from membrane precursors is 
catalysed by the enzyme NAT followed by NAPE-PLD. 2-AG (green circles) synthesis occurs from membrane 
precursors through DAGL enzyme. Once synthesized, eCBs are transported in both directions of the plasma 
membranes by simple diffusion or trough the transporter EMT. After cellular uptake they are rapidly degraded. 
AEA is hydrolysed by FAAH into EA and AA or by an alternative oxidative mechanism, by COX-2 into 
prostaglandin-ethanolamides or PMs (orange circles). 2-AG is mainly hydrolysed by the enzyme MAGL into 
glycerol and AA, and by COX-2 into prostaglandin-glycerol ester (pink circles). AA: arachidonic acid; AEA: 
anandamide; DAGL: diacylglycerol lipase; Cyclooxygenase-2: COX-2; EA: ethanolamine; EMT: 
endocannabinoid membrane transporter; FAAH: fatty acid amide hydrolase; MAGL: monoacylglycerol lipase; 
NAT: N-acyltransferase; NAPE-PLD: N-acyl-phosphatidylethanolamines-specific phospholipase D; PMs: 
prostamides; 2-AG: 2-Arachidonoylglycerol.  
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2.3.1  Biosynthesis of Anandamide 
The synthesis of AEA occurs upon a stimulus, such as cell depolarization or 
mobilization of intracellular Ca2+ stores. The classic biosynthetic pathway of AEA is a two-
step process (Figure 3). Firstly, the membrane Ca2+ dependent enzyme N-acyltransferase 
(NAT) synthesizes and releases N-acylphosphatidylethanolamine (NAPE) (93). NAPE is 
formed by the transfer of an arachidonate from sn-1 position of the membrane 1,2-
diacylglycerolphospholipid to the amine group of phosphatidylethanolamine (94). 
Subsequently, AEA is released by NAPE-hydrolyzing-phospholipase-D (NAPE-PLD), a 
highly conserved member of the zinc metallo-lactamase-ß family Ca2+ dependent (95, 96). 
This enzyme uses as substrate, not only NAPE, the main precursor of AEA, but also other 
NAPEs with different N-acyl groups, generating their respective N-acylethanolamines 
(NAEs). Notably, NAPE accumulates in ischemic heart and brain or after toxic insults (97).  
 
Figure 3. Major pathway for AEA synthesis and degradation. AEA synthesis involves the transfer of AA 
from 1-arachidonoyl-PC to PE by NAT, via the intermediate NAPE. The latter is then cleaved by NAPE-PLD 
releasing AEA and PA to the extracellular space. Anandamide is hydrolyzed by the enzyme FAAH into AA and 
EA. At blue and red are represented the principal biosynthetic and degradative pathways, respectively AA: 
arachidonic acid; AEA: anandamide; EA: ethanolamine; FAAH: fatty acid amide hydrolase; lyso-PC: 
lysophosphatidylcholine; NAT: N-acyltransferase; NAPE: N-acylphosphatidylethanolamine; NAPE-PLD: N-
acyl-phosphatidylethanolamine- phospholipase D; PA: phosphatidic acid; PC: phosphatidylcholine; PE: 
phosphatidylethanolamine. 
 10 
 
Nonetheless, the finding of endogenous NAEs in NAPE-PLD knockout mice denoted 
the existence of alternative biosynthetic routes (98). In fact, NAEs may also result from 
NAPE through sequential deacylations, yielding lyso-NAPE and glycerophospho-
ethanolamines. Accordingly, it has been described that phospholipase A2 (sPLA2) 
converts NAPE to 2-lyso-NAPE, which is then metabolized into AEA through a Ca2+-
independent mechanism by lyso-phospholipase D (lyso-PLD) (99). However, the 
restricted brain expression of sPLA2 suggested the involvement of additional enzymes in 
the production of lyso-NAPE (99). One such enzyme is the recently identified αβ-
hydrolase 4 (Abhd4), which catalyses double deacylation of NAPE or directly interacts 
with lyso-NAPE to generate the glycerophospho-acylethanolamine (GP-NAE) (100). The 
latter, is then converted into NAEs by a metal-dependent phosphodiesterase, 
glycerophosphodiesterase 1 (GDE1) (101).  
Another alternative pathway identified in the RAW264.7 mouse cells involve the 
hydrolysis of NAPE by a phospholipase C to yield phosphoanandamide (pAEA), which is 
then dephosphorylated by  a tyrosine phosphatase, PTPN22, to form AEA (102). 
 
 
2.3.2  Biosynthesis of 2-Arachidonoylglycerol 
The metabolic pathway for the synthesis and degradation of 2-AG is displayed on 
Figure 4. In most cases, 2-AG is produced from the hydrolysis of membrane 
phospholipids through a phospholipase C (PLC), producing 1,2-diacylglycerol (DAG). The 
latter, is then converted to 2-AG by a diacylglycerol lipase (DAGL) (88). Regarding the 
enzymatic conversion of DAGs into 2-AG, two DAG lipase isozymes (DAGLα and DAGLß) 
have been cloned and enzymatically characterized (103). Alternatively, 2-AG biosynthesis 
may involve phospholipase A1 (PLA1), yielding lyso-phosphatidylinositol, which is then 
metabolized by lyso-phospholipase C (lyso-PLC). Much alike the enzymes involved in 
AEA biosynthesis, DAG lipases do not appear to be selective.  
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Figure 4. Major pathway for 2-AG synthesis and degradation. Firstly, membrane PI is cleaved by PLC 
yielding 1,2- DAG. The latter is dehydratated by DAGL releasing 2-AG. Following uptake, 2-AG is mainly 
hydrolyzed by MAGL, releasing AA and glycerol. FAAH may also hydrolyze 2-AG. At blue and red are 
represented the principal biosynthetic and degradative pathways, respectively. AA: arachidonic acid; DAG: 
diacylglycerol; DAGL: diacylglycerol lipase; MAGL: monoacylglycerol lipase; PLC: phospholipase C; 2-AG: 2-
arachidonoylglycerol. 
 
 
2.3.3  Cellular uptake and degradation of eCBs 
Termination of eCB signalling occurs in a two-step process involving the transport into 
the intracellular space followed by rapid degradation. The accepted models proposed for 
eCBs uptake and intracellular trafficking will be discussed below and are resumed on 
Figure 5. Mostly, this knowledge relies on studies exploiting AEA, though it appears that 
2-AG may also be transported and accumulated in cells by common mechanisms. 
Nevertheless, this research field is still at the present a matter of controversy. Due to their 
lipophilic nature, eCBs are believed to cross cell membranes by simple diffusion, in favour 
of the concentration gradient, which is essentially determined by the intracellular 
sequestration and hydrolysis (104). Additionally, it has been reported a facilitated diffusion 
mechanism through a specific and substrate selective transporter (105). For long, a still 
currently molecular-uncharacterized transporter, referred to as “endocannabinoid 
membrane transporter” (EMT), temperature sensitive, saturable, bidirectional and energy-
independent has been described (106). Meanwhile, in 2011 Fu et al. found a variant of the 
enzyme FAAH-1 that acts as a specific transporter of AEA in neurons and other cell types. 
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This enzyme, designated FAAH-1–like anandamide transporter (FLAT), lacks amidase 
activity, but appears to facilitate AEA uptake (107). Nevertheless, it has also been recently 
proposed as an intracellular protein transporter with residual catalytic activity (108). 
Moreover, there is also evidence that AEA can be internalized by a caveola-
related endocytic process (109). 
Even less understood is the intracellular trafficking of eCBs (Figure. 5). Recent 
insights on intracellular stores and binding proteins challenged reconsideration on the 
dogma that eCBs are exclusively synthesized on demand. In fact, purported intracellular 
stores, named adipossomes, have been linked to trafficking and accumulation of AEA, 
maintaining a concentration gradient that enables simple diffusion. Moreover, since they 
have been associated with degrading enzymes, they may also be responsible for the 
metabolic control of AEA (110).  
 
 
 
Figure 5. Major pathways for AEA uptake and intracellular trafficking. In the left (dark blue), AEA 
concentration gradient drives simple diffusion across the plasma membrane; in the center (blue), AEA 
reuptake occurs via a caveolae-related endocytic process; in the right (grey), AEA is transported across the 
plasma membrane by a carrier protein, EMT. The intracellular sequestration of eCBs by binding to intracellular 
proteins has also been suggested as a mechanism for eCBs uptake and to maintain the gradient 
concentration of AEA. Hsp70, FABP5 and FABP7 are reported to be AIBP. AEA can be stored in adiposomes 
that can also interact with AIBP. Additionally, FLAT facilitates the internalization and transport of AEA on the 
cell. AEA: anandamide; Anandamide Intracellular Binding Proteins: AIBP; CBR: cannabinoid receptor; EMT: 
endocannabinoid membrane transporter; FAAH: fatty acid amyde hydrolase; FLAT: FAAH-1–like anandamide 
transporter; TRPV1:  transient receptor potential vanilloid-1. Adapted from (42). 
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In addition, several intracellular transporters, Anandamide Intracellular Binding 
Proteins (AIBP) have been identified to facilitate the trafficking of AEA from the plasma 
membrane to different intracellular compartments, including intracellular receptors and/or 
degrading enzymes. Those currently established are fatty acid binding proteins 5 and 7 
(FABP5/7), heat shock protein 70 (Hsp70), albumin, and FLAT (107, 108, 111). In the 
extracellular space, AEA transport may depend on carriers like serum albumin and lipid-
binding proteins, such as lipocalins (112). 
Following membrane uptake, AEA is primarily degraded by the specific fatty acid 
amide hydrolase (FAAH, or FAAH-1), yielding arachidonic acid (AA) and ethanolamine 
(EA) (113). FAAH is an intracellular membrane-bound enzyme member of the amidase 
signature family of enzymes. It is widely distributed throughout the CNS, mostly coincident 
to CB1 receptor localization, but it is also found at the periphery (114). FAAH has an 
alkaline optimal pH and preferentially hydrolyses AEA over other NAEs.  
Contrary to rats, an isozyme of FAAH, FAAH-2 was discovered in humans, mainly in 
heart and ovaries (115). In contrast to the endoplasmic reticulum-localization of FAAH, 
FAAH-2 is expressed in lipid droplets, like adipossomes. The different distribution of the 
two FAAH enzymes might suggest different biological roles and FAAH-2 is also less 
efficacious than FAAH at hydrolysing NAEs (114, 116).  A third NAE-hydrolysing enzyme 
was recently discovered, N-acylethanolamine-hydrolyzing acid amidase (NAAA), which 
appears to be highly expressed in immune cells, especially in macrophages, and localized 
in lysosomes (117). No sequence homology was found between NAAA and FAAH (118).  
FAAH in some cases, may catalyse 2-AG hydrolysis to AA and glycerol (119). 
Nevertheless, monoacylglycerol lipase (MAGLs), present in both membrane and cytosolic 
subcellular fractions, is considered the main route of 2-AG enzymatic hydrolysis (Fig. 4) 
(119). MAGL may also recognize other unsaturated monoacylglycerols as substrates, 
which, in some cases, compete with 2-AG inactivation. Furthermore, unlike AEA, 2-AG 
can be re-esterified into phospholipids before being hydrolysed (88).  
 
 
2.3.4  Oxidative metabolism of endocannabinoids 
The oxidative metabolism represents an alternative route for termination of the eCBs-
signalling. Nevertheless, it is also emerging as a metabolic pathway providing a wide 
range of novel oxidative-derivatives of endocannabinoids with physiological significance. 
As shown in Figure 6, AEA may be subjected to a direct oxidative metabolism by the 
same enzymes that are responsible for arachidonic acid oxidation. These include the 
cyclooxygenase-2 (COX-2), yielding prostaglandin-ethanolamides or prostamides (PMs), 
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the 12- and 15-Lipoxygenase (12-LOX, 15-LOX) which give rise to 12- and 15-
hydroperoxyeicosatetraenoylethanolamide, 12- and 15-HETE-EA, respectively, and 
Cytochrome P-450 is able to oxidize AEA to hydroxyeicosatetraenoic and 
epoxyeicosatrienoic acid ethanolamides (120). 
  
Figure 6. Metabolism of AEA. Oxidative metabolism of AEA by COX-2, the main oxidative pathway, 12- and 
15-LOX and P-450, yielding PMs, HETE-EAs, and hydroxy- and epoxy-AEA, respectively. The hydrolytic 
metabolism by FAAH generates AA and EA. AA can be oxidized by COX-2 to form PGs. AA: arachidonic acid; 
AEA: anandamide; COX-2: cyclooxygenase-2; EA: ethanolamine; FAAH: fatty acid amide hydrolase; HETE-
EAs: hydroxyeicosatetraenoic-ethanolamides; LOX: lipoxygenase; P450: cytochrome P450; PGs: 
Prostaglandins; PMs: prostamides. 
 
As AEA, the other main eCB, 2-AG, was also described as substrate for COX-2, 
lipoxygenase, and cytochrome P-450 metabolism (121, 122). In contrast to AEA, COX-2 
metabolizes 2-AG as efficiently as AA (121). COX-2 oxidative metabolism of 2-AG 
produces an identical repertoire of molecules as AEA, named prostaglandin-glyceryl 
esters (PG-GEs) (120, 121) (Figure 7). This mechanism involves an intermediate, the 
endoperoxide prostaglandin–glycerol ester (PGH2-glycerol ester), which is hydrolysed by 
yet unidentified enzymes to respective PG-GEs. Still little is known regarding the 
metabolic pathways of PG-GEs. Interestingly, it has been described that prostaglandin 
glycerol-ester D2 (PGD2-GE) is preferentially hydrolysed by the α/β-hydrolase enzyme 
ABHD6 (123), which also controls 2-AG activity at CB receptors (124). Moreover, PG-GEs 
were described as substrates for MAGL, the main hydrolytic enzyme of 2-AG (125). 
Different from prostamides, in rat plasma, PG-GEs are rapidly hydrolysed in vivo to the 
corresponding PGs (126, 127). 2-AG derived PG-GEs may play a role in physiological 
events (126, 128-130). For instance, the prostaglandin glycerol-ester E2 (PGE2-GE) 
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induced opposite effects to its precursors on inhibitory synaptic transmission and 
neurodegeneration, via CB1- and prostanoid- receptor-independent mechanisms (131-
133).  
 
Figure 7.  Oxidative metabolism of 2-arachidonoylglycerol by COX-2. 
 
 
2.4  COX metabolism of anandamide and biological activities 
Once inside the cells, AEA is rapidly hydrolysed by FAAH into arachidonic acid and 
ethanolamine. Cyclooxygenase-2 (COX-2) is an inducible enzyme that by using AA as 
substrate gives rise to prostaglandins (PGs). In fact, the latter have been associated with 
AEA-induced apoptotic and antiproliferative effects (134, 135), contraction or relaxation of 
isolated vascular ring preparations (136), changes in arterial pressure in perfused lung 
(137), adipocyte differentiation (138) and inhibition of IL-2 secretion in splenocytes (139).  
On the other hand, the direct oxidative metabolism by COX-2 over AEA also 
constitutes one of the main alternatives routes of degradation, yielding prostamides. 
Although it has been reported by Yu et al. back in 1997 (140), the biological significance 
of PMs as lipid mediators is only currently emerging in the literature. Accordingly, AEA is a 
substrate of COX-2, but not of the constitutive COX-1, leading to the formation of the 
intermediate endoperoxide prostaglandin-ethanolamide (PGH2-EA). The latter is then 
converted in several prostamides, including PME2, as a major product, PMF2α and PMD2, 
by tissue- and cell-specific PG synthases (120, 141, 142) (Fig. 8). With the exception of 
PMF2α synthase, no other synthases for PMs have yet been identified (141, 143). The 
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former is abundantly expressed in male and female reproductive organs and also in the 
CNS (143, 144). Since low nanomolar concentrations of AEA are typically observed in 
vivo (145), it could be advocated that the production of such COX-2-derived metabolites 
was unlikely to occur in vivo, but this is starting to be demystified. Furthermore, it has 
been shown that under physiological conditions, in rat and human plasma and whole 
blood, PMs are highly stable to oxidation and hydrolysis, thus, having a longer half-life 
when compared to PGs and eCBs (142, 146). Regarding their metabolism, PMs are not 
substrates for 15-hydroxyprostaglandin dehydrogenase, the enzyme responsible for the 
initial step of PG inactivation (127) nor for FAAH (147-149), although, some reports 
described tissue-specific hydrolysis to the corresponding PGs (150, 151). 
 
Figure 8. Oxidative metabolism of anandamide by COX-2. 
 
Prostamides are not able to activate CB receptors (152) nor TRPV1 or PPAR (149), 
and exhibit no meaningful activity at PG receptors (147, 149, 150). Instead, several 
evidences point to a potential interaction with novel and yet-to-be characterized molecular 
targets (149). Hence, PMF2α, the most studied prostamide, appears to interact with a 
specific subset of receptors (152, 153). Also, they do not inhibit FAAH or MAGL by a 
feedback mechanism (148). The pharmacological properties of PMs are beginning to be 
disclosed, including in ocular hypotension and smooth muscle contraction (154-156). The 
first evidence of their biological effect came from the therapeutic efficacy of the PMF2α 
analog, bimatoprost, used in the treatment of glaucoma (150, 157, 158). Moreover, the 
contractile activity of PMF2α was described in rabbit uterus, feline iris and feline lung 
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parenchyma (149, 159, 160). In addition, the involvement of PMs in inflammatory 
conditions has been referred. In a rat-model of inflammatory pain, spinal PMF2α levels 
were increased and shown to exert pro-inflammatory effects (161). PME2, like AEA, was 
identified as an anti-inflammatory molecule in activated microglia cells, suppressing IL-
12p40 expression (162). In addition, PME2 reduced lipopolysaccharide (LPS)-induced 
tumor necrosis factor-α (TNF-α) production in human blood, monocytes and the THP-1 
monocytic cell line (163). In a human explant colitis model, the AEA-induced anti-
inflammatory effect was mediated by PME2 and PMF2α (164). Interestingly, in contrast to 
AEA-stimulatory adipogenic effect through CB1 and PPAR, PMF2α is an antiadipogenic 
mediator (165, 166). The role of PMs in apoptosis has also been addressed. In fact, PMD2 
together with PME2 mediated AEA-induced apoptosis in colorectal carcinoma cells, 
whereas, curiously, PGE2 was shown to stimulate cell proliferation (151). Recently, a 
novel ethanolamide-conjugated J-series prostaglandin, (15d-PMJ2) was found to mediate 
selectively AEA-endoplasmic reticulum stress cell death in non-melanoma skin cancer 
that overexpresses COX-2 (167, 168).  
Following the discovery that the anti-anti-inflammatory molecules like (R)-profens 
selectively inhibit eCB oxygenation over AA (169), a key role of COX-2 as a crucial 
regulator of the eCB tone has been established and the therapeutic exploitation of this 
metabolic route explored. In fact, (R)-flurbiprofen reduces neuropathic pain by restoring 
the endogenous eCB balance following neuronal injury (170). In this way, selective COX-2 
inhibition has been proposed as novel therapeutic strategies for neuropathic pain, 
neuropsychiatric and anxiety disorders (171, 172).  
In summary, COX-2 oxidative metabolism is more than a pathway to terminate eCB 
signalling and PMs are emerging as a novel class of eicosanoids with separate receptors 
and unique transduction pathways. On the other hand, as eCBs synthesis is activated 
following certain conditions, which often concur with COX-2 up-regulation, it is likely that 
eCB-derivatives may not only mediate or extend AEA-effects, but also exert their own 
activities. Moreover, PMs have been identified in much higher levels in several tissues 
from FAAH knockout mice (173), which are often characterized by elevated AEA  levels.  
 
 
2.5  Endocannabinoid signalling  
Cannabinoid receptors are crucial to the transduction of extracellular stimuli into 
intracellular signals of endocannabinoids. The proposed signalling pathways triggered by 
eCBs through CB receptors are resumed in Figure 9. In contrast to other GPCR proteins, 
CB1 receptor is constitutively present with a high degree of basal activity, even in the 
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absence of exogenous agonists (174). Stimulation of CB1 receptor signal transduction, 
results in adenylyl cyclase (AC) inhibition (175), activation of the mitogen-activated protein 
kinase (MAPK) (176) and focal adhesion kinase (FAK) (177), activation of inwardly 
rectifying potassium (Kir) channels and inhibition of voltage-gated Ca
2+ channels (178). 
Moreover, CB1-inhibition of AC and decreased cyclic adenosine monophosphate (cAMP) 
accumulation consequently prevents protein kinase A (PKA) activation. These effects 
were blocked by pertussis toxin (PTX), suggesting the involvement of G inhibitory (G i/0) 
proteins (179).  
 
Figure 9. Main signal transduction pathways of CB1 activation. Coupled to Gi/0 proteins, CB1 activation by 
AEA (blue circles) leads to a manifold of signal transduction pathways including: inhibition of AC, decrease 
cAMP and PKA activity; activation of MAPK (ERK1/2, JNK, p38), PI3K/Akt and FAK kinases. Also, Ca
2+
 
intracellular levels are increased. The binding of FAN protein to CB1 induces ceramide accumulation by 
sphingomyelin hydrolysis by SMase. De novo synthesis of ceramide is mediated by SPM. When CB1 triggers 
Gs protein, AC is stimulated increasing cAMP levels. AC: Adenylyl Cyclase; AEA: anandamide; ATP: 
Adenosine triphosphate; CB1: cannabinoid receptor 1; ERK1/2: Extracellular signal-regulated kinase 1/2; 
FAN: factor associated with neutral sphingomyelinase activation; FAK: focal adhesion kinase; JNK: Jun N-
Terminal kinases; p38: p38 Mitogen-activated protein kinase; PKA: Protein Kinase A; SM: sphingomyelin; 
SMase: Sphingomyelinase; SPM: serinoylpalmitoyltransferase. 
 
CB1 through Gi/0 stimulation, induces phosphorylation of MAPK kinase, including 
p42/p44 mitogen-activated MAPK also known as extracellular signal-regulated kinase 1/2 
(ERK 1/2), Jun N-terminal kinase (JNK) and p-38, resulting in a manifold of cellular events 
such as cell differentiation, survival and death, cell migration, regulation of cytoskeletal 
status and intracellular trafficking (180-185). Recently, the neuroprotective role of CB1 
receptor has been shown to involve phosphorylation of ERK1/2  and phosphoinositide 3-
kinase/Akt (PI3K/Akt) pathway (186, 187). In fact, it is postulated that CB1 may enhance 
or inhibit PI3K/Akt pathway (188, 189).  The inhibition of voltage-dependent ion channels, 
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primarily L-, N- and P/Q-type Ca2+ channels, and activation of K+ channels is also 
dependent on CB1 activation coupled Gi/0 pathways (190-192). Although it is still 
controversial, CB1 may increase intracellular Ca2+ concentrations through different 
pathways (193, 194). CB2 does not seem to modulate ionic channels, but it is also able to 
increase Ca2+ levels (195).  
Nevertheless, with lower efficacy, CB1 can also directly interact with Gs and Gq/11 
proteins (196-198). Consistent with Gs activation, CB1 can stimulate cAMP production 
(199). The CB1-induced cAMP activation is dependent on the agonist-specific G-protein 
interactions, the isoform of AC expressed in target cells and also the way that each 
isoform responds to Gi/o-mediated regulation. As so, AC-I, III, V, VI and VIII are inhibited 
by CB agonists whereas AC-II, IV and VII are stimulated (200). 
The knowledge that CB1 signal transduction can be synchronized via regulation of 
the second messenger ceramide unveiled a novel eCBs signalling pathway. The adaptor 
protein factor associated with neutral sphingomyelinase activation (FAN), mediates the 
interaction between CB1 and a neutral sphingomyelinase (SMase), which directs the 
hydrolysis of sphingomyelin (SM) leading to the transient production of ceramide. On the 
other hand, CB1 activation also induces a long term ceramide accumulation through 
stimulation of de novo synthesis through the serine palmitoyltransferase (SPM) (201).  
 
 
2.5.1  Endocannabinoid controlling cell fate 
As abovementioned, endocannabinoids differentially modulate cell proliferation, 
survival and differentiation in several (pato)physiological processes (Figure 10).   
In human hepatocellular carcinoma cells, AEA inhibited cell proliferation by cellular 
arrest at the G1-S transition via upregulation of p21, and induced apoptosis trough 
upregulation of BCL2-antagonist/killer 1 (Bak) (202). In human breast and prostate cancer 
cells, AEA-induced cell cycle arrest at G1-S phase and apoptosis through CB receptors 
activation, cAMP/PKA inhibition and activation of ERK1/2 kinases (203-206). In addition, 
the inhibitory effect of eCBs on tumour cells proliferation is usually linked to a diminished 
activation of growth factors receptors, such as the epidermal growth factor receptor, the 
nerve growth factor receptor and the vascular endothelial growth factor receptor (VEGF-
R), and to inhibition of downstream signalling pathways, such as the PI3K/Akt (207, 208). 
In rat C6 glioma cells, inhibition of cell proliferation involved activation of both CB and 
TRPV1 receptors (209), while in neuroblastoma cells it was through a lipid raft-dependent 
mechanism (210). 
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Figure 10. Control of cell fate by AEA. AEA (blue circles) blocks cell cycle progression through several 
pathways and inhibits activation of PI3K/Akt, a survival pathway. Apoptotic cell death induced by AEA may 
also derive from different cellular pathways, including increased production of ceramide and subsequently 
MAPK activation, ROS generation and inhibition of PI3K/Akt. In addition, binding of AEA to CB1 can trigger 
ROS production, activation of MAPK and induce mitochondrial transmembrane potential loss. Alternatively, 
AEA can activate TRPV1 triggering activation of caspases and the COX and LOX pathway as well as ROS 
prodction. On the other hand, PMs (orange circles) derived from oxidative metabolism of AEA may induce 
apoptosis. AEA: anandamide; Ca
2+
: calcium; CB: cannabinoid receptor; COX: Cyclooxygenase; LOX: 
Lipogynease; MAPK: Mitogen-activated protein kinases; PKA: protein kinase A; PMs: prostamides; TRPV1: 
transient receptor potential vanilloid 1. 
 
Anandamide is also able to induce apoptosis in PC-12 pheochromocytoma cells 
(211), CHP100 neuroblastoma cells (29), prostate cells (206) and uterine cervix cancer 
cells (212). In the reproductive biology field, AEA mediates cell death in human 
cytotrophoblast cells and in rat primary decidual cell cultures through a CB-receptor 
dependent mechanism (56, 65, 213). Most of the apoptotic cellular events 
abovementioned involve CB1-mediated phosphorylation of MAPK kinases, which may 
also be associated with oxidative stress, endoplasmic-reticulum stress, loss of 
mitochondrial transmembrane potential (Δψm), increased Ca2+ production and 
cytochrome c release (67, 213-215). However, in PC12 cells, AEA triggered apoptosis 
through direct activation of the apoptosis signal-regulating kinase 1 (ASK1) and p38/JNK 
pathways (216). Nevertheless, eCBs may also activate the death receptor pathway (86, 
217) or both the intrinsic and extrinsic pathways (56, 67). In addition, as abovementioned, 
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activation of both CB receptors may trigger de novo synthesis of ceramide. The latter may 
also regulate apoptosis through activation of MAPK kinases and induced ROS production 
(185, 218-220). Interestingly, while ceramide elicits proapoptotic effects in glioma cells, 
CB1-induced ceramide act as a neuroprotector in astrocytes and neurons. These opposite 
effects were related to the PI3K/Akt pathway, which is inhibited in glioma but upregulated 
in glia by eCBs (221). 
Anandamide-mediated production of cellular reactive oxygen species (ROS) also 
takes part in the apoptotic-signal transduction pathway. In this context, it must be recalled 
that LOX and COX, are redox stress sensors implicated in various death programs via 
production of AEA hydroperoxides. In PC12 cell line, in human coronary artery endothelial 
cells and primary hepatocytes, activation of CB1 by AEA resulted in apoptosis by 
generation of intracellular superoxide anion and altered redox state (211, 222, 223).  
AEA also exhibits the ability to activate the TRPV1 receptor. In human endothelial 
cells, AEA-induced cell death through TRPV1-mediated phosphorylation of p38/JNK 
kinases (224). In neuroblastoma and lymphoma cells, AEA proapoptotic effect by TRPV1 
binding, involved a series of events such as an increase in Ca2+intracellular levels, 
activation of the COX and LOX pathways, release of cytochrome c and activation of 
caspases -9 and -3 (29, 225). On the contrary, in these cells, activation of CB1 promoted 
AEA uptake and subsequent hydrolysis thus preventing cell death. These observations 
suggested that the different localization of AEA-binding receptors, intracellular for TRPV1 
and extracellular for CB receptors, may play a role in discriminating AEA-effects on cell 
fate (225). Furthermore, whereas high concentrations of AEA are  associated with cell 
death in human melanocytes through a TRPV1-mediated pathway, lower AEA 
concentrations stimulate melanin synthesis (226).  
Increasing evidences also point towards the role of lipid rafts in mediating eCB-
induced apoptosis through a CB1-dependent mechanism (217, 227). In human 
neuroglioma cells a stable analogue of AEA induced apoptosis through lipid rafts, 
involving ceramide production, activation of MAPK and increased PGs synthesis (228). 
Furthermore, methyl-β-cyclodextrin (MCD), a membrane cholesterol depletor prevented 
AEA-apoptotic effects on hepatocytes in a mechanism independent of receptors (229). 
Nevertheless, the frame picture is more complex, since it has been shown that eCBs 
are also able to modulate the PI3K/Akt, a pivotal antiapoptotic pathway (29). This finding 
is of particular interest, because it indicates a protective role of CB receptors against 
programmed cell death in human astrocytoma cells (230). However, inhibition of the 
PI3K/Akt pathway has also been reported in AEA-apoptotic role in cancer cells (207).  
Additionally, proliferative properties of cannabinoids have been described in a manner 
dependent on CB2 activation (49, 231, 232).  
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Remarkably, eCBs have also ability to induce other types of cell death (227, 233). In 
fact, in rat primary decidual cell cultures, high AEA concentrations caused a dramatic 
cytotoxic effect in cell viability, which was preserved by depletion of the membrane 
cholesterol (65). On the other hand, cannabinoids have also been associated with 
pancreatic adenocarcinoma cell growth inhibition by a ROS-dependent autophagic cell 
death (234). Autophagy has also been described as a mechanism by which cannabinoids 
promote the activation of mitochondrial pro-apoptotic pathway, through inhibition of 
PI3k/Akt, induction of endoplasmic-reticulum stress and ROS generation, through CB2 in 
glioma cells and independently of CB receptors in breast cancer (235, 236).  
Noteworthy, AEA also affects cell differentiation in glioma and astroglial cells (237, 
238). In this regard, in neuronal cells, AEA inhibits cell differentiation through binding to 
CB1 receptor and attenuation of ERK1/2 kinases (62), and prevents keratinocyte 
differentiation by inducing DNA methylation (59). In reproductive systems, AEA limits rat 
decidual cell differentiation (239), while 2-AG impairs human cytotrophoblasts cells 
syncytialization (240) and eCBs may also be involved in rat leydig cell differentiation 
(241). In rat adipocytes, AEA increased differentiation through PPARγ and up-regulation 
of CB1 (138). The involvement of both AEA and 2-AG in the activity of human osteoblasts 
has also been recently described, in which AEA increased early cell differentiation, while 
2-AG decreased late osteoblast-specific markers of differentiation (49).  
For years, the “unpredictable” fate of eCB transduction cascade, mainly dependent on 
the stimulus and cell-type by modulation of a countless variety of signalling pathways 
motivated the studies on this field, showing that much more remains to be discovered. 
More recently, it has been highlighted that AEA-oxidative metabolites are also associated 
with programmed cell death, particularly in conditions where COX-2 is up-regulated. For 
instance, PME2 and PMD2, were associated with AEA-induced apoptosis in tumorigenic 
keratinocytes (242), in resistant colon cancer cells (151), and in JWF2 tumour cells that 
over-express COX-2 (243). Moreover, in tumorigenic keratinocytes, which overexpress 
COX-2, AEA-apoptosis was shown to be mediated by a novel J-prostamide, PMJ2 
resultant from COX-2 oxidative metabolism (167, 168), while in melanoma cells, it was 
reported that COX-2 and LOX metabolites mediate AEA-proapoptotic effects (244). 
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3. Human endometrium 
 
A new life starts on the union between a sperm and an egg. The fertilized egg 
proliferates and undergoes several mitotic cell divisions eventually forming the blastocyst. 
The latter is comprised of two distinct cell types, the inner cell mass (ICM) that forms the 
embryo and the outer cell mass, called trophectoderm cells (TE), which contributes to the 
formation of trophoblasts and extra-embryonic tissues. Embryonic development depends 
on growth-factors secreted by the uterus, and upon contact with luminal epithelium, 
trophoblasts release chemotactic and invasive migration signals to the uterus. In turn, 
maternal endometrium undergoes an extensive remodelling process to allow implantation. 
Thus, the human endometrial stromal cells (HESCs) proliferate and differentiate into 
specialized decidual cells, a process named decidualization, to prepare a receptive 
endometrium. Notably, only for a short period of time, endometrial receptivity allows 
implantation, designated “window of implantation” (WOI) period (245, 246). In many 
species, decidualization of the stromal compartment is only observed upon blastocyst 
implantation. However, in humans, this process is initiated in the midsecretory phase of 
the menstrual cycle, independent of pregnancy. Besides humans, it occurs in a handful of 
species, including higher primates (apes, and old world monkeys), some bats and the 
elephant shrew. Impaired decidualization underpins a variety of reproductive disorders, 
ranging from implantation failure, recurrent miscarriage, pregnancy disorders and 
infertility. 
The uterine corpus is composed of a modified mucosa known as the endometrium, a 
fibromuscular wall, the myometrium, and a serosal lining. The endometrium is composed 
by single-layered simple columnar epithelium, a thin basal layer (basalis), which bounds 
the myometrium, and a functional layer. In contrast to the basal layer, the latter is highly 
responsive to hormonal ovarian influence. The functional endometrium consists of a 
superficial layer with few glands and abundant stroma, and a deep layer that has many 
glands and relatively less stroma. In each menstrual cycle, the functional layer 
proliferates, secretes and sheds, whereas the basal layer provides the endometrial 
stem/progenitor cells that will regenerate the functional layer.  
The major hormones that control uterine physiology are the ovarian steroids, 
progesterone and estrogens. The proliferative phase of the menstrual cycle is 
orchestrated by estradiol, and aims endometrial regeneration. It is characterised by re-
epithelialization of endometrium, followed by the rapid renewal of the uterine glands and 
stromal compartment and repair of the vascular bed (247, 248). Ovulation marks the start 
of the progesterone driven luteal phase, which is characterized by cessation of 
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endometrial proliferation and the onset of stromal cell transformation (249). Differentiation 
of the stromal compartment represents a tipping point after which the fate of the 
endometrium becomes irreversibly dependent on progesterone signalling. In the absence 
of a conceptus, and on progesterone withdrawal, the functional layer undergoes cell 
death, infiltration of inflammatory cells and sloughs by menstruation (250, 251). In the 
case of pregnancy, persistently elevated progesterone levels ensure the extension of 
decidual reaction to the basal endometrial layer which is critical for trophoblast invasion 
and placenta formation (249). 
 
 
3.1 Decidualization 
The term ‘decidua’ is derived from the Latin ‘decidere’, meaning to die, to fall off or to 
detach. The decidualization process occurs in humans and few other species 
characterized by deep placentation that involves breaching of the luminal epithelium and 
invasion of maternal vascular network and of decidual tissue by fetal trophoblasts. This 
type of placentation, named hemochorial placentation, occurs in both primates and 
rodents, and underpins a close connection between maternal and fetal tissues (252). 
During early pregnancy, maternal uterine spiral arteries (SA) are remodeled to allow the 
transformation of an high resistance relatively hypoxic vascular bed into an increased 
oxygen tension, low resistance and high flow circuit (253). Uterine natural killer cells 
(uNK), the major maternal immune component of the decidua, accumulate around SAs 
before trophoblast invasion. Although not yet clarified, it was suggested that both uNK 
cells and fetal trophoblasts play important roles in vascular remodelling (254). In this 
regard, inadequate invasion by trophoblasts into uterine environment results in a deficient 
blood supply, which eventually leads to fetal prematurity, fetal growth restriction and pre-
eclampsia (255). However, excessive invasion of uterine wall, which occurs in the 
absence or defective establishement of decidua, results in placenta creta (256). 
From an evolutionary perspective the ´spontaneous´ decidualization likely evolved 
from the need of maternal tissue to protect from the onslaught of invasive trophoblasts or 
as a response to the ineficiency of human reproduction (257). Under maternal control, the 
differentiation process occurs cyclically each month, irrespective of pregnancy and no 
longer triggered by an implanting embryo. On the other hand, menstruation enables the 
activation of progenitor/stem cells and cyclic endometrial repair (258).  
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3.1.1  Decidualization: morphological and biochemical perspectives 
Decidualization is characterized by transient local edema, influx of macrophages and 
uNK, angiogenesis and the extraordinary transformation of resident endometrial stromal 
fibroblasts into secretory decidual cells (249).  
Morphologically, the non-differentiated endometrial stromal cells, have a fibroblast-
like appearance with well-developed rough endoplasmic reticulum (ER) and Golgi 
apparatus, little and elongated cytoplasm (259, 260). When exposed to a decidual 
stimulus, these cells transform, both in vivo and in vitro, into larger cells, expanded 
cytoplasm accumulating glycogen and lipid droplets, a prominent nucleus and dilated ER 
and Golgi systems. In the late secretory phase, decidualizing stromal cells (DSCs) show 
pseudopodia-like extensions and possess phagocytic activity. In addition, intense changes 
are observed in the extracellular matrix composition (ECM) that becomes rich in type IV-
collagen, laminin, decorin, fibronectin and heparan sulphate proteoglycans (261). 
This morphological transition of stromal cells is accompanied by secretion of various 
factors, such as prolactin (PRL) and insulin growth factor-binding protein-1 (IGFBP-1) 
(262, 263), the most widely used decidual biomarkers to assess decidualization in vitro. 
The former has been suggested to stimulate trophoblast growth and invasion, promote 
angiogenesis, modulate uNK cell survival, prevent immune rejection and regulate water 
transport across the amnion (264-266). The role of IGFBP-1 is not fully clarified, though it 
has been postulated that it controls trophoblast invasion and regulates stromal cell growth 
and differentiation (247, 267, 268). Another factor released by decidualizing cells, is a 
member of the transforming growth factor-β superfamily, termed LEFTY, that appears to 
play a rate-limiting role in the extension of the decidual process (269, 270). Many other 
molecules have been described to act as paracrine/autocrine factors. These include key 
transcription factors such as forkhead box protein FOX01, the CCAAT/enhancer-binding 
protein (C/EBP1), the Hox genes (HoxA) (271-273), secretory products like, bone 
morphogenetic potein-2 (BMP2) and its downstream activator Wingless 4 (Wnt4) (274). 
The microarray analysis has been used to elucidate the extension and magnitude of 
the molecular mechanisms underlying the decidualization process. On the basis of these 
studies, decidualization has been described as a process of sequential reprogramming of 
functionally related families of genes involved in cell cycle regulation, ECM organization, 
cell adhesion, cytoskeletal organization, angiogenesis, immune modulation of 
implantation, steroid hormone action and metabolism, stress response and apoptosis 
modulation (275, 276).  
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3.1.2  Differentiation pathways and deciduogenic cues 
Initiation of the decidual process requires the increase of cAMP levels to sensitize 
estrogen-primed endometrial stromal cells to progesterone. Despite the importance of 
progesterone in maintaining the decidualized status, through transcriptional regulation of a 
variety of decidual proteins, it is not considered an initiation signal for this process (249, 
277). Cyclic AMP is an ubiquitous second messenger generated upon activation of GPCR 
that leads to sustained activation of the PKA pathway (278). Upon binding of two cAMP 
molecules to each PKA regulatory subunit, the latter undergo a conformational change, 
which eventually results in the activation of several transcription factors (249). Several 
molecules that act through GPCR, particularly the Gs subunit, such as the luteinizing 
hormone/human chorionic gonadotrophin (LH/hCG), corticotrophin releasing hormone 
(CRH), relaxin (RLN), and PGE2 are also involved in the onset of decidualization process 
by increasing cAMP levels (279-281). Once the decidual process is initiated, the DSCs, 
the epithelial cells, the local immune cells and the endometrial vasculature secrete a 
number of factors like cytokines, interleukins and growth factors, such as IL-11  and the 
leukemia inhibitory factor (LIF), members of the TGFβ superfamily including activins, 
inhibins, and follistatin and the transmembrane heparin-binding epidermal growth factor 
(HB-EGF) that are involved in the propagation of the differentiation signal (282-287).  
In rodents, it is well established that cellular proliferation, differentiation, 
polyploidization and apoptosis occur in a spatiotemporal manner during the reproductive 
cycle and pregnancy. Decidual cell polyploidy is often characterized by the development 
of multinucleated giant cells, whose physiological significance is still unclear (288). It is 
speculated that polyploidy limits the life span of decidual cells to allow the growth of the 
implanting embryo (289). Hence, polyploid decidual cells are thought to be terminally 
differentiated cells that develop via an endoreplication cycle, involving cell mitoses without 
subsequent cytoplasmatic division, the cytokinesis (289, 290). Although several cell cycle 
regulators are involved in uterine decidualization, such as cyclins, cyclin-dependent 
kinases and their inhibitors, in rodents, cyclin D3 is the most studied. For instance, cyclin 
D3 has been identified as a downstream controller of several decidual regulators, such as 
the death-effector domain-containing protein (DEDD) and the homeobox A10 (Hoxa-10) 
(291-293). In humans, decidualization of HESCs was associated initially with cell cycle 
arrest at G0/G1 phase and G2/M phase at later stages (294) and, although, the presence of 
bi-nucleated cells has been reported several years ago, their significance has never been 
addressed (295). 
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3.1.3  Functions of decidua 
It is established that cyclic endometrial decidualization and menstrual shedding are 
an example of physiological preconditioning that prepares uterine tissue for the dramatic 
vascular remodelling, reactive oxygen species production and inflammation associated 
with deep placentation (296). The functions of decidua are summarized on Figure 11. 
Decidualizing stromal cells transit from an initial acute pro-inflammatory response to 
an anti-inflammatory highly secretory response. The inflammatory phenotype renders an 
endometrium transiently receptive to implantation. While the mature secretory phenotype 
enables the endometrium the capacity to sensor embryo quality and to mount a tailored 
response to individual embryos in a manner that either supports further development or 
facilitates early rejection (297). Notably, it has been suggested that DSCs are able to 
recognize and eliminate developmental impaired embryos through a process similar to 
menstruation (298-300). This paradox of DSCs represents another hallmark of human 
decidualization, since they are programmed to resist a variety of environmental stressors 
in early pregnancy and to trigger tissue destruction in the absence of implantation or in 
response to a compromised embryo. On the other hand, although impaired 
decidualization does not prevent implantation, it predisposes to subsequent pregnancy 
failure by disabling natural embryo selection (298).  
Once the luminal epithelium is breached, DSCs surround and encapsulate the 
invading conceptus. Hence, recent evidences demonstrate that decidualized endometrial 
cells produce a repertoire of matrix metalloproteinases (MMP) that endow an invasive 
capacity to these cells (301-303).  
Furthermore, decidual tissue not only provides a favorable matrix for trophoblast 
expansion, allowing placental development and growth of the offspring, but also has the 
ability to regulate fetal invasion. DSCs also provide protection to inflammatory and 
oxidative insults, and modulate maternal immune response to fetal alloantigens (257). 
Early pregnancy is characterized by profound vascular remodelling and fluctuations in 
oxygen tension at the maternal-fetal interface. Initially, the fetoplacental interface develops 
in a low-oxygen environment, protecting the embryo against reactive oxygen species 
(ROS). However, decidual compartment underpins resistance to oxidative-stress induced 
apoptosis, including increased free radical scavenging, selective silencing stress MAPK 
pathways and inhibition of FOXO3a, a pro-apoptotic transcription factor that mediates 
oxidative cell death in undifferentiated stromal cells (304).  
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Figure 11. Decidual transformation of human endometrial stromal cells (HESCs). The decidual process 
transits from an acute inflammatory initiation phenotype (pro-inflammatory HESC) to an anti-inflammatory, 
highly secretory phenotype (decidualizing cells). This transformation underpins the acquisition of specialized 
functions. 
 
 
3.1.4 Decidualization in rats 
In rodents, decidualization is triggered by a physic stimulus, blastocyst implantation, 
though it can also be artificially induced in pseudopregnant and ovariectomized rats, 
giving rise to deciduoma. This suggests that the decidual response is an intrinsic program 
of uterine stromal cells, not influenced by embryo (305). Intra-luminal infusions of oil or 
scratching with a needle are widely used as a decidual stimulus (306). Figure 12 depicts a 
schematic representation and a timeline of day-specific morphological changes of rat 
uterine tissues along pregnancy.  
At the site of blastocyst implantation, endometrial fibroblast-like stromal cells 
proliferate and differentiate into decidual cells, which consequently dye by programmed 
cell death (305, 307, 308). The pattern of the decidualization is not simultaneous, but 
rather a dynamic temporal and spatial sequence of events, occurring in different regions 
at different times. 
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Figure 12. Schematic representation of rat uterine tissues morphological alterations and timeline of 
day-specific morphological characteristics along pregnancy. D1 of pregnancy is confirmed by the 
presence of spermatozoa in rat vagina smear. Implantation occurs between d4/5 at the anti-mesometrial side 
of the uterus and is followed by a fast growth of the feto-placental unit. Decidualization process begins 
antimesometrially after blastocyst attachment. Degeneration of this tissue starts at d10 and by d12 it has 
completely regressed. Alongside, mesometrial pole begins to differentiate on d9. After d12, when it reaches its 
maximum development, mesometrial decidua progressively regresses to allow placental growth. Meanwhile 
invading trophoblast cells breach the uterine basement membrane to infiltrate the decidua, which will lead to 
formation of the placenta. AMD: antimesometrial decidua; L: Lumen; MD: mesometrial decidua; P: placenta. 
 
In the rat, decidualization begins in the vicinity of the implanting blastocyst, on the 
antimesometrial pole, giving rise to the antimesometrial decidua (AMD). Parallel, epithelial 
cells at the site of blastocyst apposition progressively undergo apoptosis. Between days 
5-6 of pregnancy, stromal cells surrounding the implanting embryo cease to proliferate 
and undergo differentiation into polyploid decidual cells, forming an avascular and dense 
zone termed the primary decidual zone (309). These cells are large, round or polygonal 
with basophilic cytoplasm, two or more nucleus with prominent nucleoli. By day 8, the 
decidual reaction reaches the basal zone adjacent to the circular muscle coat, achieving 
its maximum development at day 10. Subsequently, it progressively regresses by 
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apoptosis and secondary necrosis, forming the decidua capsularis (310). Parallel, 
endothelial cells proliferate rapidly in the lateral wing of the uterus, resulting in the 
formation of large venous sinusoids, in a region called glycogenic wing area, which 
appear to intervene in the transfer of nutrients (308). 
Thereafter, on day 9, differentiation extends to the opposite side of the uterus, named 
the mesometrial side of the endometrium, comprising the mesometrial decidua (MD) (311, 
312). Mesometrial decidual cells are smaller than those of the antimesometrial decidua, 
irregular in shape and contain a single nucleus. The MD reaches its maximum 
development on day 12 of gestation, and upon day 14 it begins to regress by programmed 
cell death, allowing fetoplacental development, and giving rise to the decidua basalis. The 
latter forms the maternal component of placenta and persists till the end of pregnancy. By 
day 14 the hemochorial placenta is fully established.   
Simultaneously to the development of mesometrial decidua there is the appearance 
of uNK population (313). Like in humans, uNK cells are phenotypically and functionally 
different from circulating NK cells, they express integrins, which allow their migration 
towards the decidualizing endometrium (314, 315). After maturation, they acquire a 
granular phenotype containing perforin, granulysin and granzyme B, contributing to 
maternal vascular remodelling and angiogenesis (315, 316). By day 12 these cells also 
appear in the mesometrial triangle, a region between the circular and longitudinal muscle 
coat, through which the blood vessels gain access to the uterine endometrium (313). 
After, uNK cells degranulate and die by apoptosis. The mesometrial triangle region 
enlarges during the second half of pregnancy to give rise to the metrial gland.  
Degeneration of both antimesometrial and mesometrial decidua is a remarkable 
feature of rat placentation. AMD has all the characteristics of an endocrine organ, 
secreting a variety of hormones and growth factors, such as decidual prolactin-like 
hormones, follistatin, activin and transforming growth factors (317). MD regression is 
intimately related with trophoblast invasion and placental development. The main 
secretory product of rat mesometrial decidua is a glycoprotein termed 'decidualization-
associated protein', which shares identical properties with the acute phase protein α2-
macroglobulin, a general protease that has the ability to bind to all types of proteases and 
numerous growth factors, controlling in that way their activity (318). Although it is not 
present in human endometrium, in rodents this protein is important for spiral arterial 
modification and prevention of excessive trophoblastic invasion (319). 
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4. Endocannabinoids and reproduction 
 
The hazards of C. sativa consumption in reproduction are known for decades. THC 
inhibits ovulation, suppresses the production of sex hormones, crosses placenta, 
accumulates in maternal milk, and impairs pregnancy outcome (320). Prenatal use has 
been associated with infertility, placental complications, low birth weight, preterm labor 
and fetal growth restriction. Whereas long-term effects of prenatal marijuana use on 
exposed offspring include poorer executive functioning skills and attention, increased 
conduct and behaviour problems, and poorer school achievement (321). In men, studies 
have reported the role that marijuana plays in disrupting spermatogenesis, and sperm 
function such as motility, capacitation, and the acrosome reaction (322). Nevertheles, the 
mechanisms underlying these adverse effects remains unclear. 
In the past few years, the ECS has emerged as an essential player in male and 
female reproduction. eCBs together with their metabolic enzymes and molecular targets 
have been identified in reproductive cells, organs, and fluids of invertebrates, vertebrates 
and mammals, highlighting a key role in reproduction processes along the evolutionary 
axis. In fact, CB1 receptor is expressed in the embryo, in much higher levels than those in 
the brain, and, among the reproductive tissues, the endometrium is the major source of 
AEA (323, 324).  
 
 
4.1 The Endocannabinoid System and early pregnancy 
It is widely known that endocannabinoids are involved in all stages of female 
reproduction, from oocyte development to parturition (325). Figure 13 resumes eCBs 
effects on pregnancy events.  
Besides cannabinoid receptors, preimplantation mouse embryo, as well as the 
oviduct and the uterus, possess the full enzymatic machinery to synthesize and degrade 
AEA. In mice, CB1 mRNA is detected from the 4-cell embryo, while CB2 mRNA is present 
from the zygote to blastocyst stage (323, 326). While CB1 receptor is the functional 
receptor responsible for normal embryo growth and development, CB2 controls stem cell 
populations (327, 328). In fact, it has been demonstrated that CB1 activation inhibits 
embryo development in vitro (326, 329). At the same time, while NAPE-PLD is present 
from the early fertilized egg to the blastocyst stage, FAAH expression was detected later 
at the 2-cell embryo, suggesting a protective role against AEA cytotoxicity (330).  
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During early pregnancy, CB1 plays another critical role in the transport of embryos 
from the oviduct to the uterus. In CB1 -/- mouse, embryos are retained in the oviduct and 
fail implantation, due to an impairment of oviduct smooth muscle contraction and 
relaxation required for embryo transport (331, 332). Accordingly, the oviductal transport of 
the fertilized egg and its development to the competent stage are controlled by a gradient 
of AEA concentration, which increases from the ampulla to isthmus. The appropriate local 
tone of AEA is controlled in the uterus by the differential expression of NAPE-PLD and 
FAAH and is conducive to a successful implantation (332). In this respect, FAAH −/− mice 
exhibit retarded embryo development and also altered oviductal transport (333, 334).  
Synchronized embryo development and uterine differentiation are crucial for 
implantation, and it is well established that a deregulation of the eCB signalling disrupts 
both processes (331). Down-regulated levels of AEA detected at implantation sites are 
associated with uterine receptivity, while high AEA levels are found in the non-receptive 
uterus, refractory to implantation, and at inter-implantation sites (324, 326). In addition, 
this eCB also plays an important role in rat decidual remodelling and stromal cell 
differentiation (65, 213, 239). On the other hand, eCB signalling is also implicated in 
blastocyst development. In this respect, CB1 expression is lower in the activated 
blastocyst than that in dormant blastocysts (57, 335). Furthermore, through CB1 binding, 
low AEA levels stimulate blastocyst differentiation and trophoblast outgrowth, while high 
levels inhibit embryo development and zona-hatching of blastocysts. These dual effects of 
AEA depend on the activation of different signal transduction pathways. While low levels 
of AEA activate ERK signalling pathway, higher concentrations inhibit Ca2+ influx (324, 
328).  
Altogether these observations support a role for the endocannabinoid signalling in 
embryo synchronization with the uterine receptivity. Although still controversial, it has 
been reported that mouse blastocysts secrete a molecule, not yet identified, that regulates 
uterine activation of FAAH activity and inibits NAPE-PLD (336, 337). Hence, FAAH 
emerges as the main metabolic gatekeeper controlling AEA tone and CB1-activated 
pathways to ensure early pregnancy events.  
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Figure 13. Schematic representation of the fetomaternal interface and potential adverse effects arising 
from deregulated endocannabinoid signalling based on rodents and human studies. Endometrial 
stromal cells differentiate into decidual cells, preparing uterine tissues for pregnancy, whereas the invading 
trophoblast cells critically regulate placental growth and function. All the physiological and molecular 
processes occurring during those periods are complex but highly organized. Endocannabinoids have reported 
to be involved in decidualization, implantation, trophoblast differentiation and invasion. Aberrant 
endocannabinoid signalling (shown in yellow boxes) is reflected in compromised reprogramming of the 
endometrial stromal cells, implantation and placentation manifesting in ectopic pregnancy, intrauterine growth 
restriction, preeclampsia, miscarriage, and spontaneous abortion. Adapted from (338). 
 
In humans, cannabinoid receptors are active at the ovaries in cortex and medulla. In 
contrast, FAAH and NAPE-PLD are only expressed in secondary and tertiary follicles, 
corpus luteum and corpus albicans, but not in oocytes (339). Interestingly, in the follicular 
fluid AEA levels correlated with follicle size, being lower in follicles from which oocytes are 
not retrieved, thus indicating that AEA may be involved in follicular maturation and 
development (340).  
The expression of the components of the ECS has also been reported in the human 
endometrium. CB1 expression is higher in endometrial glands than in the stromal 
compartment, and it was found that CB1 mRNA and protein levels are increased in the 
secretory phase likely due to progesterone modulation (341, 342). CB2 expression is 
minimal at the beginning of the cycle and reaches a peak during the late proliferative 
phase (341). At the secretory phase, besides increased FAAH expression in the decidual 
compartment, it has been recently described that COX-2 expression is also high, 
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suggesting that together, these enzymes may promote an appropriate eCB tone for 
decidualization and a successful implantation (343). Regarding NAPE-PLD expression 
during the menstrual cycle there is still some controversial information (343, 344). 
Throughout the menstrual cycle, plasmatic AEA levels fluctuate. High AEA levels are 
found in the follicular phase, peaking at ovulation and, subsequently decreasing towards 
the luteal phase, which coincides with the “window of implantation” (333, 339). Altogether 
these observations reinforce that high levels of AEA in ovulation and lower levels in 
implantation period are required for a successful pregnancy. 
During the menstrual cycle, a link between AEA and FSH during the follicular phase 
and between AEA, LH and estradiol during ovulation was observed (345). In this way, it 
has been suggested that eCBs may modulate reproductive function both locally and at the 
hypothalamic–pituitary–gonadal axis (346). In addition, it has been demonstrated that 
FAAH regulation in the peripheral lymphocytes, both at activity and expression levels, is a 
key point during menstrual cycle. Under the control of progesterone, high FAAH 
expression/activity and concomitant decreased AEA levels characterize the “implantation 
window” (347).  
Recently, it has been reported that eCBs also control endometrial plasticity by 
regulating stromal cell motility and migration via CB1-dependent activation of Akt and 
ERK1/2 pathways (348). Also, methanandamide enhances HESC proliferation and 
induces apoptosis in longer exposures (346). However, still little is known about the role of 
eCBs in proliferation and differentiation of HESCs. Nevertheless, it has been reported that 
the CB1 agonist, WIN 55212-2, exerts an anti-proliferative action on stromal endometriotic 
cells linked to a reduction of ROS production and Akt pathway inactivation (349). On the 
other hand, it was found that CB1 expression, both at mRNA and protein levels, was lower 
in endometriosis, suggesting that reduced eCB signalling correlates with enhanced 
proliferative capacity of endometriotic lesions (342). Besides, WIN 55212-2 through CB1 
binding, inhibited human decidualization and stimulated apoptosis by a cAMP-dependent 
mechanism (350). 
It has been described that the interplay of sex steroids, cytokines and eCBs result 
essentially from the modulation of FAAH, the major controlling enzyme of AEA, by 
oestrogen, progesterone, leptin and cytokines, indicating a role for eCBs-hormone-
cytokines in the regulation of human fertility (330). Disruptions in the endocannabinoid 
system, especially a shift in the balance between AEA levels and FAAH activity have been 
implicated in human implantation disorders and infertility (345, 351). Lower CB1 mRNA 
expression was found in fallopian tubes and decidua of women with ectopic pregnancies 
compared to normal pregnancy (352). In addition, aberrant AEA levels and reduced CB1 
and FAAH expression in fallopian tubes, as well as decreased FAAH activity in peripheral 
 35 
 
blood cells were reported in women with ectopic pregnancy (353, 354). In women 
undergoing in vitro fertilization (IVF)/intracytoplasmic sperm injection (IVF/ICSI)-embryo 
transfer, it was verified that AEA plasma levels decreased from the day of oocyte retrieval 
to that of the embryo transfer in pregnant women. Thus, it was suggested that low serum 
AEA levels at the time of implantation was a sign of a successful pregnancy (345, 355, 
356). Furthermore, low FAAH and high AEA levels in blood are associated with 
spontaneous miscarriage, as reported in two studies where low FAAH activity was found 
in lymphocytes of women who spontaneously aborted (357, 358). Trabucco et al. (2009) 
investigated placental tissue from women after spontaneous miscarriages and identified 
low FAAH expression and increased CB1 expression (359). As occurs in rodents, these 
studies reinforce a biphasic role for AEA, under FAAH control, in regulating both 
blastocyst development and transport with uterine receptivity and implantation. 
During the first and second trimesters of pregnancy, plasma AEA levels are 
comparable to those of luteal phase, consistent with successful pregnancy maintenance. 
Then it significantly rises at term and further during labor (360, 361). Therefore, AEA plays 
a role in folliculogenesis, follicle maturation, oocyte maturation, ovulation, implantation, 
decidualization and early pregnancy (Table 1). 
 
Table 1. Overview of the most important biological action of AEA in the female reproductive organs. 
 
 
4.2 Decidualization: the affair between endocannabinoid and 
prostaglandin network 
Decidualization is a remarkable feature of human reproduction, involving the cross-
talk of a complex network of hormones, cytokines and interleukins, transcriptional and 
growth-factors. In rat uteurs, the interaction between lysophosphatidic acid (LPA), PGs, 
and ECS during the window of implantation has been reported (362), although in humans 
it is not yet elucidated.  
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A growing body of evidences, supported by studies using the rat as a model, 
indicates that anandamide has an important role in the determination of endometrial cells’ 
fate. Elevated AEA levels induced apoptosis in rat decidual cells, via CB1-dependent p38 
activation (65, 213). In addition, CB1 expression was highest during the maximum 
development of the mesometrial decidua (363). Regarding metabolic enzymes, it has 
been observed that COX-2 and FAAH expression decrease after day 14 of pregnancy, 
which coincides with decidual regression, reinforcing the role of AEA on decidual cell 
turnover. Interestingly, the plasmatic AEA and decidual tissues levels do not correlate, 
suggesting an in situ regulation (364, 365). Furthermore, it has been recently shown that 
AEA limits uterine stromal cell differentiation and critically impairs decidualization (239).  
Besides eCBs, other pivotal lipid mediators of decidual process are currently (re)born 
in the literature. Not only they mediate a tailored role in the decidualization process, but 
foremost a cross-talk between these molecules is probable. PGs are believed to play a 
crucial role in the regulation of endometrial vascular permeability, angiogenesis and 
decidualization, trophoblast invasion and extracellular matrix remodelling during 
implantation (366). In fact, increased vascular permeability is an essential prerequisite for 
decidualization in rodents and is attributed to PGE2 (367, 368). Cytosolic phospholipase 
A2a (cPLA2a) is a major provider of AA for COX-2. Interestingly, cPLA2α-null mice failed 
in implantation (369). In rats, COX-2 is mostly restricted to implantation sites, and COX-
2−/− mice are infertile, with defective implantation and decidualization (370, 371). In 
addition, COX-2 expression in epithelium and stromal compartment is increased after 
blastocyst implantation and PGE2 levels are also higher during the period of decidual 
development (371). Blockade of PG synthesis before or during implantation causes a 
complete inhibition, a delay in implantation or a reduction in the number of implantation 
sites and impaired decidual response. However, exogenous administration of PGs can 
partially restore these processes (372, 373). COX-2-derived PGI2 appears to play an 
important role in protecting preimplantation embryo from apoptosis (374).  
In humans, the regulatory role of PGs in early pregnancy events is emerging. In fact, 
these molecules were recently perceived as potential biomarkers of endometrial 
receptivity and pregnancy failure, since PGE2 and PGF2 levels are significantly increased 
during the receptive phase (375). Moreover, a deregulation of the PG signalling has been 
correlated to poor endometrial receptivity, infertility and uterine pathologies (376, 377). On 
the other hand, PGE2 may act through prostaglandin receptors, increasing intracellular 
levels of cAMP and stimulating the activity of alkaline phosphatase, both factors critical for 
decidualization (281, 378). These observations highlight the role of COX-2 derived 
prostaglandins in early pregnancy events. In fact, arachidonic acid available from AEA 
hydrolysis by FAAH may give rise to PGs. Nevertheless, COX-2 may also intervene 
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during decidualization process by producing AEA-oxidative metabolites, the prostamides. 
On one hand, in the rat uterus, it has been suggested that eCBs mediate the stimulatory 
effect of LPA on COX-2 derived PGE2 production (362). In contrast, it has been reported 
that AEA exerts opposite effects on PGE2 and PF2α in mice uterine explants, by inhibiting 
production of the former and increasing the levels of the latter  (379). In addition, PGs-
mediate the AEA-inhibitory action on nitric oxide synthase activity in the receptive rat 
uterus (380). Fonseca et al. (2015), recently unveiled that the inhibitory role of AEA in 
uterine stromal cell differentiation may involve COX-2 down-regulation (239). While in 
humans, AEA modulates production of PG in fetal tissue, by a CB1 dependent manner 
(381).  
The fact that, in rats, pregnancy uterine tissue levels do not correlate with plasma 
eCBs levels, suggests that during pregnancy, maternal tissue levels of AEA are regulated 
by in situ production and degradation to create an appropriate eCB gradient conducive to 
a successful pregnancy (364). In this respect, prostamides may be novel lipid mediators of 
some endocrine and/or paracrine effects of eCBs. Nevertheless, both in humans and 
rodents, high FAAH expression/activity and low AEA levels correlates with the rise in PGs 
levels and COX-2 expression during the secretory phase of menstrual cycle and uterine 
receptivity (338, 343). It may be that, FAAH and COX-2 play together a crucial role in 
protecting the embryo from deleterious AEA effects at implantation, but also in regulating 
decidual remodelling and endometrial receptivity (Figure 14). The notable expression of 
COX-2 contiguous to embryo, in rats, contrasting with FAAH expression, also highlights 
the importance of COX-2 (364). Therefore, compelling evidences suggest the intimate 
coordination between eCB and PGs during early pregnancy.  
 
Figure 14. Endocannabinoid signalling during blastocyst implantation. Regulated levels of AEA in the 
receptive uterus and CB1 in activated blastocysts at the time of implantation are beneficial for implantation, 
whereas higher levels are detrimental to this process. High FAAH and COX-2 expression is found in the 
implantation sites. Because COX-2 is expressed in the uterus at the site of implantation and AEA may serve 
as substrate for either COX-2 or FAAH, the proposal suggests that uterine eCBs are tightly regulated by the 
coordinated activity of FAAH and COX-2 in the uterus during early pregnancy. AEA: anandamide; 
Cyclooxygenase-2: COX-2; FAAH: fatty acid amide hydrolase. Adapted from Dey et al. (2004) (306). 
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Aims of the study 
 
Endometrial plasticity is a remarkable feature in the biology of reproduction. Human 
endometrial stromal cells undergo a balance remodelling involving proliferation, 
differentiation and apoptosis, and an impairment of these events may result in pregnancy 
loss, miscarriage and infertility.  
Over the last decade, endocannabinoids emerged as key players in the control of cell 
fate in several physiological processes. In the reproductive system, a strictly regulated 
anandamide tone enables embryo transport and implantation, endometrial receptivity, 
fetoplacental development and labor. We have previously described that, in rats, AEA 
impairs the progression of stromal cell differentiation and induces apoptosis of decidual 
cells. On the other hand, in rats, COX-2 is recognized as a major enzyme involved in 
implantation and decidualization and COX-2-derived metabolites may mediate some 
eCBs-induced effects. Therefore, the latter may be active players under conditions of 
enhanced eCB synthesis, as in the case of Cannabis sativa derivates consumption, or in 
pathological conditions-related to ECS deregulation. Since the understanding of the 
oxidative metabolism of endocannabinoids might also delineate a new world of signalling 
pathways, one aim of this work is to unravel the role of COX-2 metabolism and derived 
AEA-metabolites in rat decidual cell cultures. 
In humans, poorly defined cellular and molecular mechanisms underpin the role of 
eCBs in the control of endometrial stromal cell remodelling. In fact, dissecting the 
regulators and the molecular basis underlying human endometrial cell turnover may shed 
light on the pathophysiology of some pregnancy disorders and/or infertility. Thus, another 
aim of this project is to characterize the ECS in human endometrial stromal-derived cells 
and to study the impact of AEA in HESCs proliferation, apoptosis and differentiation. In 
addition, we hypothesize that COX-2 may be the ‘lock-key’ to switch the balance between 
eCBs and PGs, favoring, embryo implantation and endometrial receptivity. Therefore, to 
decipher the latent cross-talk among these two major lipid mediators of reproductive 
biology, the impact of a deregulation of eCB signalling on COX-2 expression and PGs 
release during decidualization will be studied.  
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Lipidomic Approach Towards
Deciphering Anandamide Effects
in Rat Decidual Cell
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1UCIBIO, REQUIMTE, Laboratory of Biochemistry, Biological Sciences Department, Faculty of Pharmacy, University of Porto,
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Altered phospholipid (PL) metabolism has been associated with pregnancy disorders. Moreover, lipid molecules such as endocannabinoids
(eCBs) and prostaglandins (PGs) are important mediators of reproductive events. In humans, abnormal decidualization has been linked
with unexplained infertility, miscarriage and endometrial pathologies. Anandamide (AEA), the major eCB, induces apoptosis in rat decidual
cells. In this study, the PL profile of rat decidual cells was characterized by a Mass spectrometry (MS) based lipidomic approach.
Furthermore, we analyzed a possible correlation between changes in PL of rat decidual cells’ membrane and AEA-induced apoptosis. We
found an increase in phosphatidylserine and a reduction of cardiolipin and phophatidylinositol relative contents. In addition, we observed an
increase in the content of alkyl(alkenyl) acylPL, plasmalogens, and of long chain fatty acids especially with high degrees of unsaturation, as
well as an increase in lipid hydroperoxides in treated cells. These findings provide novel insights on deregulation of lipid metabolism by
anandamide, which may display further implications in decidualization process.
J. Cell. Physiol. 230: 1549–1557, 2015. © 2014 Wiley Periodicals, Inc.
Reproduction in humans is marred by early pregnancy failure.
Approximately 15% of clinically recognized pregnancies fail (Rai
and Regan, 2006). Implantation failure is common following
natural conceptions and is an important clinical hurdle to
overcome following assisted reproductive attempts. Essential
changes have to occur in endometrium to support implantation
and establishment of pregnancy. Human endometrium is
receptive to embryo for a short period of time, referred to as
the “window of implantation.” Hence, uterine endometrial
stromal cells undergo a characteristic reaction to form
transient decidual cells, termed decidualization. (Gellersen and
Brosens, 2014) Abnormal decidualization predisposes to
pregnancy complications, including unexplained infertility,
miscarriage, fetal growth restriction and endometrial
pathologies such as endometriosis (Laird et al., 2006).
Lipid molecules such as endocannabinoids (eCBs),
lysophosphatidic acid (LPA) and prostaglandins (PGs) are
relevant mediators of early pregnancy events (Sordelli et al.,
2012). In addition to the well-known structural features and
regulatory functions, lipids are also signalingmolecules involved
in many cellular processes such as cell growth, differentiation
and apoptosis. Furthermore, deregulation of lipid metabolism
is currently emerging among adverse pregnancy outcomes
(Vilella et al., 2013). In fact, increasing evidence suggests that
anandamide (AEA), the major endocannabinoid (eCB), has
regulatory functions during implantation, decidualization and
fetoplacental development (Fonseca et al., 2013a; Meccariello
et al., 2014). AEA, among other endogenous cannabinoids, acts
mainly through G-protein coupled receptors or GPCRs,
termed cannabinoid receptors (CB), which along with the
metabolic enzymes form the endocannabinoid system.
Currently, it is well established that to achieve a receptive
phase, low AEA levels in uterine environment are maintained
by N-acylphosphatidylethanolamine-specific phospholipase D
(NAPE-PLD), the enzyme responsible for its synthesis, and by
fatty acid amide hydrolase (FAAH), which control its
degradation to arachidonic acid (AA) and ethanolamine (EA)
(Wang et al., 2007; El-Talatini et al., 2009). Implications of the
harmful effects caused by high AEA levels involve lower FAAH
protein levels and activity in women who miscarry and those
who fail in-vitro-fertilization (IVF) treatment (Maccarrone et
al., 2000, 2002; Habayeb et al., 2008; El-Talatini et al., 2009).
We have previously described that ECS operates in rat decidual
cells and demonstrated the upcoming role of AEA in uterine
remodeling process (Fonseca et al., 2009, 2013b). Particularly,
we showed that AEA through CB1 receptor induces apoptosis
in rat decidual cells (Fonseca et al., 2009). Furthermore,
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aberrant eCB signaling has been associated with decidua-
related pregnancy disorders (Horne et al., 2008).
Recently, the development of lipidomic tools have enable the
identification of potential biomarkers of endometrial receptivity
towards the understanding of clinical disorders and forecasting
pregnancy outcome (Vilella et al., 2013). Proteomic analysis of
plasma from preeclamptic pregnancies showed the differential
expression of several proteinsmainly related to lipidmetabolism
and extracellular matrix remodeling (Blumenstein et al., 2009;
Liu et al., 2011). On the other hand, lipidomic studies allowed
lipid characterization of human endometrial fluid, and showed
that PGs were significantly increased at the window of
implantation/receptive phase (Vilella et al., 2013). Analysis of the
phospholipid molecular species in human placenta showed a
plasmenylphosphatidylethanolamine deficiency, as well as an
increase of free fatty acids (Jain et al., 2004) and phospholipid
levels in pre-eclamptic pregnancies (Huang et al., 2013). Also,
increased contents of phospholipids, lipid peroxides and
cholesterol was found in the decidua basalis of womenwith pre-
eclampsia (Staff et al., 1999).
The molecular signaling network that coordinates successful
strategies for decidualization is not well understood. Thus, in an
attempt to better appreciate the cellular membrane dynamics
underlying the decidual remodeling and the effect triggered by
AEA-induced apoptosis we analyzed the phospholipid (PL)
profile of rat decidual cells, in the absence and presence of AEA,
using a MS based lipidomic approach. The alterations on
phospholipid composition and levels may manifest a source of
AEA-induced effects during uterine remodeling.
Materials and Methods
Animals and cell cultures
All animal experiments were conducted with Direc¸~ao-Geral de
Alimentac¸~ao e Veterinaria (DGAV) approval and conformed to
the European legislation on the use of laboratory animals. Female
Wistar rats weighing 200–250 g (Charles River Laboratories,
Barcelona, Spain) were mated and the day on which
spermatozoa were found in the morning vaginal smear was
designated day 1 of pregnancy. Primary cultures of decidual cells
were prepared as previously described (Fonseca et al., 2009).
Briefly, mesometrial decidua was dissected from
antimesometrial decidua and digested with dispase II (2.4 U/ml)
(Roche Diagnostics GmbH, Mannhein, Germany), colagenase
(50U/ml) (Sigma Chemical Co, St. Louis, MO) and Dnase I
(200U/ml) (Roche Diagnostics GmbH, Mannhein, Germany) in
HBSS (Gibco/Invitrogen Corporation, Carlsbad, CA) for 1 h at
37 °C. Non-digested tissue was removed by filtration and
decidual cells were collected by centrifugation at 200 g for
10min. Cells were cultured in 21mm culture dishes at 1.2 106/ml
in Dulbecco’s minimum essential medium (DMEM) (Gibco/
Invitrogen Corporation, Carlsbad, CA) supplemented with
antibiotic-antimicotic solution (200U/ml penicillin G, 0.5mg/ml
amphotericine B and 200mg/ml streptomycin) (Gibco/Invitrogen
Corporation, Carlsbad, CA) and 10% FBS (Gibco/Invitrogen
Corporation, Carlsbad, CA) under a 95% air-5% CO2 humidified
atmosphere for 4 h. After adhesion, mediumwas removed and cells
were cultured for 24 h in DMEM without FBS in the presence or
absence of anandamide (AEA), 10mM. Purity of cultures was
evaluated by cellular morphology and immunocytochemistry for
detection of a2-macroglobulin, the major protein synthesized by
the mesometrial decidual cells.
Lipid extraction
Cells were detached by scraping and cell suspension centrifuged
10min at 720 g. The cell pellet was washed with PBS, and
centrifuged 4min at 720 g. The final pellet was resuspended in
distilled water (dH2O). Total lipids were extracted by the method
described by Bligh andDyer (Bligh andDyer, 1959). Briefly, 3.75ml
chloroform/methanol 1:2 (v/v) was added to the sample (1ml),
vortexed, and incubated on ice for 30min. An additional volume of
1.25ml chloroform and of 1.25ml dH2O were added, and
following vigorous vortex, samples were centrifuged at 180 g for
5min at room temperature to obtain a two-phase system: aqueous
top phase and organic bottom phase from which lipids were
obtained.
Phospholipid quantification
Total amount of PL as well as each PL class separated by TLC were
quantified with a phosphorus assay, performed according to
Bartlett and Lewis (Bartlett, 1959). To quantify the total PL extract,
5% of sample was used, and dried with a nitrogen flow. Following
TLC separation, the spots corresponding to the different PL
classes were scraped off directly to quantification tubes. Perchloric
acid (70%) was added to samples, which were then incubated 1 h at
180 °C. To all samples dH2O (3.3ml), 1% ammonium molybdate
(0.5ml) and 4% ascorbic acid (0.5ml) were added, followed by
incubation for 10min at 100 °C in a water bath. Standards from 0.1
to 2mg of phosphate underwent the same treatment and
absorbance was measured at 800 nm. The relative abundance (%)
of each PL class was calculated by the ratio between the amount of
PL in each spot and the total amount of PL in the sample. Prior to
spectrophotometric quantification, the Thin Layer
Chromatography (TLC) separated PL classes were centrifuged
5min at 2900 g to disperse PLs from silica. Three experiments
were analyzed in triplicate.
Separation of phospholipid classes by thin layer
chromatography (TLC)
PL classes from the total lipid extract were separated by TLC using
silica gel plates with concentrating zone 2.5 20 cm (Merck) as
described previously (Doria et al., 2012, 2013). First, plates were
treated with 2.3% boric acid in ethanol. Then, 20ml of PL extract
(20–30mg of PL) dissolved in chloroform were seeded in the TLC
plate. Spots were developed in solvent mixture chloroform/
ethanol/water/triethylamine (35:30:7:35, v/v/v/v). Lipid spots on
TLC plates were observed by exposure to primuline (50mg/100ml
acetone:water, 80:20, v/v), and visualized with a UV lamp
(l¼ 254 nm). Identification of the different classes of PLs was
carried out by comparison with the use of PL standards that run
side by side on the TLC plate and confirmed by mass spectrometry
analysis of each spot.
Fatty acid analysis by gas chromatography with flame
ionization detection (GC-FID)
The total fatty acyl substituents were measured by GC after
transesterification of the total lipid extracts (approximately 30mg
of total PL). The fatty acids methyl esters were prepared using a
methanolic solution of potassium hydroxide (2.0M) according to
the previously described method (Aued-Pimentel et al., 2004).
Hexane solution containing methylated fatty acids were submitted
to GC analysis. The GC injection port was programmed at
523.15K and the detector at 543.15K. The oven temperature was
programmed as follows: initially stayed 3min at 323.15K, raised to
453.15K (25K min-1), held isothermal for 6min, with a
subsequent increase to 533.15K (40K min-1) and maintained
there for 3min, performing 19min totally. The carrier gas was
hydrogen flowing at 1.7mlmin1. The gas chromatograph (Clarus
400, PerkinElmer, Inc., MA) was equipped with DB-1 column with
30m length, 0.25mm internal diameter and 0.15mm film thickness
(J&W Scientific, Agilent Technologies, Folsom, CA) and a flame
ionization detector. The relative concentrations of fatty acids were
calculated by the percent area method with proper normalization
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considering the sum of all areas of the identified fatty acids (Aued-
Pimentel et al., 2004).
Separation of phospholipid classes by high performance
liquid chromatography mass spectrometry (HPLC-MS)
PL classes were separated and analysed by HILIC-LC–MS,
performed on an HPLC system (Waters Alliance 2690) coupled to
an electrospray (ESI) linear ion trap mass spectrometer
(ThermoFinnigan, San Jose, CA). PL classes were analyzed by LC-
ESI-MS in positive mode (PC, SM and PE classes) with formation of
[MH]þ and in negativemode (PI, PA andCL classes) with formation
of [M-H]- (ThermoFinnigan, San Jose, CA) (Doria et al., 2012,
2013). HILIC conditions were: the mobile phase A consisted of
10% water and 55% acetonitrile with 35% (v/v) methanol. The
mobile phase B consisted of acetonitrile 60%, methanol 40% with
10mM ammonium acetate. Total lipid extract were diluted in the
mobile phase B and 15ml of reaction mixture was introduced into
an Ascentis Si HPLC Pore column (15 cm 1.0mm, 3mm) (Sigma–
Aldrich). The solvent gradient was programmed as follows:
gradient started with 0% of A and linear increased to 100% of A
during 20min, and held isocratically for 35min, returning to the
initial conditions in 5min. The flow rate through the column was
16mL/min obtained using a pre-column split (Acurate, LC
Packings) (Schwalbe-Herrmann et al., 2010). Chromatograms can
be provided upon request.
HILIC-LC-MS was performed with an internal standard to
confirm the ion variations observed in the MS spectra according to
the Lipid Maps methods (Ivanova et al., 2007). Amounts of internal
standard were added according to the percentage of each PL class
in the total PL extract: 7mg PC (14:0/14:0), 3,5mg PI (16:0/16:0),
5mg PE (14:0/14:0), 3,5mg PA (14:0/14:0) and 3,5mg CL(14:0/14:0/
14:0/14:0), all from Avanti polar lipids. Each molecular lipid species
was normalized to the total lipid levels in the corresponding
sample. Relative abundance of each ion was calculated by
normalizing area of each peak to total area of each class.
Electrospray mass spectrometry conditions
Analysis and interpretation of the MS/MS spectra of each ion
identified by LC-MS spectra allowed to identify PL molecular
species present in each class as well as their fatty acyl chains
composition along the glycerol backbone.
ESI conditions in electrospray linear ion trapmass spectrometer
LXQ (ThermoFinnigan, San Jose, CA) were as follows:
electrospray voltage was 4.7 kV in negative mode and 5 kV in
positive mode; capillary temperature was 275 °C and the sheath
gas flow was 25U. An isolation width of 0.5Da was used with a
30ms activation time for MS/MS experiments. Full scan MS spectra
and MS/MS spectra were acquired with a 50ms and 200ms
maximum ionization time, respectively. Normalized collision
energy TM (CE) was varied between 17 and 20 (arbitrary units) for
MS/MS. Data acquisition of this mass spectrometer was carried out
with an Xcalibur data system (V2.0). All the MS spectra obtained
were repeated with three independent samples to confirm
reproducibility of the results. Relative abundance of each ion was
calculated by normalizing area of each peak to total area of each
class.
Quantification of hydroperoxides
Hydroperoxides were determined by the FOX2 assay. Aliquots
(50ml) of total lipid extracts were added to FOX2 reagent (950ml)
in a microtube washed with methanol. Standards of H2O2 from 0
to 0.8mM were prepared and underwent the same treatment as
the samples. All the mixtures were homogenized in a vortex and
incubated for 30min in the dark at room temperature. The
absorbance of samples and standards was read at 560 nm by UV–
Vis spectrophotometry.
Statistical analysis
TLC data consisting of three independent experiments performed
in triplicate was analyzed using one-way ANOVA and Tukey’s
multiple post test. Relative ion abundance obtained from three
independent cultures by HPLC-MS was analyzed using one-way
ANOVA and Tukey’s multiple post test. FA relative content
quantification was performed from three independent cultures
performed in triplicate analyzed by one-way ANOVA and Tukey’s
multiple post test. Differences were considered significant if
P< 0.05.
Results and Discussion
Membrane phospholipid profile of rat primary decidual cells
was analyzed by thin layer chromatography (TLC) and
molecular phospholipid (PL) species were studied by HILIC-
LC-MS and MS/MS. Furthermore, a putative association
between changes in the cellular PL profile and AEA-induced
apoptosis was investigated by comparison of AEA (10mM,
24 h) treated-group with control group.
We found an increase in total PL content in AEA-treated
cells compared to control (about 1.4-fold), suggesting an
alteration of lipid synthesis and/or turnover. In this line of
evidence, Staff et al. (1999) showed a correlation between an
elevated lipid content in decidua basalis with maternal
endothelial dysfunction and the pathophysiology of
pre-eclampsia.
Fig. 1. Relative abundance of phospholipids (PLs) classes in rat
decidual cell, in absence and presence of 10mM anandamide (AEA)
for 24 h. PL classes of each group were separated by TLC and
phosphate content in each spot was related to total phosphate
content in the lipid extract. LPC, lysophosphatidylcholine; PC,
phosphatidylcholine, PI, phosphatidylinositol; PE/PG,
phosphatidylethanolamine/glycerol; PS, phosphatidylserine CL,
cardiolipin. MeanSEM values from three independent
experiments performed in triplicate are shown (* P< 0.05 vs
control; one-way ANOVA and Tukey’s multiple post test).
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TLC of total lipid extracts allowed the identification of
distinct spots corresponding to the major phospholipids
classes: LPC–lysophosphatidylcholine, PC–
phosphatidylcholine, PI–phosphatidylinositol, PS–
phosphatidylserine, PE/PG–phosphatidylethanolamine/
glycerol, CL–cardiolipin. The relative content (%) of the major
PL classes in the total lipid extract remained unchanged (Fig. 1),
indicating that the increase in total PL levels were not caused by
an increment of synthesis of a single class but due to the
modification of precursors levels, or a general increase in
phospholipid synthesis.
PC was the dominant phospholipid component followed by
PE and PS in decidual cells. PS content increased in the treated
group, which might be reflective of the induced AEA-apoptotic
cell death. Although generally considered as a result of
alterations in the phospholipid asymmetry, a more complex
machinerymay be involved. In support of these data, it has been
suggested that increased PS outward movement further
enhanced PS de novo biosynthesis (Yu et al., 2004; Ferrara
et al., 2013). In fact, a lipidomic analysis of human placental
syncytiotrophoblast microvesicles associated high PS levels
with activation of apoptosis in pre-eclampsia (Baig et al., 2013).
In parallel, we found a significant decline in CL levels in
treated group, which may underlie mitochondrial dysfunction.
We have previously reported that AEA-induced apoptosis was
associated with ceramide accumulation, mitochondrial
generated reactive oxygen species (ROS) and caspase 3/7
activation (Fonseca et al., 2013b). Among the factors
associating CL changes and apoptosis, acyl chain remodeling
and CL oxidation associated with ROS generation were
reported (Petrosillo et al., 2001; Schug and Gottlieb, 2009).
Moreover, decreased CL synthesis and cytochrome c release
into the cytosol, were critical causes in a model palmitate-
induced cardiomyocyte apoptosis (Ostrander et al., 2001). On
the other hand, a decrease in CL has been related with
ceramide production through the reverse activity of a
mitochondrial-membrane ceramidase in rat brain (El Bawab
et al., 2001). Nevertheless, CL oxidation products have been
described as apoptotic mediators and a potential cause for the
decrease of CL content observed in apoptosis (Tyurina et al.,
2006).
Fig. 2. Gas chromatography quantification of fatty acids in total lipid extract. (A) Fatty acyl profile of total lipid extracts analyzed by GC.
Results are shown as ratio of relative content of FA (percent area) from AEA-treated group versus Control group. (B) Analysis of FA
substituents of Control vs AEA-treatment. Relative concentrations of fatty acids were calculated by the percent normalized to the sum of all
areas of the identified fatty acids. MeanSEM values from three independent experiments performed in triplicate are shown (****P< 0.0001,
***P< 0.001, *P< 0.05 p vs control; one-way ANOVA and Tukey’s multiple post test). Ratio T/C, Ratio Treatment/Control.
TABLE 1. Identification of [MþH]þ ions observed in the MS spectra of PC
and PE.
Diacyl Alkylacyl
m/z C:N FA FA m/z C:N FA FA
Phosphatidyl choline
704.7 30:1 14:1 16:0 718.7 0–32:1 0–16:0 16:1
706.7 30:0 14:0 16:0 720.7 0–32:0 0–16:0 16:0
732.7 32:1 16:0 16:1 744.7 0–34:2 0–16:0 18:2
7347 32:0 16:0 16:0 746.7 0–34:1 0–18:1 16:0
756.7 34:3 16:1 18:2 748.7 0–34:0 0–18:0 16:0
758.7 34:2 16:0 18:2 16:1 18:1 766.7 0–36:5 0–16:1 20:4
760.7 34:1 16:0 18:1 768.7 0–36:4 0–16:0 20:4
762.7 34:0 16:0 18:0 772.7 0–36:2 0–18:1 18:1 0–16:0 20:2
782.7 36:4 16:0 20:4 774.7 0–36:1 0–18:1 18:0
784.7 36:3 16:0 20:3 776.7 0–36:0 0–18:0 18:0
786.7 36:02 18:1 18:1 18:0 18:2 792.7 0–38:6 0–18:2 20:4
788.7 36:1 18:0 18:1 794.7 0–38:5 0–18:1 20:4
790.7 36:0 18:0 18:0 796.7 0–38:4 0–18:0 20:4
804.7 38:7 16:0 22:7
806.7 38:6 16:0 22:6
808.7 38:5 18:1 20:4
810.7 38:4 18:0 20:4
812.7 38:3 18:0 20:3
832.7 40:7 18:1 22:6
834.7 40:6 18:0 22:6 18:1 22:5
836.7 40:5 18:0 22:5
Phosphatidyl ethanolamine
718.5 34:1 16:0 18:1 724.5 0–36:5 0–16:1 20:4
740.5 36:4 16:0 20:4 18:2 18:2 726.5 0–36:4 0–18:2 18:2 0–16:0 20:4
744.5 36:2 18:2 18:0 18:1 18:1 728.5 0–36:3 18:2 0–18:1 0–18:2 18:1
746.5 36:1 18:0 18:1 750.5 0–38:6 0–18:2 20:4
748.5 36:0 18:0 18:0 752.5 0–38:5 0–18:1 20:4 0–18:2 20:3
766.5 38:5 18:2 20:3 18:1 20:4 754.5 0–38:4 0–18:1 20:3
768.5 38:4 18:0 20:4 18:1 20:3 778.5 0–40:6 0–18:0 22:6
770.5 38:3 18:0 20:3
772.5 38:2 18:0 20:2 18:2 20:0
774.5 38:1 18:0 20:1 18:1 20:0
776.5 38:0 18:0 20:0
790.5 40:7 18:1 22:6
792.5 40:6 18:0 22:6 18:1 22:5
794.5 40:5 18:0 22:5 20:4 20:1
m/z, mass/charge of each ion; C:N, total number of carbons in the fatty acid chains: total
number of double bonds; FA, fatty acids; PC, phosphatydilcholine; PE,
phosphatydilethanolamine.
Fatty acid constitution was attributed by the analysis of MS/MS spectra.
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To further investigate the effects of AEA on membrane
structure profile, we quantified the total fatty acids by GC-FID
(Fig. 2). Considerable changes were noticed, in particular an
increase in the relative content of long chain fatty acids (FA)
with high degree of unsaturation. Fluidity properties of
biological membranes are decisive for cell homeostasis and
networks of signal-transduction pathways. Membranes
containing shorter-chain lipids and polyunsaturared fatty acids
(PUFA) are more fluid (Catala, 2012). Hence, our results may
suggest a possible protective/compensation mechanism against
changes in physical properties.
Phospholipids containing PUFAs are of fundamental
significance for a large number of biological functions (Chaurio
et al., 2009). The high degree of polyunsaturation may confer
distinct lipid bilayer properties that are, for example, crucial for
activation and stability/function of some intrinsic membrane
proteins, like G protein-coupled receptors (GPCR)
(Rajamoorthi et al., 2005). This fact is of particular importance
because AEA induces decidual cell apoptosis through
cannabinoid receptor 1 (CB1), a GPCR. On the other hand, we
previously described that higher AEA levels, due to its lipophilic
nature, exerts cytotoxic effects on rat decidual cells, probably
by interacting with cell membrane (Fonseca et al., 2009).
Moreover, lipid composition is also expected to play an
important role in modulating the integral membrane FAAH
enzyme availability and activity.
The analysis of total FA (Fig. 2), showed an increase of FA
(20:4n6), which corresponds to arachidonic acid (AA). The fact
that AA is a direct product of AEA hydrolysis by intracellular
FAAH can sustain for the increase observed in treated group.
Besides regulating apoptosis itself (Cao et al., 2000; Pompeia
et al., 2003) AA is a precursor of important lipidmediators, PGs
and eCBs. Therefore, the enrichment of AA content in AEA-
treated group may disturb eCBs and PGs, both metabolic and
signaling pathways. On the other hand, AA-containing
phospholipid bilayers are disordered and deformable
(Rajamoorthi et al., 2005).
Underlying PLmetabolism, it is known that saturated fatty acids
(SFA) are successively transformed by the action of elongases
into palmitic acid (16:0), which is then elongated to stearic acid
(18:0), and other long chain SFAs. Interestingly, the relative
increase of FA (18:0) was accompanied by a decrease in ratio of
saturated to unsaturated FA with treatment (Table 1). Also, FA
(18:2) serve as a substrate to be converted into longer fatty
acids, as arachidonic acid (C20:4) and docosahexaenoic acid
(C22:6/:5/:4), via a series of oxidative desaturation and
elongation reactions (Jump, 2002). The latter, plays important
roles on membrane fluidity, signaling, apoptosis and gene
expression. Together with a relative decrease in FA (18:2) and
FA (18:1), we found a significant increase in PUFAs (Fig. 2).
Unsaturated fatty acids are prominent target of oxidative
attack that can cause cellular dysfunction via different
mechanisms (Prasad et al., 2010). Moreover, lipid peroxidation
process can disturb themembrane assembly, causing changes in
fluidity and permeability, modifications of ion transport and
inhibition of metabolic processes (Nigam and Schewe, 2000).
Consequently, the increase of PUFA by AEA treatment may
favor oxidative reactions, producing oxidation products with
biological activities. On the other hand, the conformational
shift in fatty acyl chain upon oxidation may trigger numerous
downstream pathways, as apoptosis (Catala, 2012). In order to
confirm the presence of lipid oxidation, the quantification of
lipid hydroperoxides was performed using a modified ferrous
oxidation-xylenol orange (FOX II) assay. The results showed
an increase in the lipid hydroperoxides content in the treated
group in comparison with control (Fig. 3), which corroborates
to the putative phospholipid oxidation and the increase in
reactive-oxygen species in our model of AEA induced-
apoptosis (Fonseca et al., 2013b).
Profiling of PL molecular species
To achieve the PL profile at the molecular level, HILIC-MS and
MS/MS was performed in positive and negative modes. PC, PE,
and LPC were identified by the analysis in positive mode
(Table 1) while PE, PS, PI and CL were identified in negative
mode (Table 2). This approach allowed the identification of
fatty acyl distribution in each PL class. The low abundance of
LPC, SM and CL did not allowed further analysis, although the
main molecular species were identified (Table 3;
Supplementary material).
Fig. 3. Concentration of lipid hydroperoxides - Concentration of
lipid hydroperoxides (LOOH mg/PL) in the total lipid extract in
Control group and AEA-treated group evaluated by FOX II assay.
MeanSEM values from three independent experiments
performed in triplicate are shown (**P< 0.01 vs control; one-way
ANOVA and Tukey’s multiple post test).
TABLE 2. Identification of [MþH]- ions observed in the MS spectra of PS
and PI.
Diacyl Alkylacyl
m/z C:N FA FA m/z C:N FA FA
Phosphatidylserine
758.4 34:2 16:0 18:2 16:1 18:1 716.48 o–32:2 o-16:1 16:1
760.4 34:1 16:0 18:1 16:1 18:0 744.46 o–34:2 o-16:1 18:1
782.4 36:4 16:0 20:4
786.4 36:2 18:0 18:2 18:1 18:1
788.4 36:1 18:0 18:1
810.4 38:4 18:0 20:4
812.4 38:3 18:0 20:3 18:1 20:3
834.4 40:6 18:0 22:6
Phosphatidylinositol
833,6 34:2 16:1 18:1 16:0 18:2 817,6 o–34:3 o–16:1 18:2
835,6 34:1 16:0 18:1 16:1 18:0 819,6 o–34:2 o–16:1 18:1
857.6 36:4 16:0 20:4 821,6 o–34:1 o–16:0 18:1
861,6 36:2 18:1 18:1 18:2 18:0 843,6 o–36:4 o–16:0 20:4 o–16:1 20:3
865,6 36:0 18:0 18:0
883.6 38:5 18:1 20:4 20:3 18:2
885.6 38:4 18:0 20:4 18:1 20:3
887,6 38:3 18:0 20:3
m/z, mass/charge of each ion; C:N, total number of carbons in the fatty acid chain: total
number of double bonds; FA, fatty acids; PS, phosphatydilserine; PI, phosphatidylinositol.
Fatty acid constitution was attributed by the analysis of MS/MS spectra.
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Phosphatidylcholine
Phosphatidylcholine (PC) is the major structural phospholipid
component of eukaryotic membranes and is mostly located in
the outer leaflet and contributes to both growth and
programmed cell death (Ridgway, 2013). Analysis of molecular
species (Table 1, Fig. 4) revealed that PC (16:0/18:1) and PC
(16:0/20:4) corresponding to [MH]þ at m/z 760.7 and 782.7
were the most relative abundant, followed by PC (16:0/18:2),
PC (18:1/18:1), PC (16:0/16:1), PC (o-18:0/18:0) and PC (18:0/
20:4) at m/z 758.7, 786.7, 732.7, 776.7 and 810.7, respectively.
The less relatively abundant PCs were alkylacyl PCs, as PC (o-
16:0/16:0, o-18:0/16:0, o-18:1/18:0 (18:1)) corresponding to
ions at m/z 720.7, 748.7 and 774.7 respectively. Diacyl PCs
species are more abundant than alkylacyl PC in rat decidual
cells. PCs (o-36:0; o-36:5; 36:4; o-38:6; o-38:4; 38:7 and 38:4),
correspondent to the PC molecular species bearing longer FA
chain, were the species that exhibited the higher relative
content increase in the treated group. These species contain
the FA (20:4), assigned to AA.
Phosphatidylethanolamine
Ethanolamine phospholipids (PE) are key membrane fluidizing
PLs. Moreover they have also been linked to apoptosis (Emoto
et al., 1997). PE was analyzed by ESI–MS in positive mode, with
formation of [MþH]þ (Table 1, Fig. 5). The diacyl PE (18:0/
20:4) corresponding to [MþH]þ at m/z 768.5 was the higher
relative abundant molecular specie, followed by alkylacyl PEs
(o-18:2/20:4; o-18:1/20:4; o-16:1/20:4) at m/z 752.7; 750.5 and
724.5, respectively, and PE (18:0/18:1) atm/z 748.6. Similarly to
results obtained for PC, there is a slight increase in PE with
longer FA chains.
PC and PE plasmalogens
Plasmalogens (Pls) comprise all plasmenyl and plasmanyl
phospholipids containing ethanolamine or choline in the head
group of the glycerol backbone, synthesized in peroxisomes.
Besides structural functions, PIs have been implicated in several
biological processes where they can affect membrane fluidity,
mediate signal transduction, protect against oxidative stress
and modulate pathophysiological changes (Brites et al., 2009;
Wanders and Waterham, 2006). Several studies have
supported the hypothesis that plasmalogens, due to their high
susceptibility to oxidative damage, possess antioxidant
properties (Khaselev and Murphy, 2000; Lessig and Fuchs,
2009). In this study we found that decidual cells exhibit high
abundance of plasmalogens, and also, we found an significant
increase of relative content the of plasmenyl PCs (o-16:1/20:4;
o-18:2/20:4) and plasmanyl PCs (o-18:0/18:0; o-18:0/20:4)
molecular species with treatment (Fig. 4). This fact is of
particular relevance, as it has been demonstrated that upon
decidualization, endometrial stromal cells became resistant to
Fig. 4. Analysis of PCs molecular species profile changes and MS spectra. (A) Analysis of PCs molecular species changes expressed as a ratio
of relative content of Treated group vs Control group. (B) HILIC-MS and MS/MS spectra for PCs in the positive mode [M-H]þ of Control
group. (C) HILIC-MS and MS/MS spectra for PCs in the positive mode [M-H]þ of AEA-treated group. Significant differences between groups
were evaluated. Results from three independent experiments are shown (**** P< 0.0001, *** P< 0.001 vs control; Multiple t test, and Sidak-
Bonferroni post test). m/z, mass/charge of each ion; C:N, total number of carbons in the fatty acid chains: total number of double bonds; o-C:
N, plasmalogens; Ratio T/C, Ratio Treatment/Control.
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oxidative stress (Kajihara et al., 2013). In addition, a recent
study suggested an anti-apoptotic action of Pls in the brain by
enhanced phosphorylation of the phosphoinositide 3-kinase
(PI3K)-dependent serine/threonine-specific protein kinase Akt
and extracellular-signal-regulated kinases ERK1/2 (Hossain
et al., 2013). Although, contradictory studies reported that
plasmalogen-containing cell membranes are less fluid, more
instable and susceptible to oxidative damage than the
plasmalogen-deficient membranes (Hermetter et al., 1989).
Our results may indicate that plasmalogens may provide a
robust defensive mechanism of decidual cells against oxidative
stress. Moreover, upon AEA-treatment rat decidual cells may
reinforce this response to oxidative stress, by synthesizing
plasmalogens, though these findings require further
clarifications.
Phosphatidylserine
Phosphatidylserine (PS) is a negatively charged PL, normally
located in inner membrane leaflet. PS was analyzed by ESI–MS
Fig. 5. Analysis of PEs molecular species profile changes and MS spectra. (A) Analysis of PEs molecular species changes expressed as a ratio
of relative content of Treated group vs Control group. (B) HILIC-MS and MS/MS spectra for PEs in the positive mode [M-H]þ of Control
group. C) HILIC-MS and MS/MS spectra for PEs in the positive mode [M-H]þ of AEA-treated group. Significant differences between groups
were evaluated. Results from three independent experiments are shown (**** P< 0.0001, *** P< 0.001 vs control; Multiple t test, and Sidak-
Bonferroni post test). m/z, mass/charge of each ion; C:N, total number of carbons in the fatty acid chains: total number of double bonds; o-C:
N, plasmalogens; Ratio T/C, Ratio Treatment/Control.
Fig. 6. Analysis of PSs molecular species profile changes and MS spectra. (A) Analysis of PSs molecular species changes expressed as a ratio
of relative content of Treated group vs Control group. (B) HILIC-MS and MS/MS spectra for PSs in the negative mode [M-H]- of Control
group. (C) HILIC-MS and MS/MS spectra for PSs in the negative mode [M-H]- of AEA-treated group. Significant differences between groups
were evaluated. Results from three independent experiments are shown (**** P< 0.0001, * P< 0.05 vs control; Multiple t test, and Sidak-
Bonferroni post test). m/z, mass/charge of each ion; C:N, total number of carbons in the fatty acid chain: total number of double bonds; o-C:N,
plasmalogens; Ratio T/C, Ratio Treatment/Control.
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in negative mode, with formation of [M–H] (Table 2,
Fig. 6). The species with highest relative abundance
identified were PS (18:0/18:1), PS (18:0/20:4), and PS (18:0/
22:6) corresponding to the ion [M–H] at m/z of 788.4, 810.4
and 834.4. PS (16:/20:4) and PS (18:0/20:4) at m/z 782.4 and
810.4 were the species which exhibited a higher relative
increase and just PS (18:0/18:1) at m/z 788.4 decreased with
AEA-treatment.
PS exposure on the external leaflet of the plasma membrane
is widely observed during early apoptosis (Vance and
Steenbergen, 2005). Despite, it has also been suggested that
over expression of PS synthases and accumulation of PS might
enroll a protective effect against apoptosis in different systems
(Yu et al., 2004; Kim et al., 2010; Ferrara et al., 2013). As with
results obtained for TLC our findings suggest that PS is being
synthesized during the AEA-apoptotic stimuli.
Phosphatidylnositol
Phosphatidylinositol (PI) was analyzed by ESI–MS in negative
mode, with formation of [M-H]- ions (Table 2, Fig. 7). PI (18:0/
20:4) corresponding to m/z 885.6 was the most relative
abundant, followed by PI (18:0/20:3) at m/z 887.6 and PI (16:0/
20:4) at m/z 857.6.
PI is the primary source of the AA required for eicosanoids
biosynthesis by enzyme phospholipase A2 (PLA2). It was
observed a decreased of the majority of PI species. PIs display
major roles in intracellular signaling and cell proliferation/
apoptosis, and its downregulation may represent a protective
response against proapoptotic stressors. Furthermore,
phosphoinositides like phosphatidylinositol 3,4,5-
trisphosphate (PIP3) and phosphatidylinositol 3,4-biphosphate
(PIP2) promote cell survival and protect against apoptosis by
activating Akt/PKB phosphorylating components of the
apoptotic machinery. Also inhibition of phosphatidylinositol 3-
Kinase-Akt signaling blocked growth, and promoted apoptosis
in lung cells (Krystal et al., 2002).
As aforementionedweobserved an increase in PS levels. Both
PS and PI share the same substrate (CDP-diacylglycerol orCDP-
DAG) for synthesis. This may imply that probably AEA displayed
a preference on up-regulation of PS synthesis over PI synthesis,
probably by downregulation of PI synthesizing enzyme.
Conclusion
Membrane is strictly and dynamically regulated. Increased
phospholipid metabolism involves a multifactorial over-
activation of phospholipases and elongases, imbalances in
saturated/unsaturated fatty acids levels and oxidative stress. As
a result it may disrupt the framework of membrane dynamics
and have further harmful biologic effects. We described here a
possible key role of phospholipid changes in mediating AEA
effects, although it may also embody a natural consequence of
the membrane alterations associated with apoptosis. Albeit, in
overall our data brings out a possible adaptation, or rather a
consequence of membrane metabolism in response to AEA-
induced cell death by essentially two mechanisms: fatty acid
desaturation pathway and the deacylation-reacylation cycle,
resulting in a reorganization of membrane phospholipidome
and biochemical properties. Altered cellular lipid metabolism
contributes to pregnancy disorders and hence changes in the
lipidome may reflect metabolic alterations. To our knowledge,
this is the first study considering AEA effect on rat decidua
remodeling, revealing compositional changes in phospholipid
molecular species, and may provide a global vision of an
adaptive response of this tissue to apoptotic stimuli. On the
other hand, membrane dynamics and integrity changesmay also
affect endocannabinoid signaling and uptake. Deregulation of
the decidualization process may hamper the success of
pregnancy. Therefore, in the future, lipidomic approach may
provide a powerful tool to better understand the mechanisms
underlying the uterine remodeling process and the impact of
endocannabinoid system disturbance on decidual phospholipid
metabolism during pregnancy..
Fig. 7. Analysis of PIs molecular species profile changes and MS spectra. (A) Analysis of PIs molecular species changes expressed as a ratio of
relative content of Treated group vs Control group. (B) HILIC-MS and MS/MS spectra for PIs in the negative mode [M-H]- of Control group.
(C) HILIC-MS and MS/MS spectra for PIs in the negative mode [M-H]- of AEA-treated group. Significant differences between groups were
evaluated. Results from three independent experiments are shown (* P< 0.05 vs control; Multiple t test, and Sidak-Bonferroni post test). m/z,
mass/charge of each ion; C:N, total number of carbons in the fatty acid chains: total number of double bonds; o-C:N, plasmalogens; Ratio T/C,
Ratio Treatment/Control.
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Signalling pathwayRecently, endocannabinoids have emerged as signalling mediators in reproduction. It is widely accepted that
anandamide (AEA) levels must be tightly regulated, and that a disturbance in AEA levels may impact decidual
stability and regression.We have previously characterized the endocannabinoidmachinery in rat decidual tissue
and reported the pro-apoptotic action of AEA on rat decidual cells. Cyclooxygenase-2 (COX-2) is an inducible
enzyme that plays a crucial role in early pregnancy, and is also a key modulator in the crosstalk between
endocannabinoids and prostaglandins. On the other hand, AEA-oxidative metabolism by COX-2 is not merely a
mean to inactivate its action, but it yields the formation of a new class of mediators, named prostaglandin-
ethanolamides, or prostamides. In this study we found that AEA-induced apoptosis in decidual cells involves
COX-2 metabolic pathway. AEA induced COX-2 expression through p38 MAPK, resulting in the formation of
prostamide E2 (PME2). Our findings also suggest that AEA-induced effect is associated with NF-kB activation.
Finally, we describe the involvement of PME2 in the induction of the intrinsic apoptotic pathway in rat decidual
cells. Altogether, our findings highlight the role of COX-2 as a gatekeeper in the uterine environment and clarify
the impact of the deregulation of AEA levels on the decidual remodelling process.
© 2015 Elsevier B.V. All rights reserved.1. Introduction
The cyclical waves of proliferation, differentiation, shedding, and
regeneration of the endometrium are a remarkable feature during the
reproductive life. The endometrial stromal cells proliferate and differen-
tiate into specialized decidual cells in a process named decidualization.
In humans, this process represents a tipping point that ensures, every
month, the achievement of a receptive uterus primed for implantation
[1], while in rodents the decidual reaction occurs in response to blasto-
cyst implantation [2]. Although the highly dynamic nature of the endo-
metrium is well documented, the mechanisms that orchestrate this
process are poorly clarified.
Over the last decades, the upcoming role of endocannabinoids as
signallingmediators emerged in several physiological and pathophysio-
logical functions. The endocannabinoid system (ECS) comprises two G-
protein-coupled cannabinoid receptors (CB1 and CB2), their endoge-
nous ligands (the endocannabinoids, eCBs), and biosynthetic and
hydrolysing enzymes for eCBs [3]. This is an evolving system, operating
in coordination with a hormonal and cytokine network, which controls
several reproductive events, including decidualization [3].
Anandamide (AEA) is one of the main endocannabinoids. A physio-
logical tone of AEA, that warrants a receptive uterine environment, ismainly mediated byN-acylphosphatidylethanolamine-specific phos-
pholipase D (NAPE-PLD), the enzyme responsible for AEA synthesis,
and fatty acid amide hydrolase (FAAH), the enzyme in charge of AEA
degradation into ethanolamide and arachidonic acid (AA). The latter
serves as a precursor for prostaglandin synthesis by cyclooxygenase-2
(COX-2) [4]. In mice and humans, a shift in the balance between AEA
levels and FAAH activity has been correlated with impaired implanta-
tion and/or miscarriages [5]. Besides hydrolyses by FAAH, AEA may
undergo direct oxygenation by COX-2, resulting in the formation of
prostaglandin-ethanolamides, also termed prostamides (PMs), such as
PME2 and PMF2α [6]. The oxidativemetabolismof AEA, initially consid-
ered an alternative catabolic route, has recently gained relevance as a
source of new lipid mediators, with unique biological activity [7]. It
has been described that COX-2 mediates several cellular events of
eCBs, and that AEA modulates PG production and COX-2 expression in
reproductive tissues and other systems [7–10]. For instance, COX-2 is
involved in the AEA-induced apoptosis in human cervical carcinoma
cells and lung cancer cells [11–13]. It is known that COX-2 is critical in
implantation and decidualization [14], though the underlying mecha-
nisms are still unknown. Moreover, although several lines of evidence
reinforce the interplay between endocannabinoids and prostaglandins,
the intricate crosstalk is not yet clarified.
Apoptosis in the endometriumplays an essential role for endometri-
al receptivity and early pregnancy. Previously, the pro-apoptotic-effect
of AEA in rat decidual cells has been described [15], unravelling the
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study we investigated the role of COX-2 oxidative metabolism of AEA
in its pro-apoptotic action in rat primary decidual cells, and the
molecularmechanisms that underlie COX-2 regulation.We hypothesize
that a disruption of FAAH activity, and/or aberrant eCB signalling, may
favour COX-2-mediated oxidation of AEA and overwhelm the decidual
regression process through the formation of pro-apoptotic PMs, thereby
impairing the pregnancy outcome.
2. Material and methods
2.1. Animals
All animal experiments were conducted with Direção-Geral de
Alimentação e Veterinária (DGAV) approval and conformed to the
European legislation on the use of laboratory animals. Briefly, female
Wistar rats (Charles River Laboratories, Barcelona, Spain) were mated
and the day on which spermatozoa were found in the morning vaginal
smear was designated as day 1 of pregnancy. On day 10 of pregnancy,
animals were anesthetised and sacrificed and uterine horns were
collected for cell culture studies.
2.2. Cell cultures
Mesometrial decidua was dissected from antimesometrial decidua
and digested with dispase II (2.4 U/ml) (Roche Diagnostics GmbH,
Mannheim, Germany), colagenase (50 U/ml) (Sigma Chemical Co, St.
Louis, MO, USA) and Dnase I (200 U/ml) (Roche Diagnostics GmbH,
Mannheim, Germany) in HBSS (Gibco/Invitrogen Corporation, Carlsbad,
CA, USA) for 1 h at 37 °C. Non-digested tissue was removed by filtration
through a 60 μmmesh and decidual cells were collected by centrifuga-
tion at 200 g for 10min as previously described [19]. Erythrocytes were
removed by the addition of NH4Cl solution (0.83%) followed by incuba-
tion on ice for 10 min. Cells were cultured in Dulbecco's minimum es-
sential medium (DMEM) (Gibco/Invitrogen Corporation, Carlsbad, CA,
USA) supplemented with antibiotic–antimicotic solution (200 U/ml
penicillin G, 0.5 μg/ml amphotericine B and 200 μg/ml streptomycin)
(Gibco/Invitrogen Corporation, Carlsbad, CA, USA) and 10% FBS
(Gibco/Invitrogen Corporation, Carlsbad, CA, USA) under a 95% air–5%
CO2 humidified atmosphere for 4 h. After adhesion, cells were
cultured for 24 h in DMEM without FBS in the presence or absence of
anandamide (AEA, 10 μM). In order to study the involvement of COX-
2, cells were pre-incubated with selective COX-2 inhibitors Celecoxib
(0.1 μM) and R-Flurbirpofen (1 μM), 30 min before AEA treatment.
The effects of AEA in the presence of a FAAH inhibitor, URB 597
(10 μM), added 30 min previously to AEA treatment were studied. The
inhibitors of p38 MAPK (SB202190; 25 μM) and p44/42 (PD98059;
20 μM), were added 30 min before AEA. Stock solutions were prepared
in ethanol and stored in aliquots at−80 °C. For mesometrial explant
cultures, 100 mg of mesometrial decidua was cut out and pinned in
sterile plastic organ-culture dishes and maintained at same conditions
as the primary decidual cell cultures. After treatment the decidual frag-
ment and medium were collected and stored at−80 °C.
2.3. Immunocytochemistry
Cells (2.5 × 105 cells/well) were seeded on eight-well glass chamber
slides and incubated for 24 h in the presence or absence of anandamide.
After incubation, cells were fixed for 15 min at room temperature in 4%
paraphormaldehyde. After fixation, cells were permeabilized with PBS,
0.1% Triton X-100 and 0.2% Tween-20 solution. Nuclear factor-kappaB
(NF-kB) expression, was analysed using an avidin–biotin alkaline phos-
phatase complex immunocytochemical technique (Vectastain ABC kit,
Vector Laboratories, CA, USA). The slides were incubated overnight
at 4 °C with the primary rabbit NF-kB (1:100) (sc-372, Santa Cruz,
CA, USA). After washing with PBS they were incubated with dilutedbiotinylated secondary antibody for 30 min, followed by incubation
with Vectastain ABC-AP reagent as recommended in the kit instructions.
The reaction was developed by incubation with Sigma Fast Red™
tablets (Sigma® FastTM Fast Red-TR/Naphtol). Negative controls were
performedwith the inclusion of rabbit or goat IgG insteadof the primary
antibody. The slides were counterstained with Mayer's Haematoxylin
solution (Sigma Chemical Co, St. Louis, USA) andmounted in Aquamont
improved medium (BDH Laboratory Supplies, Pool, England).
2.4. Cell viability, cytotoxicity assays and nuclear morphology
Cells were cultured in ninety-sixwell plates at a density of 2.5 × 105/
ml for 12–48 h in the presence or absence of AEA (0.1–25 μM). After
incubation, MTT (0.5 mg/ml final concentration) (Sigma Chemical Co,
St. Louis, MO, USA) was added and the plate was incubated for 3 h at
37 °C. The formazanwas quantified spectrophotometrically by the addi-
tion of DMSO:isopropanol mixture (3:1). LDH release was measured
using CytoTox 96 nonradioactive cytotoxicity assay kit (Promega, Mad-
ison,WI, USA) according to themanufacturer's protocol. Control exper-
iments with equimolar concentrations of ethanol or DMSO alone or
with the inhibitors did not show any significant effect on the parame-
ters investigated in this study (data not shown). The results of cell via-
bility are the mean of three independent experiments performed in
triplicate and are expressed as a percentage of the untreated control
cells. The alterations in cell morphology induced by PME2 (10 μM)
treatment for 24 h were analysed by Höechst staining. This concentra-
tion was selected according to the viability assays of the cellular
model. After treatment, cells plated in 24-well lamellae were fixed
with methanol, stained (0.5 mg/ml Höechst 33342) and and examined
under a fluorescencemicroscope (Eclipse E400, Nikon, Japan) equipped
with an excitation filter with maximum transmission at 360/40 nm.
2.5. Evaluation of mitochondrial membrane potential (Δψm) and intracel-
lular reactive oxygen species (ROS)
For the assessment of Δψm and ROS production, decidual cells were
seeded in 96-well black plates and treated for 24 h. For Δψm studies,
cells were washed and incubated with DiOC6 40 nM, for 15 min, at 37
°C, in the dark. For evaluation of ROS production, cells were incubated
with the fluorescent probe 2,7-Dichlorodihydrofluorescein-diacetate
(DCDHF-DA), for 1 h, at room temperature. The fluorescence intensity
was detected using a Microplate Fluorimeter (BioTek Instruments,
Vermont, USA), with excitation and emission wavelengths of 488 nm
and 525 nm, respectively. The positive controls forΔψmor ROS produc-
tion were the carbonyl cyanide m-chlorophenyl hydrazone (CCCP) or
phorbol 12-myristate 13-acetate (PMA), respectively. The results were
expressed in relative fluorescence units (RFU). For all measurements,
basal fluorescence was subtracted.
2.6. Determination of caspase-3/-7 and -9 activities
The caspase-GloTM-3/-7 and -9 assays (Promega Corporation,
Madison, WI, USA) were used for the evaluation of caspase-3/-7 and -
9 activities. Cells were seeded (2 × 104/well) in 96-well microplates,
for 18 h and the respective caspase reagents were added to the cells
according to kit instructions Luminometer readings were taken after
1.5 h of incubation at room temperature. Staurosporine (STS) was
used as a positive control. The resultant luminescence was measured
in relative light units (RLU) using a Microplate Luminometer (BioTek
Instruments, Vermont, USA).
2.7. Western blotting
Western blotting was performed for analysis of COX-2,MAPK kinase
and IkB-α protein levels. Decidual cells were cultured and treated with
AEA for 1 h, 6 h and 24 h, in the presence and absence of URB 597. Cell
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cocktail of protease and phosphatase inhibitors. Protein concentrations
were measured by Bradford assay. Samples (25 μg) were run on 10 or
12.5% SDS polyacrylamide gels and transferred to a nitrocellulose
membrane. Membranes were then incubated with antibodies against
goat-COX-2 (sc-1745, Santa Cruz Biotechnology), rabbit Ikβ-α (sc-
847, Santa Cruz Biotechnology) and rabbit phospho-p38 Thr180/
Tyr182 (9215), phospho-p44/42 Thr202/Tyr204 (9101), phospho-JNK
(Thr183/Tyr185, 9251) (Cell Signaling Technology) or the respective
non-phosphorylated forms (anti-human rabbit IgG, Cell Signaling
Technology) at 4 °C overnight. Membraneswere thenwashed and incu-
bated with goat or rabbit IgG horseradish peroxidase-conjugated
antibody, and detected by enhanced chemiluminescence. β-Tubulin
(H-235, Santa Cruz Biotech) was used as a loading control. To quantify
and compare protein levels, the density of each band was measured
by densitometry.
2.8. COX-2 enzyme activity assay
After treatments, cells were collected by centrifugation. Cell pellets
were lysed in cold buffer (0.1 M Tris–HCl, pH 7·8 containing 1 Mm
ethylenediaminetetraacetic acid) and centrifuged at 10,000 g for
15 min at 4 °C. The COX-2 activity was measured by the peroxidase
activity of COX-2. Briefly, the peroxidase activitywas assayed colorimet-
rically bymonitoring the appearance of oxidizedN,N,N′,N′-tetramethyl-
p-phenylenediamine (TMPD) at 590 nm. The assay mixture containing
assay buffer, heme and sample, were incubated for 5 min at 25 °C,
and TMPD was added. The reactions were initiated by adding arachi-
donic acid and incubated for 5 min at 25 °C and the absorbance read
at 590 nm. COX-2 activity was then calculated using the following for-
mula whereby 1 unit is defined as the amount of enzyme to oxidize
1 nmol of TMPD per min at 25 °C: COX-2 activity = [(Δ590 / 5 min /
0.00826 μM− 1) × (0.21 ml / 0.01 ml)] / 2.Fig. 1.Effect of AEA inCOX-2 and FAAHprotein expression. A) Time-course analysis of COX-2 ex
6 h and 24 h of treatment byWestern blot. B) Relative ratios of COX-2 and β-tubulin expression
expression levels in the control group and in the presence of AEA, following 1 h, 6 h and 24 h o
after 6 h and 24 h. Effect of URB 597 in COX-2 expression. (****P b 0.001, ***P b 0.01, **P b 0.1,2.9. Extraction of COX-2-derivatives and development of an LC–MSmethod
for their quantification
Extraction from cell pellet and tissues, purification and quantifica-
tion of AEA, 2-AG and their COX-2-derived metabolites such as PMs
and prostaglandin-glycerol esters (PG-GEs), such as PMF2α, PME2,
PGF2α-GE and PGE2-GE, require several biochemical steps [16]. First,
samples are homogenized and extracted with acetone containing
internal deuterated standards (i.e. [2H]8AEA, [2H]52AG, [2H]4PMF2α,
[2H]4PME2, [2H]4 PGF2α-GE and [2H]4 PGE2-GE) for AEA, 2-AG,
PMF2α, PME2, PGF2α-GE and PGE2-GE quantification by isotope dilu-
tion LC–MS. The lipid-containing organic phase is dried down, weighed
and pre-purified by open bed chromatography on silica gel. Fractions
are obtained by eluting the column with 99:1, 90:10, 70:30 and 50:50
(v/v) chloroform/methanol. The 90:10 fraction is used for AEA and 2-
AG quantification by liquid chromatography–atmospheric pressure
chemical ionization-mass spectrometry (LC–APCI-MS), using selected
ion monitoring at M + 1 values for the four compounds and their
deuterated homologues. The 70:30 fraction is used for COX-2 deriva-
tives quantification by LC–MS-IT-TOF analysis (Shimadzu Corporation,
Kyoto, Japan) equipped with an ESI interface, using multiple reaction
monitoring. The chromatograms of the high-resolutionM +Na+ values
are extracted and used for calibration and quantification. AEA and 2-AG
were measured as previously described [17]. COX-2 derivatives were
measured by LC–MS–MS, using an LC20AB coupled to a hybrid detector
IT-TOF (Shimadzu Corporation, Kyoto, Japan) equipped with an ESI in-
terface. LC analysis was performed in the isocratic mode using a
Discovery® C18 column (15 cm × 2.1 mm, 5 μm) and methanol/
water/acetic acid (53:47:0.05 by vol.) as mobile phase with a flow rate
of 0.15 ml/min. Identification of PME2, PMF2α, PGE2-GE and PGF2α-
GE was carried out using ESI ionization in the positive mode with neb-
ulizing gasflow of 1.5ml/min and curved dessolvation line temperature
of 250 °C.pression after AEA treatment, andwith orwithout FAAH inhibitor (URB 597), following 1 h,
(used as a loading control). C) Analysis of COX-2 activity after 24 h of treatment. D) FAAH
f treatment. E) COX-2 expression upon treatment with AEA plus AM251 (CB1 antagonist)
*P b 0.05 vs. Control).
Fig. 3. Influence of COX-2 inhibition onAEA-induced cell death in rat primary decidual cell.
Co-incubation of AEA with two selective COX-2 inhibitors, Celecoxib (0.1 uM) and R-
Flurbiprofen (1 μM) significantly counteracted AEA-induced loss of cell viability. URB
598 plus AEA induced a higher decrease in decidual cell viability. (****P b 0.0001 vs. Con-
trol and ###P b 0.001 vs. AEA).
Fig. 2. Prostamides and endocannabinoid levels measured by LC–MS-IT-TOF. A) Levels of prostamide E2 (PME2) in rat decidual cells, after 24 h of treatment. B) PME2 levels in rat
mesometrial decidual explants. Endogenous PME2 levels were detected in rat uterine explants. C) Levels of PMF2α, with or without URB 597, after 24 h of treatment in decidual cell cul-
tures. D) Relative levels of endocannabinoids and N-acylethanolamines in decidual cells. Results are expressed as the ratio between the AEA or AEA co-incubated with URB 597 levels vs.
Control (in the absence of AEA). (****P b 0.0001, **P b 0.01 vs. Control and ###P b 0.001 vs. AEA).
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All assays were performed at least three times in triplicates. Statisti-
cal analysis was performed by using one-way ANOVA, followed by
Tukey's ad-hoc post-test (GraphPad PRISM version 4.0, GraphPad
Software, Inc., San Diego, CA, USA). All numerical data are expressed
as mean ± SEM and differences were considered to be statistically
significant when P b 0.05.
3. Results
3.1. Time-dependent AEA-induced increase in COX-2 expression and
activity
In this study we performed a time-course analysis of COX-2 protein
levels and activity, following AEA (10 μM) treatment (Fig. 1). Ananda-
mide exposure led to an increase in COX-2 expression after 1 h of treat-
ment, reaching peak levels after 6 h of incubation (Fig. 1A, B). This effect
was slightly decreased after 24h of treatment, though the enzymeactiv-
ity remained significantly elevated by about 40% (Fig. 1C). Pre-
incubation of AEA with a FAAH inhibitor (URB 597), for up to 24 h, led
to a sustained and pronounced up-regulation of COX-2 protein levels
and activity (Fig. 1B, C), suggesting that AEA and not its hydrolysis prod-
ucts was responsible for the effect. On the other hand, it is widely ac-
cepted that endogenous cannabinoids are primarily hydrolysed by
fatty acid amide hydrolase (FAAH). Thus, we examined FAAH protein
levels under the same experimental conditions (with or without AEA-
treatment). Although FAAH is constitutively expressed in rat decidual
cells, its expressionwas not affected by AEA-treatment (Fig. 1D). To fur-
ther explore the role cannabinoid receptor 1 (CB1) on AEA-induced
COX-2 expression, AEA was pre-incubated with AM 251 (a selective
CB1 antagonist). As shown in Fig. 1E, the AEA-induced up-regulation
of COX-2 was not reversed by CB1 antagonist (Fig. 1E). The incubation
with URB 597 alone did not induce any alteration in protein expression
(Fig. 1E).
3.2. Prostamide levels and eCB Levels
COX-2 directly oxygenates AEA into prostamides. As the involve-
ment of COX-2 became apparent, we analysed prostamide levels by
LC–MS-IT-TOF. In the control group of rat decidual cells, we could not
detect PME2 (Fig. 2A). After 24 h treatment, with 10 μM of AEA, PME2levels increased up to 7 pmol/mg. Moreover, PME2 levels were drasti-
cally increased (26 pmol/mg) when AEA was pre-incubated with URB
597 (Fig. 2A). To prove the relevance of AEA-metabolites in our
experimental conditions, rat decidual explants were used to identify
PME2 endogenously. In the control group, 8.05 pmol/g of PME2 were
found, whereas AEA-treated explants presented in a 2-fold increase in
PME2 levels, and pre-incubation with URB 597 led to a 4-fold increase
compared to control (Fig. 2B). PMF2α was found in the control group
of decidual cells. AEA-treatment induced an increase in PMF2α levels,
and FAAH inhibition resulted in a 2-fold increase compared to control
(Fig. 2C). As expected, in AEA plus URB 597-treated cells, AEA levels
were significantly elevated, while the levels of other measured eCBs or
eCB-related mediators were not affected (Fig. 2D).
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Next, the effect of COX-2 inhibition in AEA-induced loss of decid-
ual cell viability was investigated. Cells were pre-incubated with two
COX-2-selective inhibitors, Celecoxib (0.1 μM) and R-Flurbiprofen
(1 μM), and viability of AEA-treated cells assessed by MTT assay. As
shown in Fig. 3, both inhibitors significantly counteracted the AEA-
induced decrease in cell viability. Moreover, COX-2 inhibition atten-
uated the features associated with the apoptotic process triggered by
AEA, such as the drop in ΔΨm, the increase in ROS production and
caspase-3/-7 and -9 activation (Fig. 4). In the presence of URB 597,
AEA induced a more pronounced decrease in cell viability (of 40%)
(Fig. 3).
3.4. Effect of major COX-2-derivatives on rat decidual cells
Additional experiments were performed to investigate the role of
the major COX-2 derivatives on primary rat decidual cells, namely
prostaglandin E2 and F2α (PGE2, PGF2α respectively) and prostamideFig. 4. Effect of PME2 and selective inhibition of COX-2 on decidual cell-induced apoptosis. PM
initiator caspase-9 (A) and effector caspase-3/-7 (B), the drop in mitochondrial membran
(D) caused by AEA. PME2 (10 μM) induced similar effects to AEA. (STS — staurosporine; CCCP
(****P b 0.0001, ***P b 0.01, **P b 0.1, vs. Control and ###P b 0.001, ##P b 0.01, #P b 0.05 vs. AE2 and F2α (PME2, PMF2α respectively). PGE2 (Fig. 5 A), PGF2α and
PMF2α (data not shown) did not affect cell viability. On the contrary,
the exposure of decidual cells to PME2 (0.01–50 μM) resulted in a
loss of cell viability in a concentration-dependent manner (Fig. 5B).
PME2 at 10 μM induced a decrease of 20% on cell viability. At this con-
centration, no LDH release was detected, and only concentrations
higher than 25 μM caused the release of this enzyme (Fig. 5C). AEA
co-administrated with PME2, did not have an addictive or synergistic
effect on cell viability (Fig. 3). To further understand the process associ-
ated with the decrease on cell viability, nuclear morphology and
mechanisms of apoptotic cell deathwere analysed. Generalmorphology
was preserved in PME2-treated cells. However, some cells presented
chromatin condensation and the presence of apoptotic bodies, sug-
gestive of the apoptotic process (Fig. 5D). As shown in Fig. 4, PME2
induced a 25% increase of the effector caspase-3/-7 activity. More-
over, PME2 engaged the intrinsic apoptotic pathway as assessed by
an increase of 24% in caspase-9 activity and a drop in ΔΨm of 18%.
PME2 led also to a significant increase of ROS production compared
to control.E2 triggers the intrinsic apoptotic pathway. Both inhibitors reverted the activation of the
e potential (ΔΨm) (C) and the increase in reactive oxygen species (ROS) production
— carbonyl cyanide m-chlorophenyl hydrazine; MPA — phorbol 12-myristate 13-acetate).
EA).
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To understand the underlying mechanisms of AEA induced-COX-2
expression, we focused on the downstream signalling pathways, such
as the MAPK cascade and NF-kB activation. As shown in Fig. 6, AEA
produced an early and persistent phosphorylation of p38 kinase, with
total p38 expression remaining unaltered. Following 24 h, when AEA
was pre-incubated with URB 597, p38 phosphorylation returned to
baseline (Fig. 6A, B). To reinforce the involvement of p38 MAPK as an
upstream regulator of COX-2, decidual cells were pre-treated with
SB202190, a specific p38 inhibitor, in the presence and absence of
AEA. The inhibition of p38 activation attenuated the AEA-induced
increase in COX-2 protein levels, after 6 h and 24 h treatment (Fig. 6C,
D). As shown in Fig. 6, the activation of p42/44 was noted upon 6 h of
AEA-treatment, but was independent of FAAH inhibition. Interestingly,
at 24 h, p-p42/44 levels were similar to control cells, and a further
dropwas inducedwhen AEAwas co-incubatedwith URB 597. However,
COX-2 up-regulation was not abolished by pre-incubation with
PD98059, a specific p42/44 inhibitor (Fig. 6E). AEA-treated cells, both
in the absence and presence of FAAH inhibitor, did not induce any alter-
ation of JNK phosphorylation (Fig. 6A, B). As activation of NF-kB occurs
via degradation of IkB-α, we examined IkB-α levels by Western blot.
IkB-α protein levels were reduced by AEA-treatment (Fig. 7A). Further-
more, the immunocytochemistry analysis showed NF-kB translocation
from the cytoplasm to the nucleus in AEA-treated cells, compared to
control cells, suggesting the activation of NF-kB pathway (Fig. 7B).
4. Discussion
Uterine tissue remodelling is a highly coordinated process involving
proliferation, differentiation and programmed cell death of endometrial
cells. The regulation of apoptosis plays an important role in tissue
homeostasis, as well as in endometrial remodelling. Recent research
in the endocannabinoid system has unravelled eCBs as mediators inFig. 5. Effect of prostaglandins and prostamides in cell viability. A) Prostaglandin E2 had no ef
assessed by the MTT assay. C) LDH enzyme release was observed for the highest PME2 doses (2
(white arrows). (****P b 0.001 vs. Control).early pregnancy events, such as implantation [18], decidualization [19,
20] and feto-placental development [21,22]. Previously,we have report-
ed that the eCBmachinery operates in the uterine environment and that
AEA-induced apoptosis of decidual cells occurs through CB1 and via the
activation of p38 pathway [15,19].
FAAH is the main hydrolytic enzyme, which degrades AEA into
ethanolamine and AA. The latter is a substrate to cyclooxygenases
(COX-1 and -2), to produce PGs. Alternatively, AEA is subjected to a di-
rect oxidativemetabolismby COX-2, but not COX-1, into a novel class of
lipid mediators, named prostamides [6]. Amongst eCBs, AEA has been
reported to regulate PGproduction in several systems, particularly in re-
productive tissues [23]. For instance, it was described that AEA exerts
opposite effects on PGE2 and PGF2α levels in uterine explants [24]. In
addition, COX-2 mediates eCB-induced effects, particularly in apoptosis
[25,26]. In mice, target disruption of COX-2, resulted in multiple repro-
ductive impairments, including decidualization [14]. Moreover, a local
increase of COX-2 expressionwas described during the decidual regres-
sion period [20,27]. Strikingly, in rats, COX-2 is mostly restricted to im-
plantation sites, surrounding the implanting blastocyst, which may be
associated with PGs production, a crucial factor for decidual cell reac-
tion. However, COX-2 is hardly detected at the inter-implantation
sites. Although the mechanisms underlying the COX-2-temporal and
spatial pattern of expression remain unclear, it points toward COX-2
importance on early pregnancy events.
The present study unravels the role of COX-2 metabolic pathway
in AEA-induced apoptosis in rat decidual cells. Regardless being
constitutively expressed in decidual tissue, AEA led to a prompt and
time-dependent increase in COX-2 protein levels. When AEA was pre-
incubated with a FAAH inhibitor, COX-2 was persistently elevated.
This indicates that AEA main hydrolysis product, AA, was not responsi-
ble for either AEA-apoptosis or up-regulation of COX-2. On the contrary,
FAAH expression was not affected by AEA-treatment, suggesting that in
decidual environment excess levels of AEA preferentially induced COX-
2 up-regulation, over FAAH. Reinforcing the importance of COX-2 in
AEA-induced effects, COX-2 inhibition, reverted the AEA-induced lossfect on decidual cell viability. B) PME2 (0.1–50 μM) induced a decrease in cell viability as
5–50 μM). D) PME2-treated cells presenting chromatin condensation by Hoescht staining
Fig. 6. Signalling pathways involved in AEA-induced COX-2 expression. A) Time-course expression of p38 MAPK, p44/42 and JNK signalling molecules after treatment with AEA, or AEA
pre-incubatedwith URB 597, byWestern blot. B) Relative ratios of phospho-p38MAPK, phospho-p44/42 and phospho-JNK to the respective non-phosphorylated form. C)AEApre-treated
with SB202190, a selective p38 inhibitor, reduced COX-2 expression, after 6 h and 24 h of treatment andD) relative ratios of COX-2 andβ-tubulin. E) AEA pre-treatedwith PD98059, a p42/
44 inhibitor, did not affect COX-2 expression after 6 h of treatment. In the absence of AEA, COX-2 expression was not affected. β-Tubulin was used as a loading control. (***P b 0.001,
**P b 0.01, *P b 0.05 vs. Control and ##P b 0.01 vs. AEA).
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cell death in decidual cells. In particular, R-Flurbiprofen, which prefer-
entially inhibits the COX-2-mediated oxidation of AEA vs. AA [28,29],
reverted apoptosis triggered by AEA.Fig. 7. Activation of NF-kB pathway byWestern blot and immunocytochemistry analysis. A) De
Tubulinwas used as a loading control. B) Immunolocalization of NF-kB in decidual cells in the co
nuclear expression of NF-kB (black arrows). Negative control obtained by omitting the primarThe strongest piece of evidence in favour of the physiological
relevance of the COX-2 oxidative metabolism of AEA on decidual cells
was the identification of prostamides as endogenous lipid mediators
in decidual tissue, particularly PME2 and PMF2α. We also found thatcreased IkB-α levels were found in the presence of AEA and in the presence of URB 597. β-
ntrol group (A) and AEA-treatment (B) for 24 h of treatment. In AEA-treated cells note the
y antibody. (Original magnification, ×400).
Fig. 8. AEA-induced decidual cell apoptosis involves COX-2-oxidative metabolism. Proposed mechanism of action. Anandamide (blue circles), in a mechanism independent of CB1, but
through p38 MAPK activation, induces an up-regulation of COX-2 expression and local formation of prostamides, resulting in decidual cell apoptosis. Moreover, when FAAH activity is
deregulated (in this case mimicked by FAAH inhibition), altered AEA levels potentiate COX-2 oxidative metabolism and a further increase in PME2 (orange circles) and cell apoptosis.
PME2-induced apoptosis on decidual cells, in a mechanism similar to AEA. (Arachidonic acid (AA); anandamide (AEA); cannabinoid receptor 1 (CB1); cyclooxygenase-2 (COX-2); etha-
nolamine (EA); mitochondrial membrane potential (Δψm), prostamide E2 (PME2); reactive oxygen species (ROS)).
1480 M. Almada et al. / Biochimica et Biophysica Acta 1851 (2015) 1473–1481decidual cells produced significant amounts of PME2 in response to
AEA, particularly when FAAH was inhibited. Although the formation of
COX-2-derived metabolites of eCBs has been known, their biological
effects remain to be fully elucidated. To date, they have been reported
as mediators in inflammation [16,30], pain [16], apoptosis [25,26] and
adipocyte differentiation [29]. In our model, the pro-apoptotic action
of AEAwasmimicked by themajor COX-2 derivative, i.e. PME2, suggest-
ing that it may account for AEA-induced impairment on decidual stabil-
ity. On the other hand, when added together, PME2 and AEA, did not
increase the AEA-induced loss of cell viability, suggesting a possible
common molecular mechanism.
In addition,we disclosed themolecularmechanism underlying AEA-
induced COX-2 up-regulation. Previously, we reported that AEA-
induced apoptosis in decidual cell wasmediated through p38 activation
[19] and that CB1 antagonist partially attenuated this effect [15].
Presently, we further demonstrate that p38MAPK activation alsomedi-
ates the AEA-induced effect on COX-2 protein levels. Interestingly,
while short term exposure to FAAH inhibition induced p-p38 MAPK,
long term exposure prevented p38 activation [31,32]. Although differ-
ent pathways may be involved, this phenomenon was previously
reported andmay suggest a negative feedback loop to dephosphorylate
activated p38 [31], or as the level of total p38was constant, the observed
changes might reflect a drop of kinase activity [32]. On the other hand,
although AEA induced an early activation of p42/44, the inhibition of
this pathway did not prevent the effect upon COX-2 regulation.
Phosphorylation of p42/44 is generally associated with cell survival,
proliferation and differentiation, and its inhibitionmay result in apopto-
sis [32]. The reduction of IkB-α levels, as well as the translocation of NF-
kB to the nucleus after AEA treatment, also indicates the involvement of
NF-kB pathway.
Although COX-2 is not considered amajor eCB-metabolic enzyme, it
may compete with FAAH for eCB as substrates, and utmost our results
shed light on the COX-2's physiological influence on AEA-signalling.
Besides the drastic and sustained up-regulation of COX-2, FAAH inhibi-
tion led to a significant decrease of decidual cell viability and a consider-
able increase of PME2 levels. In FAAH−/− female mice, preimplantation,embryo development and pregnancy outcome are adversely affected
[33]. In a similar context, low FAAH activity and high AEA plasma levels
were apparent in recurrentmiscarriage or poor implantation in women
undergoing in-vitro fertilization [5]. Also, low or absent FAAH expres-
sion was associated with spontaneous miscarriage [34]. Thus, on the
basis of ours findings, it may be suggested that increased levels of
AEA, due to aberrant biosynthesis and/or deregulation of FAAH activity
(in this case, mimicked by FAAH inhibition), might potentiate endoge-
nous prostamide signalling.
It has been postulated that eCBs are involved in a network of
hormones, cytokines and other lipids, such as prostaglandins, which
modulate cellular events critical for early pregnancy development.
Albeit AEA levels in the uterus are higher than those in any other
organ, low levels are required in the receptive uterus or at implantation
sites [35]. Maternal eCB tissue levels are strictly regulated to allow
implantation and establishment of pregnancy. Given the COX-2 differ-
ential pattern of expression during decidual remodelling process, our
results underlie how the endometrium may represent a niche in
which COX-2 acts as a central gatekeeper toward AEA decidual signal-
ling and in situ levels.
In overall, our study unveils that in the decidual environment,
altered levels of AEA induce COX-2 upregulation, through p38 MAPK,
resulting in the local increase of prostamides and decidual apoptosis
(Fig. 8). Moreover, it is tempting to speculate that when FAAH activity
is disrupted, excess AEA levels may interfere with COX-2 regulation,
and impair decidual stability. As decidual cells may be central
controllers of uterine endocannabinoid levels during early pregnan-
cy, AEA metabolic pathway must be tightly regulated during decidu-
al remodelling process. Otherwise, a disruption on AEA signalling
might be decisive for decidual cell fate and result in deleterious
effects during pregnancy or in disorders like miscarriage and
infertility.
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Abstract 
Endocannabinoids (eCBs) are endogenous lipid mediators that bind and activate the cannabinoid receptors 
(CB1, CB2). These compounds along with their receptors, a membrane transporter and the respective 
metabolic enzymes form the endocannabinoid system (ECS). Several eCBs have been discovered with 
emphasis on anandamide (AEA). They are involved in several basic biological processes like energy balance, 
immune response and reproduction. 
A well-coordinated process, named decidualization, occurs during the secretory phase of the human 
menstrual cycle, which involves intense proliferation and differentiation of endometrial stromal cells into 
decidual cells is a prerequisite for the establishment and progression of pregnancy. In rat, we have previously 
reported that AEA impairs the progression of the decidual process, although its role on human decidualization 
is yet unknown. In this study, it was employed a telomerase-immortalized human endometrial stromal cell line 
(St-T1b) and primary cultures of human decidual fibroblasts (HdF) from term placenta, in which the ECS was 
characterized in both non-differentiated and differentiating cells, by immunoblotting and qRT-PCR 
experiments. It was shown that St-T1b cells express CB1 receptor, but not CB2, though both cannabinoid 
receptors are expressed in HdF cells. In addition, it was detected an increase in the expression of fatty acid 
amide hydrolase (FAAH), the main degrading enzyme of AEA, during decidualization. Furthermore, the impact 
of deregulated levels of AEA was explored during the decidualization process. Two major outcomes are 
highlighted in this study. Anandamide inhibits cell proliferation, interferes with cell cycle progression and 
induces polyploidy. Moreover, through CB1 binding receptor, AEA also impairs cell differentiation. Therefore, 
AEA is proposed as a novel modulator of human decidualization. Our findings may provide wider implications, 
in a clinical perspective, as deregulated levels of AEA, due to Cannabis sativa consumption or altered 
expression of the metabolic enzymes, may negatively regulate human endometrial stromal cell proliferation 
and decidualization with an impact on human reproduction and (in)fertility. 
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Introduction 
The highly dynamic nature of human endometrium 
is a hallmark of reproductive biology. Human 
endometrial stromal cells (HESCs) undergo waves 
of proliferation and differentiation into 
morphologically and functionally distinct cells 
called decidual cells. This process, named 
decidualization, occurs in women during the 
secretory phase of the menstrual cycle and 
prepares a receptive uterus for implantation. The 
decidual process is triggered by sustained 
activation of the second messenger cyclic 
adenosine monophosphate (cAMP) and the 
protein kinase A pathway (PKA), which in turn 
sensitizes stromal cells to progesterone [1]. In 
addition to uterine angiogenesis and  homeostasis 
[2], decidual cells are responsible for embryo 
recognition [3], regulation of trophoblast invasion 
and modulation of immune and oxidative stress 
response at feto-maternal interface [4]. Impaired 
decidualization, as a result of poor hormone 
responsiveness and/or impaired endometrial 
stromal cell growth and/or differentiation, is often 
associated with implantation failure, unexplained 
infertility, recurrent spontaneous miscarriage, and 
pregnancy disorders, such as preeclampsia or 
intrauterine growth retardation and premature birth 
[5]. The endocannabinoids (eCBs), and 
particularly anandamide (AEA), the best studied 
eCB, are emergent modulators of several 
pathophysiological processes. Besides the 
endogenous cannabinoids, the endocannabinoid 
system (ECS) comprises the cannabinoid 
receptors (CB1 and CB2), the enzymes involved 
in the biosynthesis and degradation of eCBs, and 
a purported transporter [6]. AEA is mainly 
synthesized by N-
arachidonoylphosphatidylethanolamine 
hydrolyzing phospholipase D (NAPE-PLD), and, 
subsequently, hydrolyzed to arachidonic acid and 
ethanolamine by the enzyme fatty acid amide 
hydrolase (FAAH) [6]. The latter is considered the 
 major metabolic gatekeeper for AEA uterine levels 
throughout menstrual cycle and pregnancy [7, 8]. 
AEA modulates basic biological processes, 
including the choice between cell proliferation, 
death and differentiation [9]. In the rat model, it 
has been demonstrated that AEA interferes with 
decidual cell turnover by inducing apoptosis [6] 
and limits uterine stromal cell differentiation [10]. It 
has also been shown that AEA induces apoptosis 
in cytotrophoblast cells [11]. Nevertheless, the 
underlying mechanisms that govern the process of 
human endometrial decidualization and the 
involvement of the eCBs in this process remain 
poorly understood. Therefore, in this work we 
aimed to investigate the role of the main eCB, 
AEA on in vitro decidualization process in two cell 
culture models, an immortalized human 
endometrial stromal cell line (St-T1B) and human 
decidual fibroblasts (HdF) derived from human 
term placenta. The ECS was characterized in non-
differentiated and in cells undergoing 
decidualization, and the role of AEA in these cells 
was investigated.  
 
Material and methods 
St-T1b cell line culture 
The human endometrial stromal cell line (St-T1b) 
was kindly supplied by Dr. Birgit Gellersen from 
Endokrinologikum Hamburg, Hamburg, Germany. 
This cell line was obtained from uterine biopsy 
samples at the time of hysterectomy from benign 
gynaecological disorders and immortalized with 
human telomerase (hTERT) [12]. Cells were 
maintained at 37 °C with 5% CO2 in DMEM/F-12 
medium (Gibco Invitrogen Corporation, CA, USA) 
supplemented with 10% charcoal-stripped fetal 
bovine serum (CT-FBS) (Gibco Invitrogen 
Corporation, CA, USA), 1 nM 17-β- estradiol (E2) 
(Sigma-Aldrich Corporation, MO, USA), 1 μg/ml 
Insulin (Sigma-Aldrich Corporation, MO, USA) and 
2% penicillin-streptomycin-amphotericin B (Gibco 
Invitrogen Corporation, CA, USA). Initially, cells 
were incubated for 24 h in complete medium and 
then experiments were performed in DMEM/F-12 
with 2 % CT-FBS.  
 
Primary cultures of human decidual fibroblast 
(HdF) 
The protocol for the isolation of cells from term 
decidua was based on Richards et al, 1995 [13]. 
Caesarean or vaginal delivery normal human 
placentas (38–40 weeks of gestation) from 
Caucasian women, living in Porto region and aged 
24–36 years old, were obtained from Centro 
Materno-Infantil do Norte, Porto. All the 
procedures using term placentas were performed 
according to the Ethical committee of Centro 
Materno-Infantil do Norte. The decidua basalis 
was scraped from the chorionic membrane, 
dissected into small pieces and enzymatically 
digested in PBS with collagenase (1 mg/ml) for 1 h 
at 37 ºC with gentle shaking. The suspension was 
then centrifuged at 260 g for 6 min. The pellet was 
ressuspended with ammonium chloride (0.84%) 
solution for red blood cells lysis at 37 ºC. The 
resulted suspension was filtered through a 40 μm 
nylon mesh and centrifuged at 260 g for 10 min. 
The isolated cells were maintained at 37 ºC with 
5% CO2 in DMEM/F-12 medium supplemented 
with 10% CT-FBS, 1 nM E2, 1 μg/ml insulin and 
2% penicillin-streptomycin-amphotericin B. After 
24 h, the non-adherent cells were removed and 
the cells were grown to confluence and sub-
cultured. The purity of primary HdF was confirmed 
by immunocytochemical analysis for the 
cytoskeletal proteins vimentin and cytokeratin-7, a 
fibroblast and an epithelial cell marker, 
respectively (Fig. 1).  
 
Differentiation treatment 
In vitro differentiation was induced in minimal 
medium MM1 (DMEM/F-12 medium 
supplemented with 2% CT-FBS and 2% penicillin-
streptomycin-amphotericin B) containing 1 μM 
medroxyprogesterone acetate (MPA; Sigma-
Aldrich, MO, USA), 10 nM of E2 and with 0.5 mM 
of 8-Bromoadenosine 3',5'-cyclic monophosphate 
(cAMP, Sigma-Aldrich, MO, USA) or 0.05 mM 
cAMP, for St-T1b and HdF, respectively. The 
differentiation process was induced for 3 or 6 days 
(d), and the medium was changed every 3 d. Cell 
differentiation was confirmed by morphological 
analysis and mRNA levels of prolactin (PRL) and 
the insulin-like growth factor binding protein-1 
(IGFBP-1), the main secretory products of 
decidual cells, were evaluated by qRT-PCR. In 
order to investigate the role of AEA during the 
decidualization process, cells were treated with 
the differentiation medium (MM1 + cAMP, E2 and 
MPA) in the presence or absence of AEA (10 µM) 
(Tocris Bioscience, MN, USA). To explore the role 
of CB receptors, cells were pre-incubated with the 
CB1 antagonist (AM281) and the CB2 antagonist 
(AM630) for 30 min before the addition of AEA (10 
µM). At this concentration, the antagonists per se 
did not affect neither the decidual response nor 
cell viability. Non-differentiated cells treated with 
MM1 were used as a control. The results are the 
mean of at least three independent experiments 
carried out in triplicate. 
 
Cell viability and cell proliferation 
HdF and St-T1b cells were plated at a density of 
2.5 x 10
3 
cells/well in 96-well plates and treated 
with AEA (10 µM) in non-differentiated medium 
(minimal medium, MM1: DMEM/F-12 medium 
 supplemented with 2% CT-FBS and 2% penicillin-
streptomycin-amphotericin B), and with 
differentiation medium (MM1 + cAMP, E2 and 
MPA). Cell viability was assessed by MTT assay 
after 6 d of treatment. The yellow tetrazole MTT 
(0.5 mg/ml final concentration) (Sigma-Aldrich, 
MO, USA) was added and cells were incubated at 
37 ºC for 3 h. The resultant purple formazan was 
dissolved in a solution of 
dimethylsulfoxide:isopropanol (3:1) and 
spectrophotometrically quantified at 540 nm. To 
study the effects of AEA on DNA synthesis,
 3
H-
thymidine incorporation assay was performed. In 
the last 32 hours of each exposure time, 
3
H-
thymidine (0.5 µCi) (Amersham, BU, UK) was 
added to cells. Cells were harvested and, after 
addition of a scintillation cocktail, 
3
H-thymidine 
incorporation was determined in a scintillation 
counter (LS 6500, Beckman 
Instruments). Results are expressed as relative 
percentage of the untreated control cells. The 
results are the mean of at least three independent 
experiments carried out in triplicate. 
 
Morphological studies 
Morphological alterations induced upon 
differentiation treatment were evaluated by 
Giemsa staining. Both cell types were plated at a 
density of 1.5 x 10
4
 cells/well in 24-well culture 
plate, and cells were exposed to differentiation 
treatment for 6 d. After treatment, cells were fixed 
with 4% p-formaldehyde in PBS for 20 min at 4 ºC, 
and stained with Giemsa for 30 min. Cells were 
observed under the microscope Eclipse E400, 
Nikon equipped with image analysis software 
LeicaQwin (Cambridge, UK).  
 
qRT-PCR analysis 
For qRT-PCR analysis, cells were seeded in 6-
well plate, at a cellular density of 5 x 10
4
 cells. 
After treatment, the cells were collected in 
TRIzol® reagent (Gibco/Invitrogen Corporation, 
Carlsbad, CA, USA) and RNA and protein were 
extracted according to the manufacturer’s 
instructions. St-T1b and HdF cells were treated 
with the differentiation medium for 3 and 6 d. To 
study the role of the AEA and the involvement of 
CB receptors on the decidualization process, cells 
were treated with differentiation medium in the 
absence or presence of AEA (10 μM) plus 
CB1/CB2 antagonists for 6 d. The assessment 
of gene transcription was carried out by q-RTPCR. 
RNA was quantified in the NanoDrop ND-1000 
Spectrophotometer (NanoDrop Technologies, Inc., 
Wilmington, DE, USA), its quality was evaluated 
with the Experion RNA StdSens Kit (Bio-Rad 
Laboratories, PA, USA) and was analysed with 
Experion analytical software (Bio-Rad 
Laboratories, PA, USA). cDNA was obtained by 
reverse transcription of RNA using the iScript™ 
Select cDNA Synthesis Kit (Bio-Rad Laboratories, 
USA) and it was subsequently amplified with 
specific primers, using KAPA SYBR® FAST qPCR 
Master Mix 2x Kit (Kapa Biosystems, Woburn, MA, 
USA) in MiniOpticon Real-Time PCR Detection 
System (Bio-Rad Laboratories, PA, USA), 
according to the kit protocol. Table 1 resumes the 
primer sequences and the qRT-PCR conditions. 
The specificity of PCR product amplification was 
assessed by analysis of the melting curve. Gene 
expression was normalized with two 
housekeeping genes, GAPDH and β-2 
microglobulin, and their analysis was achieved by 
the calculation of ΔΔCT values. The results are 
the mean of at least four independent experiments 
carried out in triplicate. 
 
Immunocytochemistry  
For immunocytochemistry studies, cells were 
seeded in 24-well plate, at a cellular density of 1.5 
x 10
4
 cells, and fixed with cold methanol after 
treatment with differentiation stimulus for 6 d. The 
expression of proteins was analysed using an 
avidin–biotin alkaline phosphatase complex 
technique (Vectastain ABC kit, Vector 
Laboratories, CA, USA). The non-specific binding 
sites were blocked and slides were incubated with 
primary antibodies vimentin (1:500; sc 6260, St 
Cruz Biotechnology, CA, USA) and cytokeratin-7 
(1:100; M 7018, Dako, GP, Denmark) overnight at 
4 ºC. It was followed by incubation with 
biotinylated secondary antibody and with 
Vectastain ABC-AP reagent, according to the 
manufacturer's instructions. The reaction was 
developed with Sigma Fast RedTM tablets 
(Sigma-Aldrich, MO, USA). For the 
counterstaining it was used Mayer's haematoxylin 
solution (Sigma-Aldrich, MO, USA) and slides 
were mounted in Aquamount medium (BDH 
Laboratory Supplies, Pl, UK). Negative controls 
were performed by the replacement of the primary 
antibodies by rabbit IgG.  
 
Cell cycle analysis 
Cells were plated at a density of 5 x 10
4
 cells in 6-
well dishes and exposed to the differentiation 
medium in the absence or presence of AEA (10 
μM), plus CB1/CB2 antagonists for 6 d. After 
tripsinization, cells were centrifuged (260 g, 5 min, 
4ºC), resuspended in PBS and fixed in 70% cold 
ethanol. After fixation, cells were centrifuged and 
resuspended in 0.5 ml of DNA staining solution (5 
µg/ml Propidium Iodide (PI), 0.1% Triton X-100 
and 200 µg/ml Dnase-free Rnase A) overnight at 4 
ºC. DNA content was analysed by flow cytometry 
based on the acquisition of 40 000 events (with a 
 threshold of 100 000) in a BD Accuri™ C6 
(Becton–Dickinson Jose, CA, U.S.A) equipped 
with BD Accuri C6 software. Detectors for the 
three fluorescence channels (FL-1, FL-2 and FL-3) 
and for forward (FSC) and side (SSC) light scatter 
were set on a linear scale. Debris and cell 
aggregates were gated out, and singlets and 
doublets cells were analysed using a two-
parameter plot of FL-2-Area to FL-2-Width of PI 
fluorescence. Data was analysed using BD Accuri 
C6 Software. The anti-proliferative effects were 
indicated by the percentage of cells in G0/G1, S 
and G2/M phases of cell cycle. The results are the 
mean of at least three independent experiments 
carried out in triplicate. 
 
Western blot 
St-T1b cells and HdF (both non-differentiated and 
undergoing differentiation) were treated in the 
presence or absence of AEA (10 μM). Cell 
extracts were prepared in a potassium phosphate 
buffer containing a cocktail of protease inhibitors. 
Protein concentrations were measured by 
Bradford assay. Samples (20 μg) were run on 
10% SDS polyacrylamide gels and transferred to a 
nitrocellulose membrane. Membranes were 
incubated with primary antibody (Table 2) at 4 °C 
overnight. Membranes were then washed and 
incubated with goat anti-rabbit IgG horseradish 
peroxidase–conjugated antibody, and detected by 
enhanced chemiluminescence Western Bright™ 
ECL and exposed to x-ray film. β-tubulin was used 
as a loading control.  
 
Evaluation of mitochondrial transmembrane 
potential (Δψm)  
 
For mitochondrial transmembrane potential (ΔΨm) 
assessment, non-differentiated and cells 
undergoing decidualization were treated with or 
without AEA (10 µM) and stained with DiOC6(3) 
(30 nM) for 30 min. PI (5 µg/ml) was added prior to 
analysis to discriminate among live cells that stain 
only with DiOC6(3) (DiOC6(3)
+
/PI
-
), early apoptotic 
cells that lost the ability to accumulate DiOC6(3) 
(DiOC6(3)
-
/PI
-
), and late apoptotic/necrotic cells 
that stain only with PI (DiOC6(3)
-
/PI
+
). As positive 
control, cells were incubated with 15 µM of the 
mitochondrial depolarizant agent carbonyl cyanide 
m-chlorophenylhydrazone (CCCP) (Sigma-Aldrich, 
MO, USA). The ΔΨm was analysed by flow 
cytometry based on the acquisition of 20 000 
events (with a threshold of 100 000) in a BD 
Accuri™ C6 (Becton–Dickinson Jose, CA, U.S.A) 
equipped with BD Accuri C6 software. Detectors 
for forward (FSC) and side (SSC) light scatter 
were set on a linear scale, while the three 
fluorescence channels (FL-1, FL-2 and FL-3) were 
set on logarithmic scale. FL-1 was used to 
measure DiOC6(3) at green fluorescence and FL-
2 and FL-3 to measure PI red fluorescence. Data 
were analysed using BD Accuri C6 Software. The 
results are the mean of three independent 
experiments carried out in triplicate. 
 
Statistical analysis 
Statistical analysis was performed using analysis 
of variance (ANOVA) followed by Tukey test for 
multiple comparisons (GraphPad PRISM version 
4.0, GraphPad Software, Inc., CA, USA).  All 
numerical data are expressed as mean ± SEM 
and differences were considered to be statistically 
significant when p < 0.05.  
 
Figure 1. Study of the decidualization 
process in St-T1b and HdF cells after 3 
and 6 days of exposure to 
decidualization stimulus. Morphological 
analysis in St-T1b cell line, by Giemsa 
staining, in non-differentiated (non-dif) (A) 
and in cells exposed for 6 d with 
differentiation stimulus (dif) (B). Similar to 
St-T1b cells, in HdF, non-differentiated 
cells (C) maintain the fibroblastic spindle-
shape, whereas after 6 d of exposure to 
decidual treatment, differentiated cells 
(D) became larger, rounded nucleus and 
with increased amount of cytoplasm. The 
purity of primary HdF was confirmed by 
the expression of the cytoskeletal 
proteins vimentin (E) and cytokeratin (F) 
by immunocytochemistry, respectively, a 
fibroblast and an epithelial cell marker. 
The mRNA levels of IGFBP-1 and PRL 
were evaluated by qRT-PCR. It was 
observed a significant increase in both 
St-T1b (G) and HdF cells (H) cells, 
particularly after 6 days of decidualization 
stimulus. (*p < 0.05 vs. Control). 
Non-dif Dif (d6) 
A B 
C D 
E F 
H 
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 Results 
Expression of decidual markers in 
decidualizing St-T1b and HdF cells 
In order to study the differentiation process, two 
endometrial cell culture systems were employed, a 
telomerase-immortalized human endometrial 
stromal cell line (St-T1b) and a primary culture of 
human decidual fibroblasts (HdF). In both St-T1b 
and HdF cell models, differentiation was induced 
for 3 and 6 days (d). The differentiation process 
was assessed by the mRNA levels of specific 
decidual markers, the prolactin (PRL) and the 
insulin like growth binding protein-1 (IGFBP-1) and 
by morphological analysis (Fig. 1). Giemsa 
staining showed that non-differentiated cells from 
St-T1b cell line (Fig. 1 A) and HdF cells (Fig. 1 C), 
maintained the elongated fibroblastic spindle-
shape, whereas decidualizing cells became larger, 
with increased amount of cytoplasm and rounded 
nucleus in both St-T1b cell line (Fig. 1 B) and HdF 
cells (Fig. 1 D). As PRL and IGFBP-1 are widely 
used biochemical markers of decidualization, gene 
transcription was analysed in non-differentiated 
and in differentiating cells upon 3 and 6 d of 
differentiation stimulus by qRT-PCR. In both St-
T1b (Fig. 1 G) and HdF cells (Fig. 1 H) the mRNA 
levels of the decidual markers were significantly 
increased, particularly in cells undergoing 
decidualization for 6 d. Therefore, the subsequent 
studies were only proceeded in cells undergoing 
differentiation during 6 d.  
 
Characterization of the Endocannabinoid 
System in St-T1b and HdF cells 
The expression of major enzymes involved in AEA 
metabolism, NAPE-PLD and FAAH, and the 
cannabinoid receptors, CB1 and CB2, were 
investigated at mRNA and protein levels by qRT-
PCR and Western Blot analysis, respectively (Fig. 
2). In St-T1b cells (Fig. 2 A, B) mRNA and protein 
levels of CB1 receptor were not affected upon 
differentiation, and it was found that these cells do 
not express CB2 receptor. No differences were 
observed in NAPE-PLD expression, while FAAH 
expression was up-regulated at both gene 
transcription and protein levels in cells undergoing 
differentiation. In HdF cells, it was found a fully 
ECS biochemical machinery (Fig. 2 A, C). CB1 
transcript and protein levels were up-regulated in 
differentiating cells, while CB2 expression 
remained unaffected. Regarding the metabolic 
enzymes, NAPE-PLD expression remained 
constant during in vitro differentiation, whilst FAAH 
was up-regulated at mRNA transcript and protein 
levels, similarly to St-T1b cell line.  
 
Anandamide effect on human endometrial cell 
viability and cell proliferation 
Non-differentiated and cells exposed to the 
differentiation medium were cultured for 6 d in the 
presence or absence of AEA (10 µM) and cell 
viability was assessed by MTT assay.  
 
CB1 
CB2 
NAPE-PLD 
FAAH 
Β-tubulin 
Dif Non-dif PC 
A 
52 
MW (kDa) 
45 
46 
67 
55 
Dif Non-dif 
St-T1b HdF 
C B 
Figure 2. Characterization of the Endocannabinoid system (ECS) by Western blot and qRT-PCR in non-differentiated (non-
dif) and differentiating cells (dif) treated for 6 days with differentiation stimulus. (A) Protein levels of the principal members of 
the ECS, in both St-T1b and HdF cells. In HdF, CB1 expression was increased in cells undergoing decidualization. St-T1b cell line, 
does not express CB2 receptor. mRNA transcript levels of the CB receptors and main metabolic enzymes of AEA, FAAH and 
NAPE-PLD in St-T1b cell line (B) and HdF cells (C). It was found that the gene encoding for FAAH was significantly up-regulated in 
decidualizing cells, in both cell models. (*p < 0.05 vs. Control). 
 In the culture conditions used, AEA did not affect 
cell viability, neither on non-differentiated (Fig. 3 
A, D) nor on cells undergoing differentiation (Fig. 3 
B, E) in both St-T1b and HdF cell models. This 
concentration was chosen because it does not 
affect cell viability and it was previously reported 
that impairs stromal cell differentiation in the rat 
model. The decidualization process involves 
extensive proliferation and differentiation of 
HESCs, thus, to investigate the role of AEA on cell 
proliferation, 
3
H-thymidine incorporation was 
examined in both non-differentiated and 
differentiating cells, in the presence or absence of 
AEA (10 µM) (Fig. 3 C, F for St-T1b and HdF cell 
models, respectively). In non-differentiated cells, 
AEA caused a decrease in 
3
H-thymidine 
incorporation of 28% in St-T1b and of 30% in HdF 
cells, compared to non-treated cells. As expected, 
cell proliferation was reduced in decidualizing cells 
compared to non-differentiated cells. However, in 
cells undergoing differentiation, AEA-treatment 
markedly decreased the rate of DNA synthesis by 
40% compared to differentiating cells, in both cell 
models.  
In order to understand this anti-proliferative effect, 
it was further explored the AEA-impact on cell 
cycle progression (Fig. 4). In non-differentiated 
cells, AEA treatment led to a cell cycle arrest at 
G2/M phase, both in St-T1b (12,37%) and in HdF 
cells (34,38%) compared to control (8,51% and 
30,16%, respectively). Upon differentiation, 
stromal cells cease to proliferate, thus, the 
differentiation stimulus, caused a significant 
increase of cells arrested at the G0/G1 phase and 
a decrease in the cellular content at the S phase, 
in both cell models. 
 
In St-T1b cells exposed to AEA during 
differentiation treatment, it was found a decrease 
in the cellular content at the G0/G1 phase, 
compared to decidualizing cells (84,77% vs. 
92,15%, respectively) and a significant arrest at 
G2/M phase of 7% compared to decidualizing cells 
(Fig. 4 A). 
A similar pattern of cell cycle distribution was 
found in HdF cells (Fig. 4 D). Consistently, during 
differentiation, in HdF cells, AEA-induced a 
decrease of cellular content at the G0/G1 phase 
compared to differentiating cells (5,32% vs. 
70,51%, respectively), and a significant cell cycle 
arrest at the G2/M phase of 13,49%, when 
compared to cells undergoing differentiation 
(40,40 vs. 26,91%, respectively).  
Analysis of decidualizing cells treated with AEA 
plus AM281, a selective CB1 antagonist, showed 
a cell cycle distribution similar to control 
differentiated cells. Moreover, when comparing to 
AEA-treated differentiating cells it was observed a 
retention at G0/G1 phase and a decrease on G2/M 
cellular content, in both cell models. 
Unexpectedly, it was noticed by Giemsa staining 
that in AEA-treated cells there was an increased 
number of bi- or multi-nucleated in cells (Fig. 4 C, 
F). The flow cytometric analysis, further confirmed 
the increased number of multi-nucleated cells (> 
2n) upon AEA-treatment (Fig. 4 A, D). In both non-
differentiated and decidualizing cells, AEA-
treatment induced at least a 2-fold increase on the 
number of bi-nucleated cells, in St-T1b and HdF 
cells.  
 
 
 
 
Figure. 3. Effect of AEA in non-
differentiated (non-dif) and 
differentiating cells (dif) viability 
and proliferation. Differentiation 
cells were treated with 
deciduogenic stimulus (cAMP, MPA 
and E2) in the absence (control 
cells) or presence of AEA (10 µM). 
Cell viability and proliferation were 
assessed by MTT and 3H-timydine 
incorporation assay, respectively. 
AEA did not affect non-
differentiated (A) and of 
differentiating (B) St-T1b cells 
viability. In St-T1b cell line AEA-
inhibits cell proliferation in both cell 
types (C). AEA did not affect non-
differentiated (A) and of 
differentiating (B) HdF cells viability. 
AEA decreased DNA synthesis in 
non-differentiated and in 
differentiating HdF cells (F). 
(*p < 0.05 vs. Control; #p < 0.05 vs. 
Dif). 
  
In contrast to St-T1b, approximately 6% of non-
differentiated HdF cells were > 2n. In addition, it 
was observed that pre-incubation with CB1 
receptor antagonist did not prevent the 
appearance of bi-nucleated cells in both cell 
models. To clarify the mechanism underlying AEA-
induced retention at G2/M, the expression of cyclin 
B1, a key regulator of G2/M transition was 
investigated by Western blot. As shown in Fig.5 A 
and B, in AEA-treated St-T1b and HdF cells 
respectively, cyclin B1 protein levels were not 
altered neither in non-differentiated nor in cells 
undergoing decidualization. To further explore the 
signalling pathway underlying AEA-induced effect, 
Akt activation was investigated by Western blot. 
AEA prevented Akt phosphorylation in both non-
differentiated and differentiating cells compared to 
respective controls, in both cell models (Fig. 5 C, 
D). In addition, as in rats, it has been suggested 
that mitochondria play a crucial role in decidual 
polyploydization [14], the impact of AEA in  
 
mitochondrial transmembrane potential (ΔΨm) 
was studied by flow cytometry on non-
differentiated and in cells undergoing 
differentiation. However, in both cell types and in 
St-T1b (Fig 6 A) and HdF cells (Fig 6 B), AEA did 
not induce any alteration in the ΔΨm. 
 
Anandamide interferes with cell differentiation 
To explore the role of AEA upon the differentiation 
process, both St-T1b and HdF cells were induced 
to differentiate in the absence or presence of AEA 
(10 µM) for 6 d, and mRNA expression of IGFBP-1 
and PRL genes was analysed by qRT-PCR. As 
expected, mRNA levels of both genes were 
significantly higher in decidualizing cells compared 
to non-differentiated cells. However, as shown in 
Fig. 7, the transcript levels of both decidual 
markers were significantly decreased in cells 
induced to differentiate in the presence of AEA, to 
similar levels of those found in non-differentiated 
cells. 
Figure 4.  Impact of AEA on cell cycle progression by flow cytometry. In St-T1b cell line, AEA led to a G2/M retention and 
appearance of bi-nucleated cells (A), as shown in Giemsa staining of differentiated (B) compared to differentiated AEA-treated St-
T1b cells, which present bi-nucleated cells (arrows) (C). In HdF cells, it was also observed a significant arrest at G2/M phase and 
the accumulation of bi-nucleated cells in AEA-treated cells (D). This effect was also detected in Giemsa staining when comparing 
differentiated cells (E) and differentiated AEA-treated cells (F). In both cell models, pre-incubation with CB1 antagonist, AM281, 
prevented cell cycle arrest at G2/M, and induced retention at G0/G1, similar to decidualizing cells. Arrows indicate the presence of 
bi- and multi-nucleated cells. (*p < 0.05 vs. Control; #p < 0.05 vs. Dif; ap < 0.05 vs. Dif (AEA). 
  
To investigate the influence of cannabinoid 
receptors, cells were exposed to the differentiation 
stimulus in the presence of AEA (10 µM) and pre-
incubated with a CB1 antagonist (AM281) or a 
CB2 antagonist (AM630). In both ST-T1b (Fig. 7 
A) and HdF (Fig. 7 B) cells, pre-incubation with 
AM281, significantly counteracted the AEA-
reduction on decidual markers gene expression to 
levels similar of control decidualizing cells. The 
contribution of CB2 in the case of HdF was also 
studied, although the expression of the genes 
encoding the decidual markers were not affected. 
 
Discussion  
Decidualization involves extensive stromal cell 
proliferation and differentiation, which is followed 
by programmed cell death, although the 
underlying molecular mechanisms remain unclear. 
Endocannabinoids (eCBs) are novel lipid 
mediators and may be important players in the 
molecular network composed by hormones, 
cytokines and growth factors that orchestrates 
human decidualization. It is known that AEA  
 
mediates several cellular events ranging from cell 
proliferation, differentiation and apoptosis, 
dependent on the biological system/environment 
and cellular context [6]. Nevertheless, its role upon 
the human decidualization is not yet disclosed. In 
rats, it was previously described that the metabolic 
enzymes expressed in decidual cells are the main 
controllers of eCB levels throughout pregnancy 
[15]. In addition, AEA induces apoptosis in rat 
primary decidual cell cultures [9, 16] and interferes 
with decidualization process [10]. Herein it was 
proposed a novel role for AEA as a modulator of 
human decidualization, through an effect on both 
endometrial stromal cell proliferation and 
differentiation.  
For the first time, in this study, it was 
characterized, the endocannabinoid system (ECS) 
in St-T1b and HdF cells, in both non-differentiated 
cells and in cells undergoing differentiation. In 
contrast to HdF, St-T1b cells do not express CB2 
receptor. In contrast to St-T1b cell line, CB1 
expression was up-regulated in HdF decidualizing 
cells, which is in agreement with a previous study 
[17]. In this regard, it is possible that the endocrine 
environment to which HdF cells have been 
exposed may influence CB1 expression. In 
addition, it was shown that FAAH expression was  
up-regulated during the decidualization process, 
while NAPE-PLD expression remained constant in 
both cell models. These findings are consistent 
with the expression of the metabolic enzymes in 
human endometrium during the menstrual cycle, 
in which FAAH protein levels are higher in the 
secretory phase, which corresponds to the 
differentiation of stromal cells, compared to the 
proliferative phase [18]. 
 
Figure 5. Effect of AEA on Cyclin B1 and Akt protein levels by Western blot. Cyclin B1 expression was not altred by AEA-
treatment in both non-differentiated and cells undergoing differentiation in St-T1b cell line (A) and HdF cells (B). However, AEA 
prevented the activation of Akt in both non-differentiated and cells undergoing decidualization in St-T1b cell line (C) and HdF cells 
(D).   
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Figure 6. Effect of AEA on mitochondrial 
transmembrane potential (ΔΨm). Neither in St-T1b cell 
line (A) nor in HdF cells (B) AEA-treatment affect ΔΨm. 
  
Moreover, our findings further support the 
recognized role of FAAH, the main AEA degrading 
enzyme, as a metabolic gatekeeper decreasing 
AEA uterine levels and promoting the implantation 
process [7].  
In this study, it was also demonstrated that AEA 
inhibited endometrial cell proliferation supported 
by a reduction on the synthesis of DNA, cell cycle 
arrest at the G2/M phase and accumulation of bi-
nucleated cells. The later features were observed 
in non-differentiated and in cells undergoing 
decidualization, in both cell models, suggesting 
that it is not cell specific. In addition, it was found 
that AEA-treatment did not affect cyclin B1 
expression, whereas it prevented phosphorylation 
of Akt, a signalling pathway involved in cell 
survival and proliferation [19]. In fact, it has been 
reported that diminished Akt phosphorylation is 
associated with inhibition of actin polymerization 
and consequently cytokinesis failure, appearance 
of multi-nucleated cells and cell growth inhibition 
[20]. Moreover, as previously described, the 
accumulation of bi-nucleated cells and cell cycle 
arrest at the G2/M phase may also result from 
aberrant mitosis and failed cytokinesis, or defects 
in mitotic spindle checkpoint [21-23]. Therefore, it 
may be suggested that although cells progress 
through G2/M phase, they may fail to undergo 
cytokinesis, probably due to a direct effect of AEA. 
 
 
Interestingly, the association of polyploidy with the 
decidualization process has already been 
reported. In rodents, endoreduplication 
(polyploidy) of endometrial stromal cells is well 
established [24-26]. In fact, it has been reported 
that decidual polyploidy develops as mono- or bi-
nucleated cells due to blockage in G2/M phase of 
the cell cycle, as a result of a mitotic cycle without 
cytokinesis [27]. Moreover, decidua with 
insufficient polyploidy limits implantation [26, 28], 
whereas aberrant decidual polyploidy was also 
shown to be detrimental to this process [29]. In 
human decidualization, the presence of bi-
nucleated cells has been reported by Tang et al 
(1993) [30], and is a topic of increasing recognition 
in the literature, however their significance has 
never been addressed. Nevertheless, in the 
conditions used, AEA-induced bi-nucleation in 
both non-differentiated and in cells undergoing 
decidualization, in a mechanism independent of 
CB1 receptor activation.  
Decidualization is a key event for successful 
implantation, in which endometrial stromal cells 
cease to proliferate and undergo a differentiation 
process into decidual cells, being the latter 
induced by an increase in intracellular cAMP 
levels. In this study, it was demonstrated that AEA 
significantly decreased the decidual markers 
transcript levels, PRL and IGFBP-1, upon in vitro 
decidualization, in a mechanism dependent on 
Figure 7. mRNA transcript levels of specific human decidual marker genes. Upon AEA-treatment, IGFBP-1 and PRL 
expression was significantly decreased in St-T1b cell line (A) and HdF cells (B). AEA-induced decreased of mRNA expression of 
both markers reverted by CB1 antagonist, AM281, in both St-T1b and HdF cells. In HdF, no reversion was observed in the case of 
AM630, the CB2 antagonist. (*p < 0.05 vs. Control; #p < 0.05 vs. Dif; ap < 0.05 vs. Dif (AEA).  
 CB1 activation. Since CB1 activation is known to 
inhibit adenylate cyclase, it is likely that the AEA 
inhibitory effect on decidualization is mediated 
through CB1-induced decrease in cAMP 
production. In addition, it was shown that AEA 
prevented cell cycle arrest at G0/G1 phase 
during in vitro decidualization, which may hamper 
cell differentiation. Reinforcing the involvement of 
CB1 receptor on the inhibitory effect caused by 
AEA, it was shown that the pattern of cell cycle 
distribution of cells treated with a selective CB1 
antagonist (AM281) plus AEA was similar to the 
untreated cells undergoing differentiation. Thus, 
our findings suggest that AEA may be a negative 
modulator of human stromal cell differentiation. 
Kessler et al [17] previously showed that WIN-55-
12, a full CB1 agonist, inhibited decidualization 
through CB1 by triggering an apoptotic pathway. 
However, in our conditions, AEA-effect was not 
accompanied by cell death. Despite in rats it has 
been suggested that mitochondria may play a role 
in polyploydization, no alterations in the 
mitochondrial transmembrane potential were 
observed.  
Understanding the molecular signature that 
underlies the role of AEA on endometrial stromal 
cells further elucidates the cellular and molecular 
basis that governs decidualization. Two major 
breakthroughs are highlighted in the present 
study. On one hand, AEA inhibits endometrial 
stromal cell proliferation and leads to the 
appearance of bi-nucleated cells, which may 
consequently impair stromal cell differentiation. On 
the other hand, AEA also act as a negative 
modulator of endometrial stromal cell 
differentiation through a CB1 dependent 
mechanism. In women, AEA levels fluctuate 
during menstrual cycle, reaching high levels at the 
proliferative phase and low levels at the secretory 
phase, which corresponds to the beginning of the 
differentiation process [15, 31]. Moreover, it is 
widely accepted that AEA levels are strictly 
regulated mainly by FAAH activity. Altogether, our 
findings corroborate that a balance tone of AEA 
uterine levels is crucial for human decidualization, 
and thus elevated levels of this eCB, due to 
cannabinoids consumption or to FAAH 
deregulation, may impair this process. We also 
suggest that AEA may be a central tie bridging 
both steps of the decidual program, stromal cell 
proliferation and differentiation. Decidualization is 
a remarkable feature of human reproduction. It is 
known that impaired decidualization process is 
associated with a variety of reproductive 
disorders, ranging from infertility, recurrent 
miscarriage, utero-placental interaction disorders. 
Nowadays, failure of the endometrium to achieve 
a receptive state is consider as a major cause of 
infertility as well as the rate-limiting step in 
assisted reproductive technology. Therefore, 
unveiling the molecular mechanisms that underpin 
decidualization process is of great importance to 
improve reproductive outcome. 
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Abstract 
The human endometrium undergoes cyclical growth, differentiation and regression periods throughout the 
reproductive life. The process in which endometrial stromal cells proliferate and differentiate into decidual 
cells, named decidualization, prepares a receptive endometrium for implantation. Prostaglandins (PGs) and 
endocannabinoids (eCBs) are crucial mediators of this process. We have recently reported that the eCB 
anandamide (AEA) interferes with rat stromal cell differentiation, and on the other hand, PGs are also crucial 
for decidualization. Therefore, in this study, we analysed AEA levels, both in non-differentiated and in 
decidualizing human endometrial stromal cells by liquid chromatography-mass spectrometry (LC-MS), and 
investigated the impact of AEA on PG release and COX-2 expression in human endometrial stromal derived-
cell differentiation. For that, an ultra-performance LC-MS/MS method to measure prostaglandin E2 (PGE2) and 
prostaglandin F2α (PGF2α) in biological samples was developed and validated. We demonstrate that AEA 
levels in decidualizing cells are lower than in non-differentiated cells, whereas PGE2 levels and COX-2 
expression are up-regulated. Thus, low AEA levels may be essential for the onset of decidualization. On the 
contrary, in AEA-treated cells undergoing decidualization, a decrease of COX-2 protein levels and PGE2 
production, in a manner dependent on cannabinoid receptor 1 activation was observed. Overall, these findings 
suggest that a deregulation of the intricate network that drives cell differentiation may compromise pregnancy 
and fertility. It is clinically relevant to understand the mechanisms that influence eCB and PG levels in the 
endometrium because they may shed light on the sequence of events that lead to a successful pregnancy.  
 
Keywords: Endocannabinoids, Prostaglandins,  Decidualization, UPLC-MS/MS 
 
 
Abbreviation list: AA – arachidonic acid; AEA - anandamide, cAMP - 8-Bromoadenosine 3',5'-cyclic monophosphate; CB1 
– cannabinoid receptor 1; COX-2 - cyclooxygenase-2; E2 – estradiol; eCBs – endocannabinoids; electrospray ionization 
source – ESI; fatty acid amide hydrolase – FAAH; human decidual fibroblasts – HdF; human-immortalized endometrial 
stromal cell line - St-T1b; insulin-like growth factor-binding protein 1 - IGFBP-1; liquid chromatography-mass spectrometry - 
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- PGE2; prostaglandin F2α - PGF2α; prostaglandin-ethanolamides - PG-EAs; relative standard deviation - RSD; ultra-
performance liquid chromatography-mass spectrometry - UPLC-MS/MS;  
 
Introduction 
Decidualization denotes the transformation of the 
endometrial stromal compartment, into specialized 
decidual cells, which is essential to accommodate 
pregnancy (1). In humans, it is widely accepted 
that a manifold of paracrine and autocrine cues, 
as growth factors, cytokines and transcription 
factors, drive decidualization (2). Although major 
advances are being put forward into the 
identification of the (bio)molecular repertoire that 
orchestrates the receptive endometrium, this is not 
yet clarified. Amongst other lipid messengers, 
prostaglandins (PGs) and endocannabinoids 
(eCBs) are considered as pivotal mediators.  
Prostaglandins, derived from cyclooxygenase-2 
(COX-2), are believed to play an important role in 
regulating decidualization, angiogenesis, vascular 
remodelling, trophoblast invasion and extracellular 
matrix remodelling during implantation (3). In rats, 
COX-2 expression is mostly restricted to 
implantation sites, and COX-2
−/−
 mice are infertile, 
with defective implantation and decidualization 
(4,5). In humans, deregulated PG signaling has 
recently been correlated to poor endometrial 
receptivity, infertility and uterine malignancies 
(6,7).  
Like PGs, endocannabinoids (eCBs) are 
endogenous mediators derived from membrane 
phospholipids. They regulate several cellular 
events, such as cell proliferation, differentiation 
and survival, with different outcomes depending 
on the molecular targets and cellular context 
(8). Over the last years, eCBs have been identified 
as novel players in the complex molecular network 
that coordinates implantation and decidualization 
(9). In rats, it was shown that anandamide (AEA) 
controls decidual turnover (10) and, recently, we 
have demonstrated that AEA interferes with rat 
decidual phospholipid membrane composition 
(11). The tight regulation of AEA levels throughout 
the differentiation process and implantation is of 
crucial importance, as aberrant eCB signaling may 
lead to spontaneous miscarriage and poor 
pregnancy outcome (12,13). Anandamide (AEA) 
and other known eCBs act primarily on G-protein-
coupled cannabinoid receptors 1 and 2 (CB1 and 
CB2), and are metabolized by specific enzymes, 
which altogether form the eCB system (ECS). 
Fatty-acid amide hydrolase (FAAH) metabolizes 
AEA into arachidonic acid (AA) and ethanolamine. 
The former provides a source for PGs production 
by COX-2. Furthermore, AEA is a direct substrate 
of COX-2 oxidative metabolism, producing 
prostaglandin-ethanolamides (PG-EAs) (14). 
Recently, it was recently shown that in rat decidual 
cells, AEA-induced cell death through COX-2 
oxidative metabolism (15). On the other hand, in 
rats, it has also been reported that AEA limits the 
progression of the stromal differentiation process 
and that PGs are important mediators for the 
differentiation process (16). The regulatory PG 
function in early human pregnancy events is not 
yet clear. Although the evidence underlying the 
crosstalk between eCBs and PGs are particularly 
apparent upon decidualization, little is known 
about this network. Therefore, in this study, we 
aimed to decipher the effect of AEA on COX-2 
expression and PG production during in vitro 
decidualization of human endometrial stromal 
derived-cells.  
 
Material and methods 
St-T1b cell line culture 
The human endometrial stromal cell line (St-T1b) 
was kindly supplied by Dr. Birgit Gellersen from 
Endokrinologikum Hamburg, Hamburg, Germany. 
This cell line was obtained from uterine biopsy 
samples at the time of hysterectomy from benign 
gynaecological disorders and immortalized with 
human telomerase reverse transcriptase (hTERT) 
(17). These cells were maintained at 37 ºC with 
5% CO2 in DMEM/F-12 medium supplemented 
with 10% charcoal-stripped fetal bovine serum 
(CT-FBS), 1 nM 17-β-estradiol (E2), 1 μg/ml insulin 
and 2% penicillin-streptomycin-amphotericin B.  
Cells from 3 to 10 subpassages were used in 
these studies. 
 
Primary cultures of human decidual fibroblast 
(HdF) 
The protocol for the isolation of cells from term 
decidua was based on Richards et al, 1995 (18). 
Caesarean or vaginal delivery normal human 
placentas (38–40 weeks of gestation) from 
Caucasian women, living in Porto region and aged 
24–36 years old, were obtained from Centro 
Materno-Infantil do Norte, Porto. All the 
procedures using term placentas were performed 
according to the Ethical committee of Centro 
Materno-Infantil do Norte. The decidua basalis 
was scraped from the chorionic membrane, 
dissected into small pieces and enzymatically 
digested in PBS with collagenase (1 mg/ml) for 1 h 
at 37 ºC with gentle shaking. The suspension was 
then centrifuged at 260 g for 6 min. The pellet was 
resuspended with ammonium chloride (0.8 %) 
solution for red blood cells lysis, at 37 ºC. The 
resulted suspension was filtered through a 40 μm 
nylon mesh and centrifuged at 260 g for 10 min. 
The isolated cells were maintained at in 37 ºC with 
5% CO2 in DMEM/F-12 medium supplemented 
with 10% CT-FBS, 1 nM E2, 1 μg/ml insulin and 
2% penicillin-streptomycin-amphotericin B. After 
24 h, the non-adherent cells were removed and 
the cells were grown to confluence and sub-
cultured. By subpassage 3, essentially all the cells 
were proliferating fibroblasts. Cells from 3 to 10 
subpassages were used in these studies. For 
each assay, it was used decidual fibroblasts from 
five different placentas and studies were 
performed independently (n=5). 
 
Differentiation treatment 
In vitro differentiation was induced in minimal 
medium MM1 (DMEM/F-12 medium 
supplemented with 2% CT-FBS and 2% 
penicillin/streptomycin), containing 1 μM 
medroxyprogesterone acetate (MPA; Sigma-
Aldrich, St. Louis, MO, USA), 10 nM estradiol  (E2, 
Sigma-Aldrich, St. Louis, MO, USA), and 0.5 mM 
of 8-Bromoadenosine 3',5'-cyclic monophosphate 
(cAMP, Sigma-Aldrich, MO, USA) or 0.05 mM 
cAMP, for St-T1b and HdF, respectively. The 
differentiation process was induced for 4 or 6 
days, and the medium was changed every 2 or 3 
days, respectively. Cell differentiation was 
confirmed by morphological analysis and 
measurement of insulin-like growth factor-binding 
protein 1 (IGFBP-1) by ELISA. Cells were treated 
with the differentiation medium (cAMP, MPA and 
E2) in the presence or absence of AEA (10 µM). In 
order to investigate the role of CB receptors, cells 
were also pre-incubated with selective CB 
antagonists, AM251 and AM281 (CB1 
antagonists, 1 µM) and AM630 (CB2 antagonist, 1 
µM) for 30 minutes before the addition of AEA (10 
µM). Non-differentiated cells treated in MM1 in the 
absence or presence of AEA (10 µM) were used 
as a control.  
 
Measurement of IGFBP-1 in cell culture 
medium by ELISA 
IGFBP-1, one of the main secretory products of 
human decidual cells, widely used as a 
biochemical marker of the decidualization process, 
was measured in culture medium from 
endometrial stromal cells by ELISA kits 
(BioVendor, Laboratorni medicina, Brno, Czech 
Republic) according to the manufacturer's 
instruction, and normalized to total DNA levels. 
The sensitivity of this assay was 0.2 ng/ml. 
 
Western blot 
St-T1b cells and HdF (both non-differentiated and 
undergoing differentiation) were cultured and 
treated as described for 4 days. Cell extracts were 
prepared in a potassium phosphate buffer (20 mM 
Tris-HCl, 100 mM of NaCl, 1mM of EDTA) 
containing a cocktail of protease and phosphatase 
inhibitors (P8340, Sigma-Aldrich, St. Louis, USA). 
Protein concentrations were measured by 
Bradford assay. Samples (80 μg) were run on 10 
% SDS polyacrylamide gels and transferred to a 
nitrocellulose membrane. Membranes were then 
incubated with goat COX-2 antibody (sc-1745, 
Goat, Santa Cruz Biotechnology, CA), at 4 °C 
overnight. Membranes were then washed and 
incubated with Rabbit anti-goat IgG horseradish 
peroxidase–conjugated antibody (sc-2922, Santa 
Cruz Biotechnology, CA) and detected by 
enhanced chemiluminescence. β-tubulin (h-235, 
Rabbit, Santa Cruz Biotechnology, CA) was used 
as a loading control. The signal intensity of each 
band was quantified by densitometry (BIO-
PROFIL Bio-1D++, Vilber Lourmat, France).  
 
LC-APCI-MS method for AEA quantification 
For AEA quantification, cell pellets from non-
differentiated and from cells differentiated for 6 
days were collected and stored at -80 ºC. 
Extraction, purification and quantification of AEA 
were performed as previously described (19). Cell 
pellets were homogenized and AEA extracted with 
acetone containing internal deuterated standards 
([
2
H]8 AEA) for AEA quantification by isotope 
dilution LC-MS. The lipid-containing organic phase 
was dried down, weighed, suspended in methanol 
and pre-purified by open bed chromatography on 
silica gel. The AEA-containing fraction was 
obtained by eluting the column with 90:10 (v/v) 
chloroform/methanol, and used for AEA 
quantification by liquid chromatography-
atmospheric pressure chemical ionization-mass 
spectrometry (LC-APCI-MS), using selected ion 
monitoring at M
+1
 values. Results are expressed in 
pmol/mg and were normalized to total amount of 
lipid content. 
  
UPLC-MS/MS based protocol for PGE2 and 
PGF2α quantification 
Sample preparation  
To the homogenized sample (2 ml) in a 4 mL 
screw-capped glass vial, it was added 25 µL of d4-
PGE2 (IS, 1 mg/L) and 2 mL ethyl acetate, 0.8 g 
MgSO4 and 0.2 g NaCl. After shacking for 5 min, 
the sample was centrifuged at 3500 g for 5 min. 
The upper-layer phase was transferred to a new 
vial, and evaporated to dryness under a gentle 
stream of nitrogen. The sample was resuspended 
in 100 µL of the mobile phase and injected in the 
UPLC-MS/MS system. 
 
UPLC-MS/MS analysis 
Separation and quantification of the target 
analytes were performed by using a liquid 
chromatography Acquit UPLC system interfaced 
to a triple quadrupole mass selective detector 
Micromass Quattro micro API™ (Waters, Milford, 
MA, USA). The injection volume was set at 10 µL. 
The chromatographic separation was carried out 
with a BEH C18 column (1.6 µm, 2.1 mm x 150 
mm (i.d.)) from ACQUITY UPLC, at a flow rate of 
0.20 mL min
-1
. The mobile phases were (A) 5% 
ammonium acetate (5 mM) in ultra-pure MilliQ 
water and (B) MeOH (UPLC grade, VWR, 
Radnor, PA) in an isocratic gradient. Mass 
spectrometry analysis was performed with an 
electrospray ionization (ESI) source in the 
negative (ESI-) ion mode for all the analytes. 
Nitrogen was used as the nebulizer gas. The 
optimum MS parameters were: capillary, 3.00 kV; 
extractor, 2 V; RF Lens, 0.5 V; Source 
Temperature, 150ºC; Desolvation Temperature, 
350ºC; Desolvation Gas Flow, 350.0 L/h; Cone 
Gas Flow, 60.0 L/h; LM Resolution, 13.0; Ion 
energy, 1.0; Entrance, 1; Exit, 2; Multiplier, 650. 
All analyses were done in multiple reaction 
monitoring (MRM) mode. The UPLC-MS/MS 
settings and ESI source parameters were 
optimized by manual infusion of standards with a 
syringe pump and acquisition of the respective 
daughters’ spectrum after collision in the 
quadrupole. The optimized parameters are 
summarized in Table 1. The analytical method 
validation was performed according to the 
guidelines of the FDA (U.S.F.D.A.—FDA, (2001)). 
The parameters studied were linearity, limit of 
detection (LOD), limit of quantification (LLOQ), 
precision, accuracy and recovery. 
 
Statistical analysis 
Statistical analysis was carried out by Student's t-
test to compare difference between the control 
and the test groups. PGE2 quantification statistical 
analysis was carried out by t-student and One-way 
ANOVA and followed by Tukey test (GraphPad 
PRISM v. 6.0, GraphPad Software, Inc., San 
Diego, CA, USA). The results are the mean of at 
least five independent experiments performed in 
triplicate. Data were expressed as mean ± SEM 
and differences were considered to be statistically 
significant at p < 0.05. 
 
Results 
AEA levels in non-differentiated and 
decidualizing endometrial stromal cells  
As expected, secretion of IGFBP-1, the main 
secretory product of decidual cells, was higher in 
decidualizing cells compared to non-differentiated 
HdF and St-T1b cells (Fig. 1 A, B). In cells 
undergoing decidualization, AEA treatment 
caused a significant decrease of IGFBP-1 release, 
to levels similar of those found in non-
differentiated cells.  
To explore the role of AEA in the endometrial 
environment, its levels were measured by LC-
APCI-MS, in both non-differentiated and 
decidualizing cells. AEA levels were lower in 
stromal cells undergoing differentiation than in 
non-differentiated cells. In HdF cells (Fig. 1 C), 
endogenous AEA levels were 14.3 pmol/mg, while 
they significantly decreased to 4.9 pmol/mg in 
decidualizing cells. In non-differentiated St-t1b 
cells we found 5.2 pmol/mg of AEA, as compared 
to 1.82 pmol/mg in cells undergoing differentiation 
(Fig. 1 D). Interestingly, in both cell types, AEA 
levels were 3-fold lower in decidualizing cells as 
compared to non-differentiated cells. 
 
UPLC-MS-MS based protocol for PGE2 and 
PGF2α quantification/Method Validation 
The deprotonated molecules of PGE2 and PGF2α 
were detected at m/z 351 and 354, respectively 
during negative ion electrospray mass 
spectrometry (Fig. 2). Collision induced 
dissociation of the [M-H]- ions, producing 
abundant fragments m/z 333, 315, 271, and 263, 
247 and 193, respectively for PGE2 and PGF2α. 
The product ion tandem mass spectra are shown 
in Figure 2 and Table 1. The most abundant 
product ion of each analyte, PGE2 and PGF2α, was 
selected for the quantitative analysis, and 
corresponded to m/z 271, and 247 respectively. 
The corresponding transition of m/z 355 to 275 
was monitored for the deuterated internal standard 
(IS) d4-PGE2 (Fig. 2 E, F). The chromatograms of 
PGE2, PGF2α and d4-PGE2 are shown in Fig 2 
respectively. The linearity of the method was 
evaluated by analyzing different concentrations 
between 0.05 nM and 100 nM for PGE2 and 
between 1 nM and 100 nM for PGF2α (Fig. 3).  
 
Figure 1 – IGFBP-1 levels in cell culture medium by ELISA and AEA levels in endometrial stromal cells by 
LC-APCI-MS. IGFBP-1 levels in the cell culture medium of non-differentiated cells (non-dif), decidualizing cells (dif 
6d) in the presence or absence of in HdF cells (A) and the St-T1b cell model (B). (*p < 0.05 vs. Control; #p < 0.05 
vs. Dif 6d). C) Anandamide levels in non-differentiated and decidualizing HdF cells by LC-APCI-MS. A 3-fold 
decrease of AEA levels was observed in decidualizing cells. D) AEA levels were significantly lower in St-T1b 
decidualizing cells compared to non-differentiated. (*p < 0.05 vs. Control; ** p < 0.01 vs. Control; #p < 0.05 vs. Dif 
6d). (HdF, Human decidual Fibroblasts; St-T1b, telomerase-immortalized human endometrial stromal cell line; non-
dif, non-differentiated cells; dif 6d, decidualizing cells after 6d of differentiation treatment).  
  
 
 
 
Calibration curves were constructed by plotting the 
analyte/IS (ratio of analyte, ARE) obtained against 
the concentration of each analyte. The calibration 
curves were linear for both PGs, presenting a 
coefficient of determination (r2) of 0.9994 and 
0.9982, for PGE2 and PGF2α, respectively (Table  
2). The linearity of the method was tested at least 
five times using the matrix-matched calibration 
(cell culture medium).  
The lower limit of detection (LOD, defined as a 
signal-to-noise of 3:1), was 0.05 nM for PGE2 and 
0.5 nM for PGF2α (Table 2). The limit of 
quantification (LOQ, which corresponds to the 
lowest concentration measured with acceptable 
accuracy, precision and relative standarddeviation 
(%RSD) <20%), was for PGE2 and PGF2α 
respectively, 1 nM and 5 nM (Table 3).  
The intra- and inter-assay precision was 
determined using samples spiked with three 
different concentrations 1 nM, 0.2 µM and 2 µM of 
each PG. Intra-assay precision was evaluated by 
performing the extraction and analysis of six  
 
 
 
 
 
 
spiked samples in the same day while inter-assay 
precision was determined by analysis of triplicate  
spiked samples in three different days for a period 
of 3 weeks. The relative standard deviation 
(%RSD) was below 12% for both intra- and inter-
assay precision (Table 3 and Fig. 3 A, B), which is 
within the normal criteria accepted for bio-
analytical methods validation. These results 
indicate that this method showed excellent 
accuracy and precision. The recovery of PGE2 and 
PGF2α from the cell culture medium was 
determined at different concentrations by 
comparing the peak areas of spiked and 
processed cell culture medium with the 
corresponding standard solutions analyzed 
without extraction. Extraction efficiency was 
evaluated considering the following formula: R = 
(SS-NS) x 100 / As (where SS is the value 
obtained from spiked sample, NS from not spiked  
sample and As the amount added). Extraction 
efficiency was higher than 98% for each analyte 
(Table 4 and Fig. 3 C, D) suggestive of a good 
efficiency of the extraction procedure. 
Figure 2 – Negative ion UPLC-MS/MS chromatograms. Total ion chromatograms (TIC) of standard solutions of PGE2 (A.1), PGF2α 
(B.1) and d4-PGE2 (C.1), and spectrum of PGE2 (A.2), PGF2α (B.2) and d4-PGE2 (C.2).   
  
AEA-induced effect on PGE2 levels 
PG levels were measured in the culture medium of 
non-differentiated cells and of cells undergoing 
differentiation, using both cell models (Fig. 4). As 
expected, PGE2 was significantly increased in 
decidualizing cells, both in the HdF (9.18 nM) and 
St-t1b cell line (6.99 nM), as compared to non-
differentiated cells (2.99 nM and 1.63 nM, 
respectively). However, PGF2α was not detected 
probably because below the detection limit.  
Due to the inverse pattern between AEA and PG 
levels during decidualization, we hypothesized 
that decidualization follows a reduction on AEA 
levels and an increase on PG levels. Therefore, 
the effect of AEA on PG production was also 
examined, in non-differentiated cells and during 
stromal cell differentiation (Fig. 4).  
Strikingly, in undifferentiated stromal cells, AEA-
treatment induced a similar 1.8-fold increase on 
PGE2 levels in both cell types. However, during 
decidualization, AEA significantly reduced PGE2 
secretion, to levels similar to those found in non-
differentiated cells. In HdF cells, PGE2 decreased 
from 9.18 nM in decidualizing cells to 2.88 nM in 
AEA-treated decidualizing cells, which represents 
a 3-fold decrease (Fig. 4 A, C). In St-T1b 
decidualizing cells, PGE2 levels were 6.99 nM and 
AEA-treatment induced a reduction of almost 5-
fold to 1.4 nM.  
To explore the involvement of cannabinoid 
receptors, cells undergoing decidualization were 
pre-incubated with selective antagonists for either 
CB1 (AM251 and AM281) or CB2 (AM630), before  
 
 
 
the addition of AEA. In HdF cells, the treatment 
with CB1 antagonists increased the levels of 
PGE2, to 8.37 nM and 7.42 nM, for AM251 and 
AM281, respectively. These levels were similar to 
those found in the untreated differentiated cells 
(9.18 nM), suggesting a CB1 receptor-dependent 
effect for AEA (Fig. 5 A, C). Instead, the CB2 
antagonist did not reverse the AEA-inhibitory 
effect, as levels (2.33 nM) were similar to those in 
decidualized AEA-treated cells. In the St-T1b cell 
line, CB1 antagonists also significantly 
counteracted the inhibition of PGE2 levels (5.22 
nM and 4.78 nM) (Fig. 4 B, C). The effect of the 
CB2 antagonist was not investigated since, as 
described previously, this receptor was not 
detected in this cell line (20).  
 
Correlation between PGE2 concentrations and 
COX-2 protein expression 
As expected, decidualizing cells express higher 
levels of COX-2 than non-differentiated cells. AEA 
treatment did not affect COX-2 protein levels in 
non-differentiated cells (Fig. 5). However, in both 
cell types, when undergoing decidualization, AEA-
induced a significant decrease in COX-2 protein 
levels, which was directly correlated with the 
reduction of secreted PGE2. As CB1 antagonists 
were able to counteract the AEA-inhibitory effect 
on PGE2 production, we also investigated the role 
of CB1 receptors in COX-2 protein expression. 
Pre-incubation with CB1 antagonists reversed the 
AEA-inhibitory effect on COX-2 protein levels in 
the St-T1b cell line, and attenuated it in HdF cells 
(Fig. 5 C, D).  
Figure 3 – Linearity and Recovery efficacy of the UPLC-MS/MS method. Linearity of the method evaluated by calibration 
curves of standard solution of PGE2 (A), PGF2α (B). Calibration curves were constructed by plotting the analyte/ARE ratio against 
the concentration of each analyte. r2 of 0.9994 and 0.9982 for PGE2 and PGF2α was obtained, respectively. The recovery of PGE2 
(C) and PGF2α (D) from cell culture medium was determined at different concentrations by comparison of the peak area of the 
spiked and processed samples with the corresponding standard solution analysed without extraction.  
  
 
 
 
 
 
 
 
Discussion 
The human endometrium is a dynamic tissue that 
in every menstrual cycle undergoes periods of 
proliferation, differentiation and programmed cell 
death. Reproductive disorders, such as 
implantation failure and infertility, have been linked 
to poor endometrial receptivity and impaired 
decidualization (2). Over the last years, the 
development of lipidomic approaches has enabled  
the identification of lipid mediator candidates for 
endometrial receptivity. Of these, 
endocannabinoids (eCBs) and prostaglandins 
(PGs) have emerged as key players. Recently, we 
reported that the eCB AEA limits the process of rat 
stromal cell differentiation, possibly through COX-
2 down-regulation (16). Nonetheless, the potential 
eCB-PG crosstalk beneath the maternal 
endometrium was not disclosed. In the present 
study we suggest that levels of AEA might disrupt 
COX-2 expression and PG release, with a 
mechanism dependent on CB1 activation.  
On the other hand, we found that AEA decreases 
the levels of IGFBP-1, suggesting that it may also  
interfere with the decidualization process. 
 
 
 
 
 
 
 
 
 
Although this study uses two in vitro models of 
human endometrial stromal derived-cells, which 
are nevertheless documented as suitable models 
for differentiation studies, we hypothesized that 
the impact of AEA on IGFBP-1 levels may, at least 
in part, reflect a deregulation of PG metabolism  
and signaling pathways. We report, for the first 
time, the AEA levels in non-differentiated and in 
decidualizing human stromal cells, in both St-T1b 
and HdF cells. Upon differentiation, AEA reached 
very low levels in both cell models, suggesting that 
this eCB may be important for maintaining stromal 
cells in an undifferentiated state and that its 
temporal down-regulation may trigger the decidual 
reaction. Consistently, it has been previously 
described that AEA plasma levels fluctuate 
through the menstrual cycle with lowest levels 
found during the mid-luteal phase, which coincides 
with the decidualization process (21). Moreover, it 
is widely accepted that a local tone of AEA in the 
human endometrium is primarily regulated by 
FAAH expression, which is the major enzyme 
responsible for AEA hydrolysis (22).  
 
Figure 4 – PGE
2
 quantification levels by the developed UPLC-MS/MS method. A) PGE
2
 measurement in the culture medium of 
HdF cells. PGE
2
 secretion was significantly increased in decidualizing cells. AEA-treatment reduced PGE
2
 levels in differentiated 
cells. Pre-incubation with CB1 antagonists abolished the AEA-inhibitory effect, while CB2 antagonist (AM630) did not affect PGE
2
 
production, as levels were similar to AEA-treated cells. B) PGE
2
 measurement in St-T1b cells. Differentiation treatment significantly 
increased PGE2 levels, whereas AEA-induced a 4-fold decreased. C) PGE
2
 levels measurements in the cell culture medium in both 
HdF and St-T1b. Results are expressed the mean ± SEM of at least five independent experiments  (***p < 0.001 vs. Control; **** 
p < 0.0001 vs. Control; #### p < 0.0001 vs. Differentiated; ΦΦΦ p < 0.001 vs. Dif (AEA); ΦΦΦΦ p < 0.0001 vs. Dif (AEA)). 
 Thus, a deregulation of eCB signaling may lead to 
inappropriate decidualization and, consequently, 
compromise embryo implantation and 
establishment of pregnancy. As previously 
mentioned, eCBs and COX-2-derived PGs are 
emergent mediators during early pregnancy. In 
humans, PGs are elevated during the receptive 
period (23). In this sense, in rodents, low AEA 
levels correlate with uterine receptivity (24). In the 
rat uterus, during the window of the implantation 
period, lysophosphatidic acid increased FAAH 
activity, reduced AEA levels and up-regulated 
COX-2 expression (25). Furthermore, the pattern 
of COX-2 expression in the pregnant rat uterus 
suggests a fundamental role during embryo 
implantation and decidualization (4,5). In animal 
models, PG signaling has been implicated in 
increased vascular permeability, stromal 
decidualization, embryo development and 
extracellular matrix remodelling during  
implantation (3). Although, in humans, still little is 
known about the role of PGs in decidualization. 
Achache et al (7) reported defective endometrial 
PG synthesis in women with repeated failures of in 
vitro fertilization, and thereby poor receptivity for 
embryo implantation. The potential use of PGs as 
biomarkers for endometrial receptivity and early  
 
pregnancy failure has increasingly been explored 
(23). However, limitations in PG measurement by 
GC-MS and by unselective immunoassays have 
hampered the thorough profiling of these 
molecules in human samples, and hence 
narrowed the translation of knowledge from 
preclinical studies and animal models into a 
clinical benefit. LC-MS based methods, relying on 
their sensitivity, high selectivity and simplicity of 
sample preparation, have evolved as tools for 
quantifying PGs (26,27). In the present study a 
fast, simple, sensitive/precise and accurate UPLC-
MS/MS based method was developed to measure 
PGE2 and PGF2α in the cell culture medium, with a 
limit of quantification 100-times lower for PGE2 (1 
nM vs 100 nM) than the method previously 
described by Cao et al (26). A more sensitive 
protocol for the quantification of PGF2α, which is 
lower than those described previously (27), was 
also developed. Nevertheless, in either ST-T1b 
and HdF cells we could not detect PGF2α. We 
believe that the method developed and used in 
this study to investigate the effect of AEA on PG 
levels in differentiating stromal cells, might be 
useful also for future works towards the 
identification of PGs as biomarkers for endometrial 
receptivity and early pregnancy failure. 
Figure 5 – COX-2 protein levels evaluated by Western Blot. A) In HdF cells, differentiation treatment was accompanied by an 
up-regulation of COX-2 expression. AEA-treatment decreased COX-2 protein levels; this effect was attenuated by CB1 
antagonists. B) Similarly to HdF, in St-T1b cells, COX-2 was up-regulated in differentiated cells, and AEA induced a down-
regulation of COX-2, mediated through CB1 receptor. C) Quantification of the COX-2 expression. Β-Tubulin was used as a control. 
(AU) arbitrary units (# p < 0.05 vs. Differentiated; Φ p < 0.05 vs. Dif (AEA)). 
As expected, PGE2 levels were higher in 
decidualizing stromal cells compared to non-
differentiated cells, and this was accompanied by 
an increase in COX-2 protein levels, in both cell 
models. Interestingly, AEA and PGs levels are 
inversely related during differentiation. In order to 
understand the intricate crosstalk between eCB 
and PG underlying human differentiation, the 
effect of AEA on PGE2 levels was also 
investigated by the UPLC-MS/MS method 
developed. The most striking of the present study 
was the dual effect of AEA in the control of PGE2 
release. In undifferentiated stromal cells, AEA-
treatment led to a slight increase of PGE2 levels, 
whereas, in cells undergoing decidualization, 
AEA-inhibited PGE2 production through a CB1-
dependent mechanism. Interestingly, these dual 
effects of AEA on PGE2 levels further corroborates 
the importance of the down-regulated AEA levels 
in the onset of stromal cell differentiation and/or 
negative control of decidualization. A previous 
study reported that eCBs modulate PG production 
in the fetal membrane in late pregnancy, rather 
than in maternal tissue explants (28). Yet, while 
this previous study used term decidual explants, 
herein we describe AEA-induced effects in cells 
undergoing decidualization. In support of our 
findings, we observed that AEA induced a down-
regulation in COX-2 protein levels. This effect was 
also attenuated by CB1 receptor antagonists in 
HdF cells and totally reversed in St-T1b cells, and 
directly correlated with AEA effect on PGE2 levels. 
Therefore, it is tempting to speculate that AEA 
effect on PG levels in differentiating cells is due to 
a corresponding inhibitory effect on COX-2 
expression.  
Overall, we provide strong evidence that 
deregulated AEA levels, through CB1 activation, 
interfere with PGE2 production and signaling, 
which may interfere with the onset and 
progression of stromal cell differentiation. To our 
knowledge, this is the first study to identify and 
quantify the crosstalk between eCBs and PGs 
during human endometrial stromal cell 
differentiation, and its potential implication in 
human reproduction. Therefore, these findings 
provide a molecular framework for the delicate 
dialogue among eCBs, PGs and stromal cell 
differentiation, which may be crucial for uterine 
embryo receptivity, implantation and fertility. In the 
near future, measurement of eCB and PG 
concentrations may be translated into clinic 
benefits, not only to monitor the acquisition of 
receptive endometrium, but also to diagnose 
potential pregnancy disorders or infertility.   
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Abstract 
The endocannabinoid system (ECS) has been recognized as a crucial player in pregnancy events such as 
implantation, decidualization and fetoplacental development. It was previously demonstrated that anandamide 
(AEA), the main endocannabinoid, induces apoptotic cell death in primary rat decidual cell cultures. In 
addition, alterations of AEA levels have been implicated in several reproductive disorders. Cyclooxygenase-2 
(COX-2) is a major enzyme expressed in endometrium, and its involvement on female reproductive system 
has evolved along the last years. Recently, COX-2 oxidative metabolism is emerging as a key mediator of 
AEA-induced effects. In this study we aimed to disclose the role of anandamide in human endometrial stromal 
cell fate. We found that AEA has an antiproliferative activity through a direct effect on cell cycle progression by 
inducing G2/M retention and accumulation of binucleated cells. Moreover, AEA triggers mitochondrial 
apoptotic pathway by causing loss of the mitochondria transmembrane potential, activation of endoplasmic 
reticulum stress and oxidative stress in a COX-2-dependent manner. Human endometrium is a remarkable 
dynamic tissue. During the reproductive life, the endometrium undergoes a balanced cellular turnover, 
between proliferation, differentiation and shedding by apoptosis. Imbalance of endometrial homeostasis is 
likely associated with pregnancy disorders, infertility and endometrial pathologies. Therefore, we hypothesize 
that altered AEA levels may deregulate endometrial cell turnover and consequently interfere with cellular 
events crucial for implantation and decidualization. In conclusion, our findings bring insights on the impact of 
altered eCBs levels upon human endometrium. 
 
Introduction 
The human endometrium is a highly dynamic 
tissue that undergoes continuous cycles of 
remodeling. The endometrial stromal cells 
proliferate and then differentiate, at the secretory 
phase of the menstrual cycle, into specialized 
decidual cells in a process named decidualization. 
Decidualization prepares the uterus for the 
“implantation window”, the period in which a 
successful pregnancy can be established through 
a suitable dialog between the activated blastocyst 
and the receptive endometrium [1]. In the absence 
of pregnancy and upon hormonal withdrawal, high 
cellular turnover in the stromal compartment 
culminates in menstruation and enables the 
subsequent tissue regeneration [2]. Apoptosis 
plays a key role in tissue remodeling and 
maintenance of cellular homeostasis throughout 
the menstrual cycle [3]. Cell death is essentially 
detected at the late secretory and menstruating 
endometrium, while very little apoptosis was 
observed during the proliferative phase or at the 
beginning of the secretory phase [4].  
The Endocannabinoid System (ECS) has 
emerged as a key modulator of multiple 
physiological and pathophysiological processes, 
including in a myriad of reproductive events like 
implantation, decidualization and placental 
development [5, 6]. Anandamide (AEA) is 
currently the best studied endocannabinoid (eCB). 
It is synthesized from membrane phospholipids by 
the enzyme N-acylphosphatidylethanolamine-
phospholipase D (NAPE-PLD). After exerting its 
effects, AEA is hydrolysed inside the cell mainly 
by Fatty Acid Amide Hydrolase (FAAH), an inner 
cellular membrane enzyme, into arachidonic acid 
and ethanolamine. The former is the precursor for 
prostaglandins production by cyclooxygenase 
enzyme (COX-2) [7]. Nevertheless, AEA may also 
be subjected to COX-2 oxidative metabolism, 
forming prostaglandin-ethanolamides or 
prostamides (PMEs) [8]. The complexity of the 
ECS is further supported by the wide range of 
signaling pathways underlying eCBs-effects. 
Besides the typical cannabinoid receptors (CB), 
which are G protein-coupled receptors (GPCRs) 
[7], AEA may intracellularly activate other targets, 
like the transient receptor potential vanilloid 1 
(TRPV1) ion channel [9], or the peroxisome 
proliferator-activated receptor (PPAR) [10]. 
Moreover, lipid-rafts appear to play a role in an 
AEA-induced signaling cascade independent of 
receptor pathways [11]. In that way, AEA 
modulates cell fate-related processes, like cell 
death, proliferation and differentiation by triggering 
different pathways, involving mitogen-activated 
protein kinase (MAPK) kinase, production of 
ceramide, enzyme expression regulation, induced 
oxidative stress, and others [7]. Particularly, in 
AEA-induced cell death it has been described not 
only the involvement of CB receptors and/or 
TRPV1 [12-14], but also other receptor 
independent mechanisms. For instance, in non-
tumor Chang liver cells AEA-induced cell death is 
mediated by ceramide and p38/JNK pathway [15], 
while in cholangiocarcinoma cells, is dependent 
upon ceramide synthesis and Fas/FasL 
localization in lipid rafts [16]. In 
cytotrophoblast cells, AEA effects involve a 
crosstalk between intrinsic and extrinsic apoptotic 
pathways [17]. In primary rat decidual cell 
cultures, AEA induces cell death through a 
mechanism partially dependent on CB1 and 
through COX-2 oxidative metabolism [12, 13, 18]. 
In addition, AEA-apoptotic cell death in colon and 
skin cancer cell lines is also mediated by COX-2 
metabolism [19, 20]. 
In humans, AEA levels fluctuate throughout the 
menstrual cycle through an interplay regulated by 
FAAH activity, sex steroids and gonadotrophins 
[21, 22]. In fact, altered AEA levels have been 
associated with implantation failure, pregnancy 
disorders and infertility and also with impaired 
responsiveness of human endometrium to 
deciduogenic cues. A balanced cellular turnover in 
the endometrium during menstrual cycle is of key 
significance, and it is widely accepted that eCBs 
modulate the choice between cell proliferation, cell 
death and differentiation. Also, non-differentiated 
endometrial stromal cells are present in both the 
endometrium and decidua [23, 24]. Nevertheless, 
up to date, the role of AEA in human endometrial 
stromal cells has never been addressed. Thus in 
this study we studied the role of AEA role on 
uterine endometrium stromal cells’ fate.  
 
Material and methods 
Cell culture 
The human endometrial stromal cell line St-T1b, 
obtained from uterine biopsy samples at the time 
of hysterectomy for benign gynaecological 
disorders, and immortalized with human 
telomerase reverse transcriptase (hTERT) [25] 
was kindly supplied by Dr. Birgit Gellersen  
(Endokrinologikum Hamburg, Hamburg, 
Germany). Cells were maintained at 37 °C with 
5% CO2 in DMEM/F-12 medium (Gibco Invitrogen 
Corporation, Carlsbad, CA, USA) supplemented 
with 10% charcoal-stripped fetal bovine serum 
(CT-FBS) (Gibco Invitrogen Corporation, 
Carlsbad, CA, USA), 1 nM 17-β- estradiol (E2) 
(Sigma-Aldrich Corporation, Saint Louis, MO, 
USA), 1 μg/ml Insulin (Sigma-Aldrich Corporation, 
Saint Louis, MO, USA) and 2% penicillin-
streptomycin (Gibco Invitrogen Corporation, 
Carlsbad, CA, USA).  Initially, cells were incubated 
for 24 h in completed medium and then 
experiments were performed in DMEM/F-12 with 1 
% CT-FBS.  
 
Cell viability and cell proliferation 
Cells were cultured in 96-well plates at a density 
of 0.5 x 10
4
 cells/ well for 24, 48 and 72 h in the 
presence or absence of AEA (0.1 μM – 50 μM) 
(Tocris Bioscience, MN, USA). After incubation, 
MTT (0.5 mg/ml) (Sigma-Aldrich Corporation, 
Saint Louis, MO, USA) was added to each well 
and the plate was incubated for 2 h 30 min at 37 
°C. The formazan was dissolved by the addition of 
DMSO: isopropanol mixture (3:1) and quantified 
spectrophotometrically (540 nm). LDH release in 
the culture medium was measured by using 
CytoTox 96 nonradioactive cytotoxicity assay kit 
(Promega, Madison, WI, USA) according to the 
manufacturer’s protocol. To verify the role of 
cannabinoid and vanniloid receptors, the 
antagonists of CB1 (AM251 and AM281; 0.1 µM, 
Tocris Bioscience, MN, USA) and of TPVR1 
(capsazepine; 1 µM) (Tocris Bioscience, MN, 
USA) were added 30 min prior to AEA. As 
previously reported, St-T1b cell line does not 
express CB2 receptor, therefore it was not object 
of study. Cells were also pre-incubated with two 
inhibitors of ceramide biosynthesis, L-cycloserine 
and fumonisin B1 (1 µM, St Cruz Biotechnology, 
CA, USA) for 30 min and a membrane cholesterol 
depletor, methyl-β-cyclodextrin (MCD; 0.5 mM) (St 
Cruz Biotechnology, CA, USA) for 1 h 30 min. In 
order to study the involvement of COX-2 and 
oxidative stress, cells were pre-incubated with 
selective COX-2 inhibitor, Celecoxib (0.1 μM) (St 
Cruz Biotechnology, CA, USA), and N-
acetylcysteine (NAC 1mM) (St Cruz 
Biotechnology, CA, USA) 30 min before AEA 
treatment. At the concentrations used in the study 
none of the compounds per se affected cell 
viability.  
To evaluate the effect of AEA on St-T1b cell 
proliferation after 48 h of treatment, thymidine 
incorporation assay was performed. Thymidine 
incorporation was assessed by the addition of 3H-
thymidine (0.5 μCi) (Amersham Biosciences 
Corporation, NJ, USA) in the last 36 h of the 48 
hof AEA- treatment. After a cycle of 
freezing/defrosting, cellular content was harvested 
and after addition of a scintillation cocktail, 
3
H-
thymidine incorporation was determined in a 
scintillation counter (LS 6500, Beckman 
Instruments, CA, USA). All results are expressed 
as relative percentage of the untreated control 
cells.  
 
Morphological studies 
Morphological alterations induced by AEA (10 μM) 
treatment for 48 h were evaluated by Giemsa and 
Hoechst staining. After treatment, cells plated in 
24-well culture plates (1.2 x 10
4
 cells/well) were 
fixed with methanol and stained with Giemsa. For 
Hoechst staining, cells were exposed to 0.5 µg/ml 
Hoechst 33342 (Sigma-Aldrich Corporation, Saint 
Louis, MO, USA) for 20 min and examined under 
a fluorescence microscope (Eclipse Ci, Nikon, 
Tokyo, Japan) equipped with an excitation filter 
with maximum transmission at 360/400 nm and 
processed by Nikon NIS Elements v 4.0 software. 
 
Cell cycle analysis 
After treatment, cells were fixed in 70% cold 
ethanol and resuspended in 0.5 ml of DNA 
staining solution (5 µg/ml Propidium Iodide (PI), 
0.1% Triton X-100 and 200 µg/ml Dnase-free 
Rnase A in PBS) (Sigma-Aldrich Corporation, 
Saint Louis, MO, USA) overnight at 4 °C. DNA 
content was analysed by flow cytometry based on 
the acquisition of 40 000 events (with a threshold 
of 100 000) in a BD Accuri™ C6 (Becton–
Dickinson, San Jose, CA, USA) equipped with BD 
Accuri C6 software. The three fluorescence 
channels (FL-1, FL-2 and FL-3) and detectors for 
forward (FSC) and side (SSC) light scatter were 
set on a linear scale. Debris and aggregates were 
gated out and cell singlets and doublets were 
analysed using two-parameter plot FL-2-Area to 
FL-2-Width of PI fluorescence. The 
antiproliferative effect was indicated by the 
percentage of cells in G0/G1, S and G2/M phases 
of cell cycle.  
 
Determination of caspase -3/-7 activities 
The Caspase-Glo® 3/7 (Promega Corporation, 
Madison, WI, USA) was used to evaluate caspase 
3/7 activities according to the manufacturer’s 
protocol. Cells were seeded in 96-well white plates 
and treated with AEA (10 μM), in the presence or 
absence of Celecoxib and NAC. Staurosporine 
(STS, 100 nM) (Sigma-Aldrich Corporation, Saint 
Louis, MO, USA) was used as a positive control. 
The resultant luminescence was measured in 
relative light units (RLU) using a 96-well 
Microplate Luminometer (BioTek Instruments, 
Vermont, USA). 
 
Evaluation of mitochondrial transmembrane 
potential (Δψm)  
Mitochondrial transmembrane potential (Δψm) 
was studied by flow cytometry, using 3,3-
dihexyloxacarbocyanine iodide DiOC6(3) at 30 nM 
for 30 min at 37 °C (Gibco Invitrogen Corporation, 
Carlsbad, CA, USA) and. After treatment, PI (5 
µg/ml) was added prior to flow cytometry analysis 
to discriminate among 
live cells that stain only with DiOC6(3)
+
/PI
-
, early 
apoptotic cells that lost the ability to accumulate 
DiOC6(3)
-
/PI
-
, and late apoptotic/necrotic cells that 
stain only with DiOC6(3)
-
/PI
+
. As positive control, 
cells were incubated with 15 µM of the 
mitochondrial depolarizing agent carbonyl cyanide 
m-chlorophenylhydrazone (CCCP) (Sigma-Aldrich 
Corporation, Saint Louis, MO, USA). Detectors for 
forward (FSC) and side (SSC) light scatter were 
set on a linear scale. Detectors were set on 
logarithmic scale, the FL-1 was used to measure 
DiOC6(3) at green fluorescence and FL-2 and FL-
3 to measure PI red fluorescence. Data was 
analysed using a BD Accuri C6 software based on 
the acquisition of 20 000 events (with a threshold 
of 100 000). 
 
Intracellular reactive oxygen species (ROS) 
measurement 
For assessment of ROS production it was used 
2,7-dichlorodihydrofluorescein diacetate (DCDHF-
DA) probe (Sigma-Aldrich Corporation, Saint 
Louis, MO, USA) at 15 µM. After treatment, cells 
were washed with PBS and incubated with 
DCDHFDA for 1 h, at room temperature. As 
positive control, cells were incubated with phorbol 
12-myristate 13-acetate (PMA) (Sigma-Aldrich 
Corporation, Saint Louis, MO, USA) at 25 ng/ml. 
The fluorescence intensity was detected using a 
Microplate Fluorimeter (BioTek Instruments, 
Vermont, USA) with excitation and emission 
wavelengths of 480 nm and 530 nm, respectively. 
The results were expressed in relative 
fluorescence units (RFU). For all measurements, 
basal fluorescence was subtracted.  
 
Western blot 
Cells were cultured with AEA in the presence or 
absence of Celecoxib for 48 h. Cell extracts were 
prepared in potassium phosphate buffer 
containing a cocktail of protease inhibitors. Protein 
concentrations were measured by Bradford assay. 
Samples (20 μg) were run on 10% SDS-
polyacrylamide gels and transferred to a 
nitrocellulose membrane. Membranes were then 
incubated with antibodies against goat-COX-2 
(1:100) (sc-1745, St Cruz Biotechnology, CA, 
USA), rabbit-CHOP-10 (1:100) (sc-575, St Cruz 
Biotechnology, CA, USA), rabbit-pAkt-123 (1:100) 
(sc-7985-R, St Cruz Biotechnology, CA, USA) and 
rabbit-Akt (1:200) (sc-8312, St Cruz 
Biotechnology, CA, USA) at 4 °C overnight. 
Membranes were then washed and incubated with 
goat or rabbit IgG horseradish peroxidase- 
conjugated antibody (St Cruz Biotechnology, CA, 
USA) and detected by enhanced 
chemiluminescence, Western Bright™ ECL and 
exposed to x-ray film. β-Tubulin (1:500) (H-235, 
Santa Cruz Biotechnology, CA, USA) was used as 
a loading control.  
 
Statistical analysis 
Statistical analysis was performed using analysis 
of variance (ANOVA) followed by Tukey test for 
multiple comparisons (GraphPad PRISM version 
4.0, GraphPad Software, Inc., San Diego, CA, 
USA). The results are the mean of at least three 
independent experiments carried out in triplicate.  
All numerical data are expressed as mean ± SEM 
and differences were considered to be statistically 
significant when p < 0.05.  
 
Results 
AEA-effects in St-T1b cells viability and cell 
proliferation 
To evaluate the effects of AEA in St-T1b cells 
viability and cytotoxicity, MTT and LDH assays 
were performed after 24, 48 and 72 h of treatment. 
As shown in Fig. 1A, it was found a decrease in 
cell viability for concentrations higher than 5 µM. 
At 10 µM AEA-induced a significant reduction of 
viable cells (20%), after 48 and 72 h of treatment. 
However, after 24 h of treatment, higher 
concentrations of AEA led to a marked decrease 
in cell viability, which was accompanied by the 
release of LDH, indicative of membrane integrity 
loss (Fig. 1A, B). Since, AEA at 10 µM after 48 h 
caused a reduction in cell viability without inducing 
LDH enzyme release, this concentration was 
selected for the subsequent assays. To analyse 
whether the reduction in cell viability was due to 
inhibition of cell proliferation, thymidine 
incorporation assay was carried out. As shown in 
Fig. 1C, AEA-induced a drastic decrease in the 
rate of DNA synthesis (50%). To further explore 
the underlying mechanism associated with the 
antiproliferative activity of AEA, it was evaluated 
its effect on cell cycle progression by measuring 
DNA content by flow cytometry. In AEA-treated 
cells, a decrease in the percentage of cells at 
G0/G1 phase was observed compared to control 
(64,89 % vs 83,25 %, respectively). It was also 
found a significant cell cycle arrest of 18 % at 
G2/M phase compared to control (Fig. 1D). 
 
 
 In addition, it was also observed a drastic increase 
in the number of bi- or multinucleated cells (11%) 
upon AEA-treatment. Giemsa and Hoeschst 
staining further confirmed the presence of 
binucleated cells (Fig. 2B, D). Through cell 
counting it was shown a significant increase of 
10% in binucleate cells when compared to control 
(Fig. 2F). Additionally, it was observed that AEA-
treated cells exhibited a decrease in cell density 
and some typical features of apoptotic cell death, 
such as chromatin condensation (Fig. 2B, D).  
 
AEA-induced cell viability loss in a 
cannabinoid and vanniloid receptor-
independent manner  
To further understand the possible involvement of 
cannabinoid and vanniloid receptors on AEA-
induced effects in St-T1b cell viability, cells were 
pre-incubated with two selective CB1 receptor 
antagonists (AM251 and AM281 at 0.1 µM) and 
Capsazepine, a selective antagonist of TPVR1 (1 
µM). At these concentrations the compounds per 
se did not affect cell viability. 
 
 
Moreover, it was found that neither CB1 nor 
TPVR1 receptor antagonists counteracted the 
AEA-induced decrease in cell viability (Fig. 3A). In 
addition, it has been proposed that ceramide 
production may also be involved in eCB-induced 
apoptosis. Therefore, St-T1b cells were pre-
incubated with two inhibitors of ceramide 
biosynthesis, L-cycloserine (1 µM), an inhibitor of 
serine palmitoyltransferase, and fumonisin B1 (1 
µM), an inhibitor of ceramide synthase. As shown 
in Fig. 3A, neither L-cycloserine nor fumonisin B1 
were able to revert the effect in cell viability. Also, 
the inhibitors per se did not affect cell viability.  
On the other hand, as eCBs may also interact with 
cell membrane regions enriched with cholesterol, 
it was shown that the membrane cholesterol 
depletor, methyl-β-cyclodextrin (MCD at 0.5 mM) 
reverted the AEA-induced decrease in cell viability 
(Fig. 3A). As oxidative stress is also associated 
with eCB induced cell death, cells were pre-
incubated with an antioxidant, N-acetylcysteine 
(NAC 1 mM). In the presence of NAC, the 
reduction of cell viability was prevented.  
 
Fig. 1- Effects of Anandamide in St-T1b cell viability and cell proliferation. (A) AEA at 10 µM induced a decreased of 20 % in 
cell viability after 48 h. Only concentrations higher than 10 µM caused the release of LDH enzyme (B). (C) Cell proliferation was 
evaluated by measuring the rate of DNA synthesis. 10 µM AEA-induced a drastic decrease on the rate of DNA synthesis. (D) The 
study of AEA effects on cell cycle distribution showed a G2/M retention and appearance of binucleated cells. (*p < 0.05 vs. Control; 
#p < 0.05 vs. AEA). 
 Furthermore, as recent studies evidenced the role 
of COX-2 oxidativemetabolism mediating AEA 
activity, the effect of a selective COX-2 inhibitor 
(Celecoxib) was analysed. Celecoxib (0.1 µM) 
significantly reverted the loss of St-T1b cells 
viability (Fig. 3A). As the involvement of COX-2 
became apparent, the effect of AEA on COX-2 
protein levels was investigated by Western blot. 
However, upon 48 h of treatment, COX-2 protein 
levels were not significantly altered in AEA-treated 
cells (Fig. 3B). To get further insight on the role of 
Celecoxib and NAC in the AEA-induced 
antiproliferative effect, it was also investigated 
their effects in cell cycle progression. Neither 
Celecoxib nor NAC were able to prevent the cell 
cycle arrest at G2/M phase, nor the percentage of 
binucleated cells observed with AEA treatment. 
Nevertheless, as can be seen in Fig. 1D, it was 
found a significant S phase accumulation in cells 
treated with AEA plus Celecoxib (13%) or AEA 
plus NAC (12%) vs the respective control (7,64% 
and 5,90%, respectively) or AEA-treated cells 
(8.02 %).  
 
Oxidative stress, endoplasmic reticulum stress 
and Δψm loss underlying AEA-induced 
apoptosis: a role for COX-2 oxidative 
metabolism To explore the ability of AEA to 
induce cell death in St-t1b cells, the effects on 
mitochondrial transmembrane potential (Δψm) 
loss and the activity of caspase 3/7 were 
evaluated by flow cytometry and luminescence, 
respectively. Once the generation of intracellular 
reactive oxygen species (ROS) may also be 
implicated with apoptosis, ROS production was 
assessed by fluorometry. As shown in Fig. 4A, 
after AEA treatment, it was observed a significant 
increase in the percentage of depolarized cells 
(44,68 %) comparing to control (5%). Comparing 
to the ratio treatment/control, it was also observed 
that Celecoxib partially reverted the AEA-induced 
Δψm loss, whereas the antioxidant NAC was not 
able to counteract this effect (Fig. 4A). In addition, 
it was detected a significant increase of 28% in the 
generation of ROS in AEA-treated cells compared 
to control, an effect counteracted by pre-
incubation with Celecoxib and NAC (Fig. 4B).   
Fig. 2 – Effects of AEA in St-T1b 
cells morphology. In AEA-treated 
cells it was found a significant 
accumulation of binucleated cells by 
Giemsa staining (arrows) (B) in 
comparison to untreated cells (A). 
Höechst staining also supported the 
presence chromatin condensation 
and binucleated cells (arrows) in 
AEA-treated cells (D) when 
compared to the control (C). (E) Cell 
counting of binucleated cells (10%) 
after treatment. (*p < 0.05 vs. 
Control). 
Fig. 3 – The involvement of AEA 
binding receptors and oxidative 
metabolism in cell viability. (A) Effect 
of selective CB and TPVR1 
antagonists plus AEA on cell 
viability.  AEA-effects are not mediated 
through receptor activation. Methyl-β-
cyclodextrin (MCD), a membrane 
cholesterol depletor completely 
reversed the AEA-induced effect on St-
T1b cell viability. Celecoxib, a selective 
COX-2 inhibitor, and NAC a potent 
antioxidant were also able to revert the 
AEA-induced decrease on cell viability. 
(B) Representative western blot 
showing that AEA did not significantly 
affect COX-2 protein expression. 
(*p < 0.05 vs. Control; #p < 0.05 vs. 
AEA). 
  
 
 
 
 
 
 
 
To confirm the presence of apoptosis, the activity 
of caspase -3/7 was evaluated. AEA caused a 
significant increase on caspase -3/-7 activity of 
approximately 20% in comparison to control. Pre-
incubation with Celecoxib and NAC showed a 
significant decrease in activation of caspase 
activity (Fig. 4C). To further clarify the apoptotic 
pathway underpinning AEA-effect, Akt 
phosphorylation was analysed by Western Blot. 
AEA inhibited the phosphorylation of Akt, an effect 
that was counteracted in the presence of 
Celecoxib (Fig. 4D).  
To investigate whether endoplasmic reticulum 
(ER) stress was underlying AEA-induced effect, 
the protein levels of the cytotoxic ER stress 
marker, the transcription factor C/EBP (CCAAT/ 
enhancer-binding protein) homologous protein, 
known as CHOP, were evaluated by Western blot. 
Upon 48 h of treatment, in AEA-treated cells it was 
observed an increase of CHOP protein levels, 
whereas in the presence of Celecoxib, CHOP 
levels were similar to control (Fig. 4E).  
 
Discussion 
The role of the endogenous cannabinoids, in 
particular AEA, upon several reproductive events, 
such as embryo implantation, decidualization,  
 
 
 
 
 
 
 
 
 
placental development and labour, has been 
extensively reviewed over the last years [6]. 
Nevertheless, still little is known about the impact 
of altered AEA levels on the human endometrial 
stromal cells. Therefore, in this study a human 
endometrium immortalized cell line (St-t1b) was 
employed to unveil the role of AEA upon cell 
proliferation, cell cycle progression and induction 
of cell death. 
Our findings revealed that AEA-induced a 
reduction in St-T1b cells viability along with a 
significant reduction in cell proliferation. The effect 
in cell viability was independent of CB and TPVR1 
receptors, but prevented by MCD, a membrane 
cholesterol disruptor, thus suggesting that AEA 
acts intracellularly. Our results also showed that 
celecoxib, a selective COX-2 inhibitor, and NAC, a 
potent antioxidant, were able to revert the AEA-
induced loss of St-T1b cells viability. In this study, 
we have further demonstrated that AEA-
antiproliferative activity was associated with a cell 
cycle arrest at G2/M phase and the appearance of 
bi- and multi-nucleated cells. Since neither 
Celecoxib nor NAC, were able to prevent these 
features, it may be suggested that AEA inhibits 
cell proliferation through a direct effect on cell 
cycle progression.  
Fig. 4 – Effect of AEA on apoptosis: ΔΨm, ER stress and oxidative stress. (A) Mitochondrial transmembrane potential (ΔΨm) 
of St-T1b cells treated with AEA (10 µM) with or without Celecoxib and NAC. Only Celecoxib partially reverted the loss of ΔΨm 
induced by AEA. Data are presented as viable cells and cells with ΔΨm loss. Cells not exposed to AEA were considered control 
cells. Cells treated with Celecoxib alone were considered control cells of AEA plus Celecoxib. While cells treated with NAC were 
considered control cells of AEA plus NAC. The ratio treatment/control is presented in bold within brackets. (B) AEA caused a 20% 
increase of ROS, an effect prevented by pre-incubation with both Celecoxib and NAC. (C) AEA caused a significant increase on the 
activity of caspase -3/-7, an effect reverted in the presence of Celecoxib and NAC. (D) AEA inhibits phosphorylation of Akt as 
showed by analysis of protein levels by Western blot. (E) AEA-induced apoptosis involves ER stress, as demonstrated by the 
analysis of CHOP protein levels which were up-regulated in AEA treated cells, an effect reverted by Celecoxib.  (*p < 0.05 vs. 
Control; #p < 0.05 vs. AEA). 
Contrary to our results, the antiproliferative effect 
of AEA in human hepatocellular carcinoma cells 
[26], human breast and prostate cancer cell lines 
appears to be dependent on CB receptors [27-29].  
Furthermore, in neuroblastoma cells this effect 
was achieved through a lipid raft-dependent 
mechanism [30]. However, in St-T1b cells, the 
AEA-induced G2/M retention and subsequent 
accumulation of binucleated cells may result from 
aberrant mitosis and failed cytokinesis, as it has 
been previosuly suggested for other studies [31, 
32]. Moreover, it has also ben reported that 
defects in mitotic spindle checkpoint, like impaired 
microtubule depolymerisation, can result in G2/M 
arrest [33, 34]. Nevertheless, the physiological 
and molecular significance of this finding has not 
yet been disclosed and is being object of study. 
Reinforcing the antiproliferative effect, it was also 
observed that AEA inhibits phosphorylation of Akt, 
a kinase of PI3k/Akt pathway, which mediates cell 
survival and proliferation [35]. Besides associated 
with an antiproliferative effect, G2/M cell cycle 
arrest may also be related with enhanced 
apoptosis [36].  
 
 
 
 
 
 
 
 
Herein, we further disclosed that AEA triggered 
the intrinsic apoptotic pathway, supported by the 
loss of ΔΨm and caspase -3/7 activity, through 
COX-2 oxidative metabolism. Moreover, the 
involvement of ROS generation and increased 
CHOP expression was also shown. Strikingly, it 
was shown that AEA-apoptotic events were 
independent of receptor activation but rather occur 
through a mechanism dependent on COX-2 
oxidative metabolism. In fact, the oxidative 
metabolism of AEA by COX-2 is a source of 
bioactive lipid messengers, named prostamides. 
The latter are emerging as mediators of AEA-
induced apoptosis in tumorigenic keratinocytes 
[20], and in colorectal carcinoma cell lines [37]. 
Moreover, in primary cultures of rat decidual cells, 
AEA-induced cell death through the main AEA-
oxidative derivative, prostamide E2 [18]. Also, in 
non-melanome skin cancer, AEA-induced ER 
stress and apoptosis are mediated by oxidative 
stress and COX-2 oxidative metabolism [20, 38]. 
As expected, Celecoxib and NAC were able to 
inhibit AEA-induced ROS production and caspase 
3/7 activity.  
 
 
 
 
 
 
 
 
Fig. 5 – Proposed mechanism of AEA action on human endometrial stromal cells. AEA inhibits endometrial stromal cell 
proliferation, as shown by the reduction on the rate of DNA synthesis, probably associated with Akt inhibition. This antiproliferative 
effect is mediated through cell cycle arrest at G2/M phase and accumulation of binucleated cells. COX-2 is a major enzyme 
expressed in the human endometrium. Hence, under the studied conditions, it is suggested that AEA may be subjected to COX-2 
oxidative metabolism giving rise to Prostamides (PMEs). In the one hand, PMEs may lead to ΔΨm loss which may induce ER 
stress and ROS production. On the other hand, it may also be that PMEs induce ER stress with consequent loss of ΔΨm and ROS 
generation. These signaling pathways will ultimately lead to caspase -3/7 activation and cell death. PI3k/Akt pathway may also be 
involved in apoptosis. Hence besides AEA, PMEs may also inhibit Akt phosphorylation. Moreover it appears that AEA may also 
cause ΔΨm loss directly. AEA – blue circles, PMEs – orange circle. 
Concerning the decline of ΔΨm, NAC was not 
able to revert this effect, suggesting that changes 
in mitochondrial dysfunction may lead to oxidative 
damage and ROS production. On the other hand, 
Celecoxib only partially prevented the loss of 
ΔΨm, indicating that AEA may, at least in part, 
directly modulate mitochondrial depolarization. 
Accordingly, it has been recently reported the 
ability of (endo)cannabinoids, but also their 
derivatives, to control mitochondrial function 
directly [39]. Although the molecular events linking 
ΔΨm, ROS and the ER stress pathway are still 
elusive, evidence connecting these distinct 
processes is increasing. Recently, the 
mitochondrial production of ROS, as a result of ER 
stress–induced Ca
2+
 release or impairment of 
endogenous antioxidant defence mechanism, has 
gained considerable importance in cell death [40-
42]. In addition, CHOP may also down-regulate 
Bcl-2 and induce the translocation of Bax to 
mitochondria leading to apoptosis [43]. On the 
other hand, mitochondrial dysfunction may also 
contribute to ER stress [44]. 
 Although ER stress can lead to ROS production, 
redox status or generation of ROS may also 
directly or indirectly (or both) affect ER 
homeostasis [40]. In response to ER stress, the 
unfolded protein response (UPR), an intracellular 
signal transduction pathway may be activated to 
promote cell survival or induce cell death through 
CHOP up-regulation [45]. Consistent with our 
results, other groups have demonstrated that ER 
stress may regulate AEA-induced apoptosis [46, 
47]. On the one hand, CHOP-induced apoptosis 
may be mediated through inhibition of the PI3K-
Akt signaling pathway [48, 49]. On the other hand, 
the association with Akt inactivation, Bad 
dephosphorylation and mitochondrial dysfunction 
and apoptosis has also been addressed [50]. 
Hence, we further unveil the mechanisms 
associated AEA-induced cell death, through an 
inhibitory effect on Akt activation via COX-2 
dependent mechanism. Herein we provide strong 
evidences on the role of COX-2 oxidative 
metabolism in AEA-induced cell death in 
endometrial stromal cells.  
In this regard, it has been recently reported that 
COX-2 mRNA expression is highest during the 
proliferative phase. Therefore, it is tempting to 
speculate that in an endometrial environment with 
high COX-2 expression, elevated AEA levels may 
represent a niche for prostamide production which 
may mediate AEA-apoptotic cell death. In 
conclusion, we describe the impact of AEA in 
human endometrial stromal cell turnover and 
propose the cellular pathways that may be 
involved (Fig. 5). Two major breakthroughs are 
highlighted: the AEA-COX-2 oxidative metabolism 
underlying-ER stress and oxidative stress, 
mitochondrial dysfunction and apoptosis and it is 
also disclosed, for the first time, an 
antiproliferative effect of AEA mediated through a 
direct effect on cell cycle progression.  
In this way, we also reinforce the relevance of 
balanced eCBs signaling upon uterine 
environment, since exacerbated AEA levels may 
interfere with endometrial cell turnover leading to 
implantation failure, inappropriate decidual 
response and/or miscarriage.  
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Discussion and general conclusions  
 
The highly dynamic nature of endometrium is a remarkable feature of reproductive 
biology and a major challenge of human infertility. Endometrial stromal cells undergo 
cyclical waves of proliferation and differentiation, which are followed by programmed cell 
death and endometrial repair. These events are imposed after a miscarriage, parturition 
and menstrual shedding. A network of cytokines, hormones, growth-factors and other 
molecules contributes to endometrial homeostasis and remodelling. In the past few years, 
endocannabinoids (eCBs) have been recognized as important mediators of several 
aspects of human physiology. Anandamide (AEA), the main eCB, is a key player in 
reproduction involved in embryo development and transport, implantation, uterine 
receptivity, pregnancy maintenance and labor. Hence, a deregulation of AEA signalling 
has been associated with poor implantation, recurrent miscarriage, pregnancy disorders, 
and infertility (333). In this way, fatty acid amide hydrolase (FAAH) and cyclooxygenase-2 
(COX-2), the degrading enzymes of AEA may be considered important controllers of 
these reproductive events. 
Previous studies have focus on the role of anandamide in rat decidual remodelling. 
Furthermore, a dual effect of AEA in primary rat decidual cell cultures has been reported. 
While at lower concentrations AEA induced cell death by a cannabinoid receptor-1 (CB1)-
dependent mechanism, higher doses caused dramatic changes in cell viability probably 
due to a cytotoxic interaction with cellular membranes (65). Endocannabinoids derive from 
cell membrane phospholipid (PL) precursors. Their levels are maintained by integral 
membrane enzymes and their biological actions are mediated through cell surface 
receptors. Therefore, membrane integrity and phospholipid composition are expected to 
interfere in eCB signalling. In this study, a novel understanding on the mechanisms 
underlying AEA effects on membrane phospholipid dynamics during rat decidual 
remodelling process was provided. Herein, the membrane phospholipid profile of rat 
primary decidual cells was characterized for the first time using a mass spectrometry 
based lipidomic approach. In addition, it was shown that AEA treatment caused an 
increment in the total PL content. Interestingly, at the molecular level, the main changes 
were observed in phosphatidylserine, phosphatidylinositol and cardiolipin relative content, 
which was correlated with the reported AEA-induced apoptosis in rat decidual cells (65). 
These changes may result from a cellular adaptation and reorganization of membrane 
phospholipidome to AEA-induced effect or rather represent a natural consequence of 
apoptosis. Furthermore, it was reported an increase in the relative content of PL bearing 
long chain fatty-acids with high degree of insaturation, in almost all molecular PL species. 
This fact is of particular importance in AEA-induced signalling and metabolism. On one 
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hand, the high degree of polyunsaturation may influence the function as well as the 
stability of membrane proteins, such as the CB receptors or the eCBs-metabolic enzymes 
(382). Besides, membrane fluidity may also be affected and, as so AEA diffusion through 
plasma membranes. In addition, lipid rafts, which are microdomains enriched in 
cholesterol, sphingolipids and glycosphingolipids are involved in the modulation of eCBs 
and CB1-mediated apoptosis (227). Therefore, alterations in membrane composition of 
lipid rafts are also likely to disrupt AEA transduction pathways. In conclusion, altered lipid 
composition of plasma membranes may interfere not only with AEA metabolism and 
uptake, but also with the enzymatic cascade triggered by AEA, directly or indirectly related 
with CB receptor activation. On the other hand, as previously referred, AEA cytotoxic 
effects on rat decidual cells may reflect direct interactions with membranes, which may 
also explain the changes observed in this study (65). Hence, the characterization of the 
phospholipidome of decidual cells may, in the future, bring insights in the pathophysiology 
of early pregnancy-related complications associated with disruption of the 
endocannabinoid system (ECS). In fact, disturbances on lipid metabolism has been 
associated with some pregnancy disorders, such as pre-eclampsia (383). 
Although the precise mechanisms by which eCBs influence reproduction are 
uncertain, COX-2 is thought to have a major role. COX-2 is increasingly being recognized 
as a “metabolic keeper” of eCB levels in several biological processes, such as 
neuroprotection, obesity, inflammation, apoptosis and cell differentiation (384). Therefore, 
the impact of the oxidative metabolism by COX-2 in AEA-induced decidual cell apoptosis 
was investigated. Regardless being constitutively expressed in rat decidual tissue, it was 
found that AEA caused a time-dependent stimulation on COX-2 expression, whereas 
FAAH expression was not affected. It was further demonstrated that selective inhibitors of 
COX-2 oxidative metabolism prevented all the previously reported apoptotic features 
induced by AEA in primary cultures of rat decidual cells, such as chromatin condensation, 
presence of apoptotic bodies, caspase-3/-7 and -9 activation, loss of mitochondrial 
transmembrane potential (ΔΨm) and increase in reactive species of oxygen (ROS) (65). A 
remarkable finding of this work was the elucidation of the physiological relevance of the 
COX-2 oxidative metabolism over AEA during the decidual remodelling process. Although 
the formation of COX-2-derived metabolites of AEA, named prostamides (PMs), has been 
known for long, their role on several human pathophysiological events is only recently 
being explored (384). In this work, PME2 and PMF2α were identified as endogenous 
mediators operating in decidual cells. In particular, it was described the molecular 
pathway involved in the pro-apoptotic effect of PME2 in rat decidual cells, which was 
similar to the one described for AEA. 
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It was previously reported that, in rat decidual cells, AEA induced apoptosis through 
p38 activation and that CB1 antagonist partially attenuated this effect, suggesting that 
multiple pathways may modulate this eCB effects (65, 213). In this study, it was further 
demonstrated that AEA-induced p38 phosphorylation was followed by COX-2 up-
regulation, but this effect was independent of CB1 activation. In fact, it has been 
postulated that eCBs may directly modulate phosphorylation of MAPK kinases under the 
regulation of cell fate boundaries between proliferation and apoptosis in several biological 
systems (29). Interestingly, it was also observed that AEA in the presence of a FAAH 
inhibitor induced phosphorylation of p38 after a short term exposure, while long term 
treatment reduced p38 activation. Nevertheless, in the presence of the FAAH inhibitor, 
COX-2 expression was drastically elevated, as well as PME2 levels. Although the 
molecular basis of such an observation is still elusive, it may indicate that excess levels of 
AEA or of its oxidative metabolites, mimicked by FAAH inhibition may trigger a negative 
feedback loop of p38 phosphorylation, as suggested in other studies (385, 386). In 
addition, it was also verified that this effect involved NF-kB pathway, which has also been 
reported by other authors (387, 388). In rats, COX-2 expression is increased upon 
endometrial stromal cell differentiation, and PGs are crucial for this process (371). In this 
study, COX-2 metabolism was described as a metabolic controller of AEA decidual 
signalling and tone. Moreover it was unraveled a novel role for PME2 as a mediator of cell 
death during rat decidual remodelling process. Thus, we hypothesize that a disruption of 
FAAH activity, and/or aberrant eCB levels, may favor COX-2-mediated oxidation of AEA 
and overwhelm the decidual regression through the formation of pro-apoptotic PMs.  
Decidualization occurs during the secretory phase of the menstrual cycle and 
prepares, each month, a receptive uterus for an eventual pregnancy. In fact, impaired 
decidualization, as a result of poor hormone responsiveness and/or impaired endometrial 
stromal cell proliferation and/or differentiation, can be associated with implantation failure, 
infertility, miscarriages, and pregnancy disorders, such as pre-eclampsia or intrauterine 
growth retardation and premature birth (389). As it was already referred, it is well 
established that a complex network of molecules coordinates endometrium differentiation, 
in which endocannabinoids and prostaglandins (PGs) may be central mediators. 
Nevertheless, the knowledge regarding the role of eCBs and PGs on human reproduction 
is scarce and provided mainly from studies in animal models. In rodents, it has been 
postulated that a tight regulation of in situ levels of AEA are indispensable for early 
pregnancy events. 
In this work, for the first time, it was demonstrated that both non-differentiated and 
differentiated human endometrial stromal cell line (St-T1b) and human decidual fibroblasts 
(HdF) derived from term placenta, possess the full ECS biochemical machinery. Contrary 
 114 
 
to HdF, which expressed both receptors, St-Tb1 cells only expressed CB1 receptor. 
Interestingly, while NAPE-PLD expression was not affected, the expression of FAAH, at 
mRNA and protein levels, was up-regulated during the decidualization process. This is 
consistent with the recognized role of FAAH as a metabolic controller of AEA uterine 
levels (390). Moreover, it was found that in decidualizing cells, AEA levels dramatically 
decreased compared to non-differentiated cells, suggesting that this eCB may be 
important to maintain stromal cells in an undifferentiated state. In fact, it was previously 
referred that during the menstrual cycle, AEA achieves the lowest levels during the 
midsecretory/luteal phase which coincides with the occurrence of the decidualization 
process (360, 364). Based on these observations, it was further explored the role of AEA 
during human decidualization process in vitro in both cell models. In this regard, it was 
verified that AEA decreased the levels of the genes encoding for IGFBP-1 and PRL, 
recognized as biochemical markers of decidualization, and these effects were reversed by 
CB1 blockade. These findings are in agreement with a previous study by Fonseca et al. 
(2015) showing that, in rats, AEA  also impairs stromal cell differentiation (239). 
Several lines of evidences point that COX-2 derived PGs may also be important 
players in this process (366). Since an intimate dialogue between eCBs and PGs appears 
to be involved in major reproductive events, the influence of AEA on COX-2 expression 
and PGE2 release was investigated. In fact, the potential use of PGs as biomarkers for 
endometrial receptivity and early pregnancy failure has increasingly been explored (375), 
though limitations in PG measurement greatly hamper the profiling of these molecules in 
human samples. To overcome this limitation, a fast, simple, with a good linearity, 
sensitive/precise and accurate UPLC-MS/MS based method was developed and validated 
to measure PGE2 and PGF2α in cell culture medium. This new method allowed the 
identification of both PGs with lower quantification and detection limits compared to others 
described in the literature (391, 392). As expected, upon endometrial stromal-derived cell 
differentiation, COX-2 protein expression and PGE2 levels were increased. The inverse 
correlation pattern between AEA and PGE2 levels observed during decidualization 
indicated that low levels of AEA and increased PGE2 levels may be essential to the onset 
of the decidual program. In addition, another major finding of this study was the dual effect 
of AEA in the regulation of PGE2 production. While in non-differentiated cells, AEA-
induced a slight increase of PGE2 levels, in cells undergoing decidualization COX-2 
expression and PGE2 release were diminished. Collectively, these findings highlight AEA 
as a novel mediator of human decidualization process in a mechanism dependent on CB1 
receptor and through deregulation of COX-2 expression and PGE2 production. Moreover, 
this work greatly contributes to the knowledge that PGE2 and AEA tone have the potential 
to be exploited as novel diagnostic biomarkers of infertility.  
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Parallel to these observations, it was found that AEA inhibited endometrial cell 
proliferation in both non-differentiated and in cells undergoing decidualization, which was 
not accompanied by programmed cell death. The ability of AEA to suppress cell 
proliferation was previously described in various tumor cell types. For instance, in human 
breast cancer and prostate cancer cell lines it appears to be dependent of CB receptors 
(203, 204, 206), while in neuroblastoma cells this effect was achieved through a lipid raft-
dependent mechanism (210). A remarkable finding of this work was the appearance of 
polyploidy upon AEA-treatment in both models and cell types, non-differentiated and 
differentiated stromal-derived cells which was independent of CB1 activation. Although the 
biological significance of this fact is not yet disclosed, evidences support that this effect 
may derive from failed cytokinesis and/or impaired microtubule depolymerisation, causing 
a G2/M blockade, as it has been suggested in other studies (393-397). In fact, in rodents, 
endoreduplication (polyploidy) of endometrial stromal cells is well established (288, 291) 
and appears to result from a mitotic cycle without cytokinesis. This fact was associated 
with the limited life-span of decidual cells and may ensure the increased protein synthesis 
required during feto-placental development (289). In human decidualization, the presence 
of bi-nucleated cells has been reported by Tang et al. in 1993 (295), and is a topic of 
increasing recognition in the literature. However, their significance has not been disclosed. 
Noteworthy, was the ability of AEA to induce bi-nucleation in both non-differentiated and 
differentiated stromal-derived cells. Curiously, the latter are genetically programmed for 
the development of polyploidy.  
Reinforcing the antiproliferative effect of AEA, it was also observed an inhibition of Akt 
phosphorylation, a kinase involved in cell survival and proliferation (398). Interestingly, 
diminished Akt phosphorylation has been associated with inhibition of actin polymerization 
and consequently cytokinesis failure, appearance of multi-nucleated cells and cell growth 
inhibition (399). Hence, this further supports the premise that AEA may directly impair 
cytokinesis. Taking into account our results showing that AEA induced changes on the 
lipid composition of rat decidual cell membranes, recent studies reported that cells actively 
regulate and modulate their lipid composition and localization during cytoplasmic division. 
In fact, it has been suggested that the metabolism of specific phospholipids, such as 
phosphatidylinositol and phosphatidylserine may be involved in the stepwise assembly 
and dynamics of regulatory complexes and cytoskeletal structures during cytokinesis 
(400, 401). In this way, deregulation of membrane phospholipid synthesis and integrity 
maintenance can have a dramatic impact on the process of mitosis and cytokinesis (402).  
Under physiological conditions, high AEA plasma levels are found in the 
follicular/proliferative phase. During this phase, a balanced cellular turnover, involving cell 
proliferation and apoptosis, mainly regulated by estrogen is responsible for the 
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endometrial regeneration, and consequently provides a privilege matrix for stromal cell 
differentiation. The impact of AEA on human endometrial stromal cells has never been 
addressed, yet we hypothesized that eCBs may also be important in coordination with 
hormones and cytokines, in the regulation of the proliferative phase of menstrual cycle. As 
referred, it is widely accepted that AEA mediates several cellular events ranging from cell 
proliferation, differentiation and cell death, dependent on the biological context and cell 
type. Moreover, the discrepancies of AEA induced effects depending on its concentration 
have been described. For instance, while low doses of AEA induced cell death in rat 
decidual cells, high doses caused a dramatic decrease of cell viability associated with the 
involvement of necrosis (65). On the other hand, eCBs were also reported to impair 
human cytotrophoblast cells syncytialization without affecting cell viability, while also being 
modulators of apoptosis (91, 240). In addition, in rat, it was postulated that while at low 
levels AEA accelerated trophoblast differentiation and outgrowth, at high levels induced 
opposite effects (57).  
In the experimental conditions used to study the role of AEA on non-differentiated St-
T1b cells, contrary to the above mentioned, AEA caused a decrease in cell viability which 
was associated with a significant reduction in cell proliferation and apoptotic cell death. In 
addition, these events were independent of CB1 activation. Nevertheless, it was observed 
that a membrane cholesterol disruptor counteracted the reduction on St-T1b cell viability 
caused by AEA. This finding, besides indicating an intracellular induced-effect, also 
underlies the importance of the phospholipid membrane integrity in regulating AEA 
biological roles. In addition, Celecoxib, a selective COX-2 inhibitor, was also able to 
prevent the loss of St-T1b cell viability, evidencing the involvement of oxidative 
metabolism on AEA-induced cell death. In this way, it was also verified that AEA triggered 
the mitochondrial apoptotic pathway, causing loss of ΔΨm, inducing endoplasmic 
reticulum (ER)-stress, ROS generation and caspase activation in a COX-2-dependent 
manner. However, Celecoxib only partially prevented the loss of ΔΨm, suggesting that 
besides the oxidative metabolites of AEA, the latter may also directly affect mitochondrial 
function. In fact, this capacity has been recently reported not only for (endo)cannabinoids 
but also for their derivatives (403). In addition, it was demonstrated that alterations in 
mitochondrial transmembrane potential preceded ER-stress and ROS production, since 
N-acetylcysteine, (NAC), an antioxidant, was not able to prevent loss of ΔΨm. In fact, in 
decidual cells, ER-stress has been associated with oxidative stress as a potential 
mechanism of early pregnancy loss (404). Thus the ability of AEA to increase ROS 
production and induce ER stress must be further investigated, though this has already 
been referred in rat decidual cells and trophoblast cells (56, 213). In addition, altered 
redox status on fetal-maternal interface has been associated with some pregnancy 
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disorders, such as pre-eclampsia (404-406). Moreover, endometrial shedding by 
apoptosis and menstruation has been associated with stimulation of COX-2 expression 
and PGF2α production through ROS-induced NF-kB activation (407). Thus, this study 
provides strong evidences on the role of anandamide and its COX-2-derivatives in human 
endometrial stromal cells. Since non-differentiated endometrial stromal cells are present in 
both the endometrium and decidua (408, 409), it may be suggested that abnormal AEA 
signalling, may interfere with important biological processes, and therefore impair the 
differentiation capacity of endometrium as well as the progression of the decidualization 
process. Moreover, in an environment privileged by a heightened COX-2 expression, 
endometrium may represent a niche for potential production of PMs that, similar to the 
referred above in rat model, may mediate AEA-apoptotic cell death and interfere with 
endometrial remodelling. 
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Final Remarks 
 
In conclusion, it was demonstrated that, depending on the environment 
conditions, AEA controls endometrial cell proliferation, differentiation and apoptotic 
cell death in a specific manner, mainly involving a particular pattern of COX-2 
regulation. In this sense, this work provides further insights on the promiscuity of 
AEA in controlling endometrial stromal cells’ fate. It is suggested that AEA may 
activate several signalling pathways, in which individual effects might be 
overloaded, and the final outcome depend on the development stage of the 
endometrium, the environmental context and the molecular targets.  
In rat decidual cells, anandamide increased COX-2 expression, via p38 
activation in cells undergoing apoptosis. Furthermore, PME2 oxidative metabolite 
was proposed as a novel mediator in endometrial remodelling. 
In human endometrial stromal-derived cells, besides characterization of the 
ECS, anandamide, the main eCB, was proposed as a negative modulator of cell 
differentiation, associated to a decrease in COX-2 protein levels and PGE2 release, 
through a CB1-dependent mechanism. Another major breakthrough of this work is 
the important role of COX-2-mediated pathways of the AEA metabolism in stromal 
endometrial cells. Hence, along with the conventional FAAH enzyme, they may be 
considered as metabolic gatekeepers of the AEA tone on human endometrium. In 
this regard, our findings further supported that eCBs and PGs may be potential 
biomarkers of human endometrium receptivity and infertility. In addition, it was 
reported for the first time, the anti-proliferative effect of AEA in endometrial stromal 
cells associated with the development of polyploidy, probably by a direct 
interference with cytokinesis. 
Understanding the molecular signature that underlies the role of AEA on 
endometrial stromal cells further elucidates the cellular and molecular basis that 
governs decidualization. Therefore we suggest that AEA may underpin the complex 
molecular network composed by hormones, cytokines and growth factors that 
orchestrates human decidualization. Nevertheless, these observations also point 
out that exacerbated AEA levels, whether resultant from deregulation of metabolic 
enzymes or Cannabis sativa consumption may impair basic cellular process 
involved in endometrial remodelling which may ultimately account for aberrant 
decidual response, pregnancy loss, miscarriage and infertility.  
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